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ABSTRACT 
 
Tara Ann Cartwright. THE BIOCHEMICAL CHARACTERIZATION OF NEURONAL 
K+ CHANNEL N-GLYCANS AND THEIR ROLE IN REGULATING K+ CHANNEL 
FUNCTION. (Under the direction of Dr. Ruth A. Schwalbe) Department of Biochemistry 
and Molecular Biology, June 2009. 
 
 
 The Kv3 and Kv1 subfamilies of voltage-gated K+ channels are critical 
components which contribute to action potential repolarization throughout the central 
nervous system. Here, it was shown that both absolutely conserved N-glycosylation sites 
of the Kv3.1, Kv3.3 and Kv3.4 proteins were occupied in the central nervous system of 
the adult rat by complex oligosaccharides. Additionally, it was demonstrated that the 
expression patterns of the Kv3 glycoproteins were different from one another throughout 
the central nervous system. Electrophoretic migration patterns of the Kv3 glycoproteins 
from different membranes of the central nervous system digested with glycosidases were 
utilized to identify the attachment of unique sialylated N-glycan structures. An 
examination of these sialylated N-glycan structures revealed that the Kv3 glycoproteins, 
along with the Kv1.1, Kv1.2, and Kv1.4 glycoproteins, were terminated with atypical 
disialyl units. Moreover, at least one of the carbohydrate chains of the Kv3.1, Kv3.3 and 
Kv3.4 glycoproteins, like Kv3.1 heterologously expressed in B35 cells, was capped with 
an oligo/polysialic acid unit. Notably, this is the first time that di/oligo/polysialyl units 
have been shown to be associated with K+ channels. Sialyl residues linked to internal 
carbohydrate residues were shown to be components of the N-glycans of the Kv1 
glycoproteins, as well as the Kv3 glycoproteins and N-CAM. To date, this unusual 
glycosidic bond for sialyl residues has not been identified on N-glycans. Whole cell 
 current measurements of glycosylated (wild type), unglycosylated mutant 
(N220Q/N229Q) and partially glycosylated mutant (N220Q and N229Q) Kv3.1 channels 
heterologously expressed in B35 cells revealed that the glycosylated Kv3.1 protein could 
favor a subpopulation of channels with fast activation and inactivation rates for 
inactivating currents. However, this subpopulation was undetectable for the inactivating 
currents of the unglycosylated and partially glycosylated Kv3.1 channels. Additionally, 
the noninactivating current type of the glycosylated and partially glycosylated Kv3.1 
channels revealed a subpopulation of Kv3.1 channels with fast activation and inactivation 
rates, as well as with fast activation and slow inactivation. We conclude that the presence 
of atypical sialylated N-glycans of Kv3 glycoproteins, and perhaps Kv1 glycoproteins, in 
mammalian brain is critical in modulating the expression of K+ currents at the surface of 
neurons. 
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CHAPTER 1 - INTRODUCTION 
 
Brief overview of K+ channels 
 Potassium channels are the largest and most diverse group of ion channels (1) 
which are present in a wide range of organisms from viruses and bacteria to plants and 
mammals (2). These channels are integral membrane proteins which mediate the flux of 
K+ ions across the phospholipid bilayer through a highly selective pore (3). The stimuli 
which gate K+ channels are quite diverse. Some K+ channels are opened by ligands or G 
proteins (4). Others are opened by changes in transmembrane voltage and yet others by a 
combination of mechanisms (4).     
 
Voltage-dependent K+ (Kv) channels 
 Voltage-gated potassium channels (Kv channels), which open and close in 
response to changes in membrane potential, are expressed in both excitable and 
nonexcitable cells (5). In neurons, these channels are major determinants involved in the 
modulation and fine tuning of excitable properties (6,7). Their functional roles are to: 
regulate the resting membrane potentials, repolarization of the action potential, the shape 
and duration of the action potential, and firing frequencies (5,7). This wide range of 
functional diversity is reflected by the large variety of Kv channel polypeptides expressed 
in the central nervous system (8-11). In nonexcitable cells, Kv channels are critical 
contributors in cell proliferation, cell volume regulation, lymphocyte differentiation and 
hormone secretion (12).   
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Biophysical properties of the Kv3 channel subfamily 
 Kv channels comprise a large family of proteins with diverse structural and 
functional properties. There are twelve known subfamilies of Kv channels (Kv1-12) 
which have been described (13). Within the Kv3 subfamily, there are four α subunit 
genes which give rise to the Kv3.1, Kv3.2, Kv3.3, and Kv3.4 proteins. The Kv3 channels 
are thought to play an important role in facilitating sustained or repetitive high frequency 
firing in neurons (14). These channels have several unique functional properties which 
distinguish them from other voltage-gated K+ channels (15). These functional properties 
include rapid activation at voltages more positive to -10 mV and very fast deactivation 
kinetics (15,16). These unusual electrophysiological properties support that Kv3 channels 
are activated at the peak of the action potential and rapidly deactivate after the spike, and 
therefore, modulate action potential duration and firing frequency (14). In heterologous 
expression systems Kv3.1 and Kv3.2 channels generate delayed rectifier type currents, 
which activate relatively fast and inactivate slowly with long durations (14,15). Kv3.3 
and Kv3.4 channels on the other hand, produce A-type or transient currents which 
activate and inactivate very quickly (14,15).      
 Of interest to our laboratory and the primary focus of this dissertation are the 
functional properties of the Kv3.1 channel. The Kv3.1 channel is defined as a “delayed 
rectifier” since the channel changes the membrane conductance with a delay after a 
voltage step relative to Na+ current (17). The Kv3.1 channel has been shown to produce 
delayed rectifier type currents when expressed in Xenopus oocytes (18-23). The Kv3.1 
channel has also been expressed in several other heterologous expression systems 
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including: Human Embryonic Kidney (HEK 293) cells (24), L929 cells (25), NIH 3T3 
fibroblasts (26) and Chinese Hamster Ovarian (CHO) cells (27,28). When expressed in 
mammalian cell lines, such as HEK 293, and NIH 3T3 fibroblasts, Kv3.1 channels 
produced noninactivating currents with transient peaks which lacked saturation at more 
positive potentials (24,26,29), as well as noninactivating currents without transient peaks 
(26,29).   
 
The structure of Kv3 channels 
 The Kv3 subfamily members, Kv3.1-Kv3.4, have been found to localize 
specifically in the axonal and somatodendritic compartments of neurons (16,30). Each of 
the four Kv3 α subunit genes generates multiple protein isoforms via alternative splicing, 
which differ in the amino acid sequence of the cytoplasmic tail (15,18,31-33). Based on 
hydropathy plots, it is predicted that each of the Kv3 subfamily members are tetrameric 
assemblies of α subunits each containing six transmembrane segments, termed S1 
through S6, with cytoplasmic amino- and carboxyl-termini (34). The fourth 
transmembrane segment (S4) is positively charged and functions as the voltage sensor, 
moving in response to changes in transmembrane potential (34). All of the Kv3 subfamily 
members and their multiple protein isoforms have two absolutely conserved sites for N-
glycosylation which lay within the S1-S2 extracytoplasmic linker. Previous studies 
conducted in our laboratory showed that both sites of the Kv3.1 channel are occupied by 
simple type N-glycans when heterologously expressed in Spodoptera frugiperdae (Sf9) 
insect cells (35). More recently, our studies demonstrated that both absolutely conserved 
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N-glycosylation sites of the Kv3.1 channel protein are fully occupied when 
heterologously expressed in B35 neuroblastoma cells, as well as in native neuronal tissue, 
along with the Kv3.3 and Kv3.4 channel proteins. Data from these studies will be 
presented in greater detail in Specific Aims 4 and 1 of this dissertation respectively. 
 
Expression of Kv3 mRNA in rat brain 
 Northern blot analysis and in situ hybridization has been utilized to analyze the 
distribution of Kv3.1, Kv3.3, and Kv3.4 mRNAs in the central nervous system of the 
adult rat (22,32). These studies provided evidentiary support that Kv3.1 and Kv3.3 
transcripts were the highest, followed by Kv3.2, and lastly by Kv3.4, which was the 
lowest (22,32). Three of four Kv3 transcripts (Kv3.1, Kv3.2, and Kv3.3), were found to 
be predominantly expressed in the central nervous system (22). In contrast, Kv3.4 
transcript levels were abundantly detected in skeletal muscle (22) and weakly detected in 
brain (15). Kv3.1 transcript levels were also observed at low but detectable levels in 
skeletal muscle (22), while low levels of Kv3.3 transcripts were found in both the kidney 
and lung (15). 
 These Kv3 channel mRNA studies also demonstrated that Kv3.1 transcript levels 
were abundant in both the cerebral cortex and spinal cord (22,32,36). In contrast, Kv3.2 
transcript levels were prominent in the thalamus and minimal in the cerebral cortex (32). 
The expression of Kv3.1 and Kv3.2 transcripts has been known to overlap in some 
neuronal populations, particularly in the anterior part of the brain, including the cortex, 
hippocampus, globus pallidus, deep cerebellar nuclei and certain thalamic nuclei (32). 
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However, there are many areas where Kv3.2 transcripts do not overlap with the products 
of the other Kv3 genes (22). Similar to Kv3.1, Kv3.3 transcript levels were also highest 
in the cerebral cortex and spinal cord (22). This overlap of transcript expression was 
expected since Kv3.1 and Kv3.3 transcripts are coexpressed in several neuronal 
subpopulations, including most auditory central processing neurons (15). Finally, Kv3.4 
transcript levels were detected only in those neurons which expressed other Kv3 genes 
(15). 
 
Brain and spinal cord distribution of Kv3 proteins 
 Recently, we have characterized the distribution of Kv3.1, Kv3.3, and Kv3.4 
proteins throughout the central nervous system of the adult rat and notable differences 
have been found relative to transcript studies (37). The data from this study will be 
presented in greater detail in Specific Aim 2 of this dissertation. There are also additional 
studies evaluating Kv3.1 protein levels with contradictory findings. Data from the group 
of M. Weiser demonstrated that Kv3.1 protein levels were higher in the cerebellum 
compared to that of the thalamus, cerebral cortex and hippocampus (38). Other studies 
showed that high levels of Kv3.1 protein were detected in the hippocampus (39,40) and 
cerebral cortex (39).   
 
Ablation of Kv3.1 and Kv3.3 channels 
 The ablation of Kv3 genes leads to a variety of physiological and behavioral 
phenotypes ranging from subtle to severe. For example, studies indicated that mice 
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lacking the Kv3.1 channel displayed an increased motor drive and required less sleep 
(41). Studies also demonstrated that Fast Spiking (FS) neurons of Kv3.1 knock-out mice 
displayed action potential broadening, as well as diminished firing frequency (42). In 
contrast, Kv3.3 deficient mice exhibited impaired motor function, as well as muscle 
twitches (43). Since Kv3.1 and Kv3.3 are coexpressed in the same neurons of the central 
nervous system, it has been suggested that the moderate phenotypic alterations observed 
in either single mutant are the result of functional redundancy of the Kv3.1 and Kv3.3 
genes (44). Kv3.1/Kv3.3 double mutant mice (DKO) displayed severe ataxia, tremulous 
movements, myoclonus and hypersensitivity to ethanol (44). In spite of these debilitating 
motor deficits, Kv3.1/Kv3.3 deficient mice displayed no obvious learning or memory 
deficits (44).  
 
The Kv1 channel subfamily 
 Kv1 channels are another main subfamily of voltage-gated K+ channels (16). A 
total of seven mammalian genes have been identified which belong to the Kv1 family: 
Kv1.1, Kv1.2, Kv1.3, Kv1.4, Kv1.5, Kv1.6 and Kv1.7 (45). These Kv channels are 
typically noninactivating or slowly inactivating with the exception of Kv1.4 and Kv1.7, 
which are fast inactivating channels (46-51). Six of the Kv1 channels, Kv1.1-Kv1.6 are 
expressed in mammalian brain with Kv1.1, Kv1.2 and Kv1.4 being the most abundant 
(16). The Kv1 channels are also expressed in excitable tissues such as smooth muscle and 
heart, as well as nonexcitable tissues and cell types including: colon, kidney, endothelial 
cells, epithelial cells, adipocytes, T cells and granulose cells (52-57). The Kv1 channels, 
 7
with the exception of Kv1.6 contain a highly conserved N-glycosylation site within the 
first (S1-S2) extracellular loop (16). Earlier studies demonstrated that the N-glycosylation 
site of the Kv1.1, Kv1.2 and Kv1.4 proteins were occupied by sialylated glycan structures 
in rat brain (16,58-60). Given these observations, it was of further interest to our 
laboratory to characterize these sialyl linkages. Our sialyl linkage studies are presented in 
Specific Aim 3 of this dissertation.          
 
Biological roles of oligosaccharides 
 Nearly all membrane proteins are N-glycosylated (61). This co-translational and 
post-translational modification may serve as a primary determinant in the biosynthesis, 
folding, trafficking and stabilization of membrane proteins (62). Since all cells are 
covered with oligosaccharides, it has been predicted that specific functions of 
oligosaccharides at the cell surface are cell adhesion, interactions between cells and 
ligands, and between cells and microbes (61). Cell surface oligosaccharides are also 
critical determinants of cell-cell interactions (61). Furthermore, modulatory effects of 
glycosylation on the function of proteins has previously been suggested, and therefore 
will be a focal point in this dissertation with regard to the Kv3.1 channel protein 
heterologously expressed in B35 cells.     
 
The N-glycosylation pathway 
 The biosynthesis of N-linked oligosaccharides begins on the cytoplasmic side of 
the endoplasmic reticulum (ER) with the formation of the lipid linked monosaccharide 
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GlcNAc-pyrophosphatedolichol (63) (Figure 1). Subsequent formation of this lipid linked 
monosaccharide, one GlcNAc and five mannose residues are attached in a stepwise 
fashion (63). The Man5GlcNAc2 intermediate structure is then translocated by flippase 
from the cytoplasmic side to the lumenal side of the ER, where four mannose and three 
glucose residues are added (64). This common precursor oligosaccharide 
(GlcNAc2Man9Glc3) is then transferred to selected asparagine acceptor sites located 
within the recognition tripeptide Asn-Xxx-Ser/Thr (where X can be any amino acid 
except for proline) of nascent polypeptides (63). This step is catalyzed by the membrane 
associated oligosaccharyl transferase (OST) complex (65). Previous studies showed that 
the asparagine acceptor sites must be spaced a minimum distance from the membrane 
surface in order to reach the active site of OST for efficient glycosylation of membrane 
proteins (66). Immediately after coupling to the polypeptide chain, the precursor N-
glycan is then subjected to processing in the ER by the trimming of three glucose 
residues and one mannose residue which is catalyzed by specific glycosidases (63). This 
glycoprotein intermediate is then directed to the cis, medial and trans compartments of 
the Golgi for maturation where specific glycosidases and glycosyltransferases catalyze 
the removal and addition of specific sugar residues (67). In the trans-Golgi apparatus 
sialic acid residues are added to generate complex type N-glycans (68). 
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Figure 1. The N-linked glycosylation pathway 
 Pink squares indicate N-acetylglucosamine (GlcNAc); blue circles indicate 
mannose (Man); peach diamonds indicate glucose (Glc); purple lines indicate the 
polypeptide chain and black curvy lines indicate dolichylphosphate. 
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N-Linked oligosaccharide structures 
 Asparagine-linked oligosaccharides are classified into three subgroups: high 
mannose, complex and hybrid (Figure 2). N-Linked high mannose oligosaccharides 
contain two to six additional mannosyl residues linked to the core pentasaccharide and 
may form branches (67). Complex type N-linked oligosaccharides bear two or more 
branches containing at least one GlcNAc, one galactose and one sialic acid residue (67). 
These N-glycans are often highly branched and can be di-, tri- or tetraantennary (67). 
Previous studies on the structure of sialylated N-glycans in the adult rat brain revealed 
that di-, tri- and tetraantennary N-glycans with either one or two sialyl residues are the 
most abundant (69,70). Hybrid N-linked oligosaccharides contain structural elements of 
both high mannose and complex type sugar chains (67). In the hybrid structure the α1-6-
linked core mannose has only mannose residues attached to it (similar to the high 
mannose type) (71). Additionally, the α1-3-linked core mannose has one or more 
GlcNAc initiated antennae attached to it (similar to the complex type) (71). In general, 
both high mannose and hybrid type N-glycans materialize as intermediates along the 
processing pathway, while complex type N-glycans denote the mature form of N-linked 
oligosaccharides (67). However, not all N-glycans are processed to complex type due to 
orientation and placement in the ER and Golgi membrane, as well as the folding state 
which may prevent access to glycotransferases. 
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Figure 2. Schematic structures of different N-glycans 
 Different structures of high mannose, hybrid and complex type N-linked 
oligosaccharides. All N-linked glycoproteins have a common pentasaccharide core as 
outlined in dark blue. Light blue squares indicate N-acetylglucosamine (GlcNAc); green 
ovals indicate galactose (Gal); pink circles indicate mannose (Man); yellow hexagons 
indicate sialic acid (Sia); and purple curved lines indicate the polypeptide chain. 
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Diseases and disorders associated with N-linked glycosylation 
 N-Glycosylation is an essential process required for eukaryotic cell survival (64). 
Inhibition of protein N-glycosylation provokes the accumulation of unfolded proteins in 
the ER, and therefore induces ER stress (72). ER stress has been suggested to be involved 
in several neurodegenerative diseases (72,73). Furthermore, defects in the assembly of 
the oligosaccharide substrate or processing of oligosaccharides after they are transferred 
to proteins in the ER have also been shown to result in severe disorders (63,74). These 
disorders have profound systemic effects including psychomotor retardation, low muscle 
tone, incomplete brain development, impaired vision, coagulation disorders, endocrine 
abnormalities and dysmorphic features (75,76). These carbohydrate related genetic 
disorders are characterized by the absence of N-glycans or structurally abnormal N-
glycans on many glycoproteins, and therefore are termed congenital disorders of 
glycosylation (CDG, formerly named carbohydrate deficient glycoprotein syndrome) 
(64).  
 To date, four types of CDG (types I through IV) have been identified based on the 
abnormal pattern of N-glycans of serum transferrin (65). CDG type I is associated with 
defects in monosaccharide synthesis, glycotransferases, synthesis of a dolichyl phosphate 
bound monosaccharide and chaperone like proteins (63). CDG type II results from 
defects in glycosyltransferases, glycosidases and transporters (65). The enzymatic defects 
for CDG type III and type IV have not yet been identified (65). 
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The Mgat-I null mouse embryo 
 A reduction of complex N-glycan synthesis in humans is debilitating (77,78). The 
gene product of Mgat-I, GlcNAc-TI transferase is essential for catalyzing the conversion 
of high mannose N-glycans to hybrid and complex N-glycans (79). Studies demonstrated 
that mouse embryos lacking GlcNAc-T1 activity and complex N-linked oligosaccharide 
synthesis do not survive past 10.5 days after fertilization (80-82). A morphological 
analysis of these Mgat-I null mouse embryos revealed several abnormalities including 
defects in neural tube formation and vascularization, as well as impaired determination of 
left-right body plan symmetry (80-82). Studies using these mutants showed that complex 
N-linked oligosaccharides provide crucial information during mouse embryogenesis.   
 
N-Glycosylation modifies Kv channel function and trafficking 
 Despite progress in the electrophysiological characterization of N-glycosylation 
processing of voltage-gated K+ channels, most studies have only been conducted in 
nonexcitable cells. Findings from earlier studies conducted in our laboratory 
demonstrated that the absence of simple type N-glycans on Kv3.1 channels, when 
expressed in Spodoptera frugiperdae, Sf9 cells, caused slower activation rates, and 
furthermore, a slight positive shift in voltage dependence compared to its glycosylated 
form (35). Further studies showed that the gating properties of Kv1.1 (58,83), Kv1.2 (84) 
and Kv10.1 (85) channels were altered by N-glycosylation. These functional differences 
included a positively shifted V1/2 (83,84), a shallower slope for the conductance versus 
voltage relationship (83,84), a dramatic decrease in current density (85), slowed 
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activation kinetics (84,85) and decreased deactivation kinetics (84). Moreover, the 
absence of N-glycosylation lead to diminished trafficking of Kv 10.1 (85), Kv1.2 (84) 
and Kv1.4 (86) channels to the cell surface, but had little or no effect on Kv1.1 channels 
(86). Also, it has been shown that when N-glycosylation of HERG was abolished, 
currents were greatly reduced and cell surface membrane expression was virtually absent 
(87). 
 
Sialylated brain N-glycans 
 The N-glycan pool of mammalian brain contains surprisingly elevated levels of 
sialylated N-glycans with atypical structures (69). Studies demonstrated that sialic acid 
enrich N-linked oligosaccharides account for at least 40% of the total N-glycan 
population in the adult mammalian brain (69,88). Sialic acids are a family of acidic 9-
carbon amino sugars containing over 50 members (89,90) which occupy the non-reducing 
terminal position of glycan chains on many cell surface glycoproteins and glycolipids 
(90-92). This terminal position, as well as their net negative charge at physiological pH, 
explains the functional importance of sialic acid in many ligand-receptor and cell-cell 
interactions (89,93). The sialylation of glycoproteins and glycolipids has also played a 
prominent role during development, regeneration and pathogenesis (93,94).  
 Typical glycosidic bonds for sialic acid residues include α2,3- and α2,6-linkages 
(69,95). Sialic acid residues with α2,3-ketosidic linkages are abundant in mammalian 
brain (69,95). A unique glycosidic bond for sialic acid residues is α2,8-linkage which 
gives rise to di/oligo/polysialic acid units (96). These α2,8-linked di/oligo/polysialic acid 
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units are primed by an initiating α2,3-linked sialic acid attached to the terminal ends of 
the N-glycans (96,97). In mammalian brains, the first two glycoproteins which were 
identified to contain polymers of 8 or more α2,8-linked sialic acid residues were neural 
cell adhesion molecules (NCAMs) (88,97-99) and the α-subunit of the voltage sensitive 
sodium channel (98). Since these initial findings, four additional polysialylated bearing 
proteins have been identified (90,100-102) Further studies demonstrated that in 
mammalian brain there are more α2,8-linked disialic acid (70) and oligosialic acid chains 
on glycoproteins than previously thought; however the proteins have yet to be identified 
(88,97,98). An additional unique glycosidic bond is sialyl residues linked to internal 
residues of the carbohydrate chains of sialoglycoconjugates (103,104). Prior to the 
present investigation, this unusual glycosidic bond for sialyl residues had only been 
identified in gangliosides, not N-glycans (103,104). 
 Furthermore, evidence has suggested that the attachment of negatively charged 
sialyl residues to N-linked oligosaccharide chains of Kv channels plays a role in 
regulating channel activity. Electrophysiological studies demonstrated that reducing the 
sialic acid content of the Kv1.1 and Kv1.2 channels had significant functional effects on 
their activation parameters (83,84). Our laboratory was the first to demonstrate that sialyl 
residues were linked to internal carbohydrate residues of the Kv1.1, Kv1.2, and Kv1.4 N-
glycans, as well as the Kv3.1, Kv3.3, and Kv3.4 N-glycans. This same investigation also 
showed that Kv3 and Kv1 channels contained N-linked glycoconjugates with 
di/oligo/polysialyl units. Until now, this linkage was not shown to be associated with K+ 
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channels. The results of this study are discussed extensively in Specific Aim 3 of this 
dissertation.  
 
Specific Aims of this Investigation 
 
Asparagine-linked glycosylation is a co-translational and post-translational 
protein modification which is initiated in the lumen of the ER (105). The addition of N-
glycan structures to proteins promotes proper folding, assembly, stability and intracellular 
trafficking (61). Glycoproteins displayed on the cell surface also play a vital role in cell 
recognition events and in cell–cell interactions (61). In recent years, the biological 
importance of N-linked glycan biosynthesis to mammalian physiology has been 
dramatically illustrated by the identification of congenital disorders of glycosylation 
(CDG) in humans (63,64). The biological role of complex N-linked oligosaccharides in 
mammalian development has also been illustrated by the generation of mouse embryos 
which lack a functional Mgat-I gene (81). Additionally, recent studies suggested that 
altered N-glycosylation occupancy provoked by ER stress may lead to several 
neurodegenerative diseases (73). N-Glycoproteins have also been shown to influence 
Kv1.1 (58,83), Kv1.2 (84) and Kv10.1 (85) channel function. Elegant experiments 
previously conducted in our laboratory demonstrated that Kv3.1 channels with 
unoccupied sites had slower activation kinetics and a slight positive voltage shift for 
channel activation compared to Kv3.1 channels occupied with N-glycans of simple type 
(35). Taken together, the primary goal of this dissertation was to characterize the N-
glycan structures of Kv3 and Kv1 glycoproteins in the adult rat brain, as well as to 
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determine how neuronal N-glycosylation processing regulates the function of the Kv3.1 
voltage-gated K+ channel in B35 neuroblastoma cells. To address this central goal, a set 
of four specific aims each representing a single published unit were devised and listed in 
the text beneath:   
 Specific Aim 1: To demonstrate that both absolutely conserved N-glycosylation 
sites of Kv3.1, Kv3.3, and Kv3.4 channels are fully occupied by complex 
oligosaccharides in rat brain.  
 Specific Aim 2: To demonstrate that sialylated N-glycan structures attached to 
Kv3.1, Kv3.3, and Kv3.4 channels are different throughout the central nervous system of 
the adult rat.  
 Specific Aim 3: To determine the different linkages of sialyl residues associated 
with N-glycans attached to Kv3.1, 3.3, 3.4, 1.1, 1.2 and 1.4 channels in rat brain, as well 
as a rat neuroblastoma cell line. 
 Specific Aim 4: To determine whether atypical sialylated N-glycans associated 
with the Kv3.1 protein modulated channel activity.  
 The experimental design employed to study these four specific aims entailed 
immunoband shift assays and functional measurements. Immunoband shifts generated by 
various glycosidase treatments of brain and spinal cord membranes, as well as 
immunoaffinity purified Kv3.1 protein from various transfected B35 cells, were utilized 
to evaluate Kv3 and Kv1 N-glycan occupancy, type, and composition. Moreover, this 
assay was utilized to identify specific Kv3 glycoforms. Metabolic radiolabeling of sugars 
combined with immunoband shifts of glycosidase digestion reactions were also employed 
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to determine whether the N-glycan structures of the Kv3 glycoproteins were composed of 
an oligo/polysialyl unit. Functional measurements were conducted in the whole cell mode 
of the patch clamp technique for glycosylated (wild type), unglycosylated 
(N220Q/N229Q), and partially glycosylated (N220Q and N229Q) Kv3.1 channels 
heterologously expressed in stable transfected B35 neuroblastoma cells. Activation, 
inactivation, and deactivation kinetics, along with current density and current type for the 
glycosylated (wild type Kv3.1) and each of the glycosylated mutant (N220Q/N229Q, 
N220Q, N229Q) Kv3.1 channels were determined and compared for statistical analysis.   
CHAPTER 2 - THE PATCH CLAMP TECHNIQUE 
 
Mastering the patch clamp technique 
 
 The patch clamp technique is a laboratory technique in electrophysiology which 
was originally developed in 1976 by Neher and Sakmann to study ion currents through 
single channels in cell membranes (106). Since then this technique has been widely used 
over the past three decades to investigate the role of how ion channels function under 
both physiological and pathological conditions in excitable and nonexcitable cells. The 
basic principal underlying the patch clamp technique involves using a fine-tipped glass 
micro-pipette. The interior of the glass micro-pipette is filled with an electrolyte which in 
the case of the whole cell recording mode may match the ionic composition of the 
cytoplasm. An electrode or chloride silver wire is placed in contact with this solution and 
is connected to an amplifier. In the case of the cell-attached configuration of the patch 
clamp technique, this electrode is used for both the passage of voltage and the recording 
of current. An additional chloride silver wire is placed in the bath chamber and serves as 
the ground electrode. 
 Once the electrode within the glass micro-pipette makes contact with the cell of 
interest, which in my case is kept in a low K+ bath solution with the appropriate 
osmolarity, a brief soft suction is applied to achieve a gigaohm seal between the glass 
micro-pipette and the membrane. As the gigaohm seal begins to form, the horizontal lines 
of the current trace collapse. After forming a tight seal on the cell membrane, vertical 
"peaks" appear in the current trace due to the glass micro-pipette capacitance. The 
amplifier is then used to compensate for the glass micro-pipette capacitance from the 
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current recording. After electrically removing the glass micro-pipette capacitance, the 
vertical spikes recede.  
 In order to break into the whole cell recording mode of the patch clamp technique, 
additional soft suction is applied. This soft suction is critical in breaking the membrane 
and establishing electrical access into the interior of the cell. Moreover, the intracellular 
solution of the micro-pipette diffuses into the cytoplasm. Once electrical access into the 
interior of the cell has been achieved both whole cell capacitance and series resistance are 
compensated for by using the amplifier. Once the micro-pipette solution has diffused into 
the cytoplasm, whole cell currents are stimulated by numerous voltage protocols.  
 Although the patch clamp technique is well utilized for determining ion channel 
functionality, it is notoriously laborious and requires great expertise. Therefore, 
mastering the patch clamp technique, along with employing it to study Kv3.1 channel 
activity, was the major focus of specific aim 4. By measuring whole cell currents in the 
whole cell configuration of the patch clamp technique, I have shown that the attachment 
of atypical sialylated N-glycans to the Kv3.1 channel is critical for channel transitions.   
  
CHAPTER 3 - MATERIALS AND METHODS 
Brain, spinal cord and heart membrane extracts 
Cerebellum, hypothalamus, cerebral cortex, hippocampus, spinal cord, thalamus, 
stripped brain and heart from adult Sprague-Dawley rats were purchased from Pel Freez 
Biological (Rogers, AR, USA). Tissues were collected from 3-18 different rats. Liquid 
nitrogen frozen hippocampus, spinal cord and thalamus were homogenized in 10 mL of 
ice-cold lysis buffer (4 mM HEPES (pH 7); 320 mM sucrose; 5 mM EDTA; protease 
inhibitor cocktail set III (100 mM AEBSF, Hydrochloride; 80 µM Aprotinin, Bovine, 
Lung, Crystalline; 5 mM Bestatin; 1.5 mM E-64, Protease; 2 mM Leupeptin, 
Hemisulfate; and 1 mM Pepstatin A) 1:500 (Calbiochem, San Diego, CA, USA). In the 
case of cerebellum, hypothalamus, cerebral cortex, stripped brain and heart the tissues 
were ground to a fine powder under liquid nitrogen prior to homogenization. Subsequent 
to centrifugation of the homogenate at 2,000 x g in an Eppendorf F-45-30-11 rotor 
(Eppendorf, Westbury, NY, USA) for 10 min at 4 ºC, the supernatant was stored on ice. 
The low speed pellet was resuspended in up to 10 mL lysis buffer, homogenized and 
centrifuged as described above. The resulting supernatants were pooled and then 
centrifuged at 197,568 x g in a TH-641 rotor (Sorvall, Newtown, CT, USA) for 1 h at 4 
ºC to produce a pellet containing tissue membranes. After resuspending pellets in 5 mL 
lysis buffer, protein concentrations were determined by the modified method of Lowry 
(107). Samples were then stored at -80 ºC until needed. In some cases, an aliquot of each 
sample was combined with reducing SDS sample buffer (2X), heated at 80 °C for 3 min 
and analyzed by immunoblotting. In order to assess the Kv3 protein levels, as well as 
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identify the various Kv3 glycoforms throughout the adult rat central nervous system, 
SDS-PAGE gels were loaded with either 25 µg/well of brain membrane proteins or with 
adjusted amounts to generate immunobands of equal intensities. 
 
Endoglycosidase N reactions 
Membrane proteins (5 g/L) or an aliquot of partially M2 immunoaffinity purified 
Kv3.1 protein from B35 cells (50 µL) was digested with recombinant endoglycosidase N 
(Endo N; 33 or 65 µg/mL) in 50 mM sodium phosphate (pH 7.5), 0.1 M sodium chloride, 
and protease inhibitor cocktail set III. Recombinant Endo N was expressed and isolated 
as previously described (108). For control reactions, 50 mM sodium phosphate (pH 7.5), 
0.1 M sodium chloride was substituted for Endo N. Reactions were incubated overnight 
at 37 oC and processed for western blotting as described below. 
 
Peptide N-glycosidase F (PNGase F) reactions 
Membrane proteins (4-5 g/L) were digested with PNGase F (4-31 U/µL or 12.5 
U/µL) (New England Biolabs, Ipswich, MA, USA) in a reaction mixture containing 50 
mM sodium phosphate (pH 7.5), and protease inhibitor cocktail set III, plus or minus 
0.8% NP-40 (Calbiochem, San Diego, CA, USA). In some cases, (Figures 9 and 12 of 
manuscript 2) membrane proteins (4-5 g/L) were treated with denaturation buffer (0.5 % 
SDS and 0.04 mol/L DTT) (New England Biolabs, Ipswich, MA, USA) at 90 ºC for 10 
min prior to digestion with PNGase F. Digestion reactions were allowed to proceed 
overnight at 37˚C. For “partial” PNGase F digestions, 1 µL of diluted enzyme (25-, 80- 
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and 100-fold) was added to membrane proteins followed by incubation for 30 min at 37 
ºC. All enzyme control reactions were performed in parallel by substituting PNGase F 
with 50 mM sodium phosphate (pH 7.5). For immunoblot analysis, 15-60 µg (Figures 9 
and 12 of manuscript 2) or 25-50 µg (Figures 5 and 6 of manuscript 1) of PNGase F 
digestion reactions were loaded per well on SDS-PAGE gels.  
 
Sialidase A, C, S, and neuraminidase reactions 
Sialidase A, C, and S were purchased from Glyko, San Leandro, CA, USA. 
Sialidase A (A. ureafaciens) removes α2,3-, α2,6-, and α2,8-linked sialyl residues from 
the non-reducing termini of carbohydrate chains, as well as sialyl residues linked to 
internal residues of oligosaccharide chains (109-111). Sialidase C (C. perfringens) 
removes α2,3-, and α2,6-linked sialyl residues from the non-reducing termini of 
carbohydrate chains (112) while sialidase S (S. pneumoniae) only removes α2,3-linked 
sialyl residues from the ends (113). Neuraminidase (C. perfringens) from New England 
Biolabs, Ipswich, MA, USA is identical to sialidase C however, much more concentrated. 
At a much higher concentration this exoglycosidase will remove α2,8-linked sialyl 
residues, along with α2,3- and α2,6-linked sialyl residues, from the non-reducing termini 
of carbohydrate chains. Sialidase A (0.2-0.5 mU/µL), sialidase C (0.5-1.0 mU/µL), or 
sialidase S (0.2-0.5 mU/µL) were added to membrane proteins (5 g/L) in 50 mM sodium 
phosphate (pH 6.0) and protease inhibitor cocktail set III. Neuraminidase (1-8 U/µL) was 
added to membrane proteins (5 g/L) in 50 mM sodium citrate (pH 6.0) plus protease 
inhibitor cocktail set III. Mock digestions lacking the enzymes sialidase A, sialidase C, 
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sialidase S or neuraminidase were performed as controls by substituting the appropriate 
enzymes with either 50 mM sodium phosphate (pH 6.0) or 50 mM sodium citrate (pH 
6.0). Membrane proteins were digested overnight at 37 ºC. For immunoblot analysis, 15-
60 µg (Figures 9 and 13 of manuscript 2) or 25-50 µg (Figure 7 of manuscript 1) of 
neuraminidase digestion reactions were loaded per well on SDS-PAGE gels.  
 
Sialidase C and endoglycosidase N double digestion reactions 
Sialidase C (0.5-1.0 mU/µL) and Endo N (33 or 65 µg/mL) were added to 
membrane proteins (5 g/L) with 50 mM sodium phosphate (pH 6.0) and protease 
inhibitor cocktail set III. Enzyme control reactions contained all of the above constituents 
except 50 mM sodium phosphate (pH 7.5) was substituted for the various glycosidases. 
Glycosidase digestion reactions were incubated overnight at 37 oC. 
 
Double digestion reactions with PNGase F and either sialidase A or 
neuraminidase 
 Different combinations of PNGase F (6 U/µL or 12.5 U/µL), sialidase A (0.4 
mU/µL) or neuraminidase (2 U/µL or 10-20 U/µL) were added to membrane proteins (4-
5 g/L) in 50 mM sodium phosphate (pH 7.5), plus protease inhibitor cocktail set III. For 
control reactions, equivalent amounts of 50 mM sodium phosphate (pH 7.5) were 
substituted for PNGase F, sialdase A or neuraminidase. All digestions were allowed to 
proceed overnight at 37 °C. 
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Endoglycosidase H (Endo H) digestions 
 Membrane proteins (5 g/L), after denaturating for 10 min at 90 ºC in denaturation 
buffer (0.5 % SDS and 0.04 mol/L DTT) were incubated with Endo H (38 U/µL) (New 
England BioLabs, Ipswich, MA, USA) in 50 mM sodium citrate containing protease 
inhibitor cocktail set III and NP-40 for overnight at 37 ºC. In some instances, an aliquot 
of partially M2 immunoaffinity purified Kv3.1 protein from B35 cells was digested with 
Endo H (50 U/µL) without denaturating. Membrane proteins and partially M2 
immunoaffinity purified Kv3.1 protein from B35 cells were mock treated by substituting 
Endo H for dH2O. To verify the activity of Endo H a control digestion was performed in 
which partially purified Kv3.1 heterologously expressed in an insect cell line, Sf9 cells 
was supplemented to rat brain membranes. This cell line adds simple type N-glycans to 
Kv3.1 (35). Subsequent to these digestions 25-50 µg (Figure 5 of manuscript 1) of 
membrane proteins were loaded per well on SDS-PAGE gels for immunoblot analysis.  
 
Construction of recombinant expression vectors 
 Kv3.1 recombinant pcDNA3.1 mammalian expression vectors 3’FLAG-Kv3.1-
pcDNA3.1, 3’FLAG-N220Q/N229Q-pcDNA3.1, 3’FLAG-N220Q-pcDNA3.1 and 
3’FLAG-N229Q-pcDNA3.1 were constructed for heterologous expression in rat B35 
neuroblastoma cells. Each of these constructs generate either single or double mutants in 
which either one or both native N-glycosylation sites at positions 220-222 (NKT) and 
229-231 (NGT) of Kv3.1 were abolished (Figure 22A). Single mutants were generated by 
site-directed mutagenesis while the double mutant was constructed by PCR overlap 
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extension. The FLAG epitope tagged Kv3.1 cDNA molecules were acquired from our 
previous study in Sf9 cells (35). Each of the respective Kv3.1 cDNA molecules were 
removed from their respective Baculovirus expression vectors 3’FLAG-Kv3.1-pACSG2 
by EcoRI (New England BioLabs, Ipswich, MA, USA) digestion. The isolated EcoRI 
fragments were then ligated into the prepared pcDNA3.1 (EcoRI) mammalian expression 
vector. The products of the ligation reaction were then transformed into Escherichia coli 
DH5αTM competent cells (Invitrogen, Carlsbad, CA, USA). The resultant transformants 
were then screened for orientation of the Kv3.1 cDNA insert by SmaI (New England 
BioLabs, Ipswich, MA, USA) restriction enzyme analysis. One clone of 3’FLAG-Kv3.1-
pcDNA3.1, 3’FLAG-N220Q/N229Q-pcDNA3.1, 3’FLAG-N220Q-pcDNA3.1 and 
3’FLAG-N229Q-pcDNA3.1 confirmed correct orientation and was isolated and 
sequenced. Standard procedures were followed for DNA amplification and isolation, as 
well as subcloning (114).  
 
B35 neuroblastoma cell culture 
 B35 cells (rat central nervous system, derived) were obtained from American 
Type Culture Collection (Manassas, VA, USA) and maintained in DMEM (Mediatech 
Inc., Manassas, VA, USA) supplemented with 10% fetal bovine serum (Invitrogen, 
Carlsbad, CA, USA), penicllin (50 U/mL) (Invitrogen, Carlsbad, CA, USA), and 
streptomycin (50 µg/mL) (Invitrogen, Carlsbad, CA, USA) at 37 ºC under 5% CO2. B35 
cells were plated on uncoated 60 mm dishes (Fisher Scientific, Suwanee, GA, USA) 
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every 4 days after a brief trypsin-EDTA (Invitrogen, Carlsbad, CA,USA) treatment and 
the cell culture medium was changed every 2-3 days.  
 
Transient and stable transfection assay 
 For the production of transient and stable cell lines expressing the various forms 
of the Kv3.1 protein, B35 cells of 75-80% confluency were transfected with neomycin 
selectable pcDNA3.1 expression plasmids encoding wild type Kv3.1, N220Q/N229Q, 
N220Q or N229Q Kv3.1 mutants using LipofectamineTM 2000 (Invitrogen, Carlsbad, 
CA, USA) according to the manufacturer’s protocol. In brief, FBS and antibiotic free B35 
cell culture media (1 mL) containing approximately 6 or 8 µg of recombinant vector and 
11.5 or 15 µL of LipofectamineTM 2000 (Invitrogen, Carlsbad, CA, USA) was added to 
each dish. Following an incubation of 5 h with the DMEM-DNA-lipid transfection 
solution, each dish of B35 cells was re-fed with 3 mL of serum and antibiotic containing 
DMEM medium. B35 cells were selected for stable transfectants by the addition of 1.0 
g/L of Geneticin® (Invitrogen, Carlsbad, CA, USA) to the cell culture medium 48 h after 
transfection. Distinct, antibiotic-resistant, individual colonies appeared after 2-3 weeks 
and were dissociated into small clumps of B35 cells, and transferred into a 60 mm dish. 
B35 cells were then expanded into two 60 mm dishes and continuously propagated in the 
presence of Geneticin. Stable B35 cells expressing wild-type Kv3.1, N220Q/N229Q, 
N220Q, or N229Q Kv3.1 mutants were seeded onto small glass chips (Fisher Scientific, 
Suwanee, GA, USA) in a 35 mm dish (Fisher Scientific, Suwanee, GA, USA) and kept 
under culturing conditions for approximately 15 h before electrophysiological 
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investigations. For electrophysiological investigations, small glass chips with attached 
stable transfected B35 cells expressing wild-type Kv3.1, N220Q/N229Q, N220Q or 
N229Q glycosylation mutants were transferred to a recording chamber (Warner 
Instruments, Hamden, CT, USA). 
 
Metabolic radiolabeling of sialylated N-glycans in B35 cells 
  For metabolic radiolabeling experiments, 1.5 mL of complete medium, plus 1.5 
mL of complete medium containing acetyl-D-mannosamine, N-[6-
3
H] (31 µCi/mL) 
(American Radiolabeled Chemicals, St. Louis, MO, USA) was added to each dish of B35 
cells following a 5 h incubation with the DMEM-DNA-lipid transfection solution. 
Acetyl-D-mannosamine, N-[6-
3
H] is a precursor of sialic acid and is commonly used to 
radiolabel sialylated N-glycans (115). After 22-24 h the unradiolabelled and radiolabeled 
transient transfected B35 cells were harvested and Kv3.1 was immunoaffinity purified as 
described in the text below. Unradiolabelled samples were loaded on 12% SDS gels and 
Western blotted using the method described below. Radiolabelled proteins were 
separated on 10% SDS gels using N,N’diallyltartardiamide (DATD) (Bio-Rad, Hercules, 
CA, USA) as the crosslinker, instead of bis-acrylamide. Gel slices of interest were 
excised between the 150 and 75 kDa Kaleidoscope
TM 
markers (Bio-Rad, Hercules, CA, 
USA). This region contained the heterologously expressed Kv3.1 protein with complex 
N-glycans as determined by Western blotting of transfected B35 membranes separated on 
10% SDS gels using DATD as a crosslinker. Surprisingly, the Kv3.1 protein ran much 
faster on this type of gel and was just above the 100 kDa marker. Excised gel slices were 
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 placed in 2% sodium periodate solution (0.5-1 mL) (Aldrich Chemical Co., Inc., 
Milwaukee, WI, USA) and incubated on a shaker at ambient temperature. After 2-4 h, 
scintillation fluid (5 mL) (Fisher Scientific Co., Hampton, NH, USA) was added to each 
sample. Samples were then refrigerated for approximately 1 h before radioactivity was 
measured by scintillation counting for 20 min to reduce the margin of error to less than 
5%.  
 
M2 immunoaffinity purified Kv3.1 protein and glycosidase digestion reactions 
 Wild type Kv3.1, N220Q/N229Q, N220Q and N229Q stable transfected B35 cells 
(4, 60 mm plates per sample) were resuspended in lysis buffer (50 mM Na2HPO4; 0.3 M 
KCl, pH7.5 and 0.5% Triton X-100) and then sonicated at a power setting of 3 with short 
pulses till solubilized. After centrifugation at 500 x g in an Eppendorf F-45-30-11 rotor 
(Eppendorf, Westbury, NY, USA) for 15 min at 4°C, supernatants were collected and 
M2-Flag® resin ( 40-50 µL, 1:1 gel slurry) (Sigma-Aldrich, St. Louis, MO, USA) was 
added. Next, samples were rotated for 1 h at room temperature and centrifuged at 400 x g 
in an Eppendorf F-45-30-11 rotor (Eppendorf, Westbury, NY, USA) for 3 min at 4 °C. 
The resin was then washed twice in 50 mM Na2HPO4; 0.3 M KCl, pH7.5 followed by 
two additional washes with PBS. In some instances, partially purified wild type, 
N220Q/N229Q, N220Q, and N229Q Kv3.1 proteins were combined with reducing SDS 
sample buffer (2X) and analyzed by western blotting as described in the text below. For 
neuraminidase digestion reactions, the resin was washed an additional time in 50 mM 
sodium citrate (pH 6.0) followed by resuspension. Equal volumes of resuspended resin 
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were then split into two separate tubes. Neuraminidase (0.83 U/µL) (New England 
Biolabs, Ipswich, MA, USA), was then added to the appropriate tube while 50 mM 
sodium citrate (pH 6.0) was added to the control reaction. For “partial” PNGase F 
digestions, 1 µL of diluted enzyme (10-, 20-, 40- and 80-fold) was added to resin washed 
and resuspended in 50 mM sodium phosphate in a total reaction volume of 50 µL. For 
metabolic radiolabeling experiments control and Endo N reactions were washed an 
additional time with 1 mL PBS, while the neuraminidase reaction was washed once more 
with 1 mL of 50 mM sodium citrate (pH 6.0). Endo N (33 or 65 µg/mL) or neuraminidase 
(10 U/µL) was then added to the appropriate tubes while PBS was added to the control 
reaction. All glycosidase digestion reactions were allowed to proceed overnight at 37 °C. 
 
B35 cell membrane isolation 
 Nontransfected B35 cells (about 11 x 107) were homogenized (70-90 strokes) in 2 
mL of lysis buffer (10 mM Tris (pH 7.4)); 250 mM sucrose, 5mM EDTA; protease 
inhibitor cocktail set III 1:500 (Calbiochem, San Diego, CA, USA), and subsequently 
centrifuged at 2,000 x g in an Eppendorf F-45-30-11 rotor (Eppendorf, Westbury, NY, 
USA) for 10 min at 4ºC. The supernatant was then centrifuged at 197,568 x g in a TH-
641 rotor (Sorvall, Newtown, CT, USA) for 1 h at 4 ºC. The high speed pellet was 
resuspended in about 1 mL lysis buffer and the protein concentration was determined by 
the method of Lowry. Samples were then stored at -80 °C until needed. In some cases an 
aliquot of each sample was combined with reducing SDS sample buffer (2X) and 
analyzed by western blotting. 
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Western blotting 
For preparation of immunoblots, reducing SDS sample buffer (2X) was added to 
all undigested and digested reactions of membrane proteins, partially M2 immunoaffinity 
purified Kv3.1 protein samples, as well as B35 membranes, and was subjected to 
electrophoresis for 100 min at 20 mAmps on SDS-PAGE gels in a Mini Protean® Cell 
(Bio-Rad, Hercules, CA, USA). 10% SDS-PAGE gels were used for Kv3 and N-CAM 
proteins while 12% and 15% were utilized for Kv1 and transferrin proteins, respectively, 
unless otherwise indicated. Separated proteins were transferred to Immobilon-P PVDF 
(Millipore, Billercia, MA, USA) membranes for 1-1.5 h at 175 mAmp using a Mini 
Trans-Blot
® 
Cell (Bio-Rad, Hercules, CA, USA) containing CAPS buffer (10 mM 3-
cyclohexylamino-1-propane sulfonic acid, 10% methanol; pH 11). However, 
nitrocellulose (Invitrogen, Carlsbad, CA, USA) membranes were utilized for the anti-
Kv1.2 antibody. Next, blotted membranes were blocked by incubation for 30 min in 
membrane blocking buffer (PBS, 3% BSA with 0.1% Tween 20). Blotted membranes 
were then incubated with commercially available anti-Kv1 (NeuroMab, Davis, CA, 
USA), anti-Kv3 (Alamone Labs, Jerusalem, Israel), anti-N-CAM (Cell Signaling 
Technology, Danvers, MA, USA), or anti-transferrin (Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA, USA) antibodies for 2 h at room temperature. However, the incubation 
of the anti-Kv1.2 antibody with heart membrane proteins was allowed to proceed 
overnight at 4 °C. The Kv antibodies are specific for: rat Kv1.1 (accession no. P10499), 
EEDMNNSIAHYRQANIRTG; rat Kv1.2 (accession no. P63142), 
EGVNNSNEDFREENLKTA; rat Kv1.4 (accession no. P15385), 
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NSHMPYGYAAQARARERERLAHSR; rat Kv3.1b (accession no. P25122), 
CKESPVIAKYMPTEAVRT; rat Kv3.3 (accession no. Q01956), 
KSPITPGSRGRYSRDRAC; and rat Kv 3.4 (accession no. Q63734), 
EAGDDERELALQRLGPHEG(C). The specificities of the anti-Kv1 (59) and anti-Kv3 
(35,37,116) antibodies have been previously described. Following incubation, blotted 
membranes were washed three times with PBS plus 0.1% Tween 20 and then treated with 
their specific alkaline phosphate conjugated secondary antibody for 2 h. In some cases, 
the incubation proceeded overnight at 4 °C. Following three washes with PBS plus 0.1% 
Tween 20, bound antibodies were detected by ImmunO alkaline phosphatase substrate 
(MP Biomedicals, Irvine, CA, USA).  
 
Western blot analysis 
 The level of each Kv3 protein in the various tissues tested was determined by 
comparing the intensity and surface area of the immunobands when equal amounts were 
loaded. Alternatively, Western blots were subjected to quantitative analysis using 
UNSCANIT computer software (Silk Scientific, Inc., Orem, UT, USA) for parametric 
tests. Immunobands were digitized and the total number of pixels for each of the 
designated immunobands was counted. Background intensity was subtracted from each 
of the designated band intensities. Values of intensity differences were normalized using 
the net intensity of stripped brain. Relative molecular masses (Mr) for the Kv3 proteins 
were estimated by plotting the log of the molecular masses for each of the Kaleidoscope 
marker (Bio-Rad, Hercules, CA, USA) bands as a function of their relative mobilities. A 
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linear equation derived from the least-squares method was then used to generate the 
apparent molecular mass. To enhance protein separation, the dye front was permitted to 
run off the gel, therefore the relative mobility (Rf) is defined as the distance migrated by 
the immunoband divided by the length of the separating gel. Differences in the relative 
electrophoretic mobility (∆Rf x 100) represent the electrophoretic mobility shifts induced 
by the various glycosidase treatments for each of the glycoproteins. Group data were 
presented as mean ± S.E. (n represents the number of Western blots). When comparing 
the significance of two groups, the unpaired Student’s t test was utilized. All experiments 
involving comparisons between multiple groups were analyzed using a one-way ANOVA 
followed by Bonferroni’s post hoc-tests. A value of P < 0.05 was considered significant.  
 
Whole cell recordings 
 Electrophysiological measurements were obtained from stable transfected B35 
cells using the whole cell configuration of the patch clamp technique. Whole cell K+ 
currents were recorded at room temperature with an Axopatch 200B amplifier (Axon 
Instruments, Sunnyvale, CA, USA) controlled by CLAMPEX 9.0 software (Axon 
Instruments, Sunnyvale, CA, USA) running on a Dell Optiplex GX270 Pentium desktop 
computer using a Digidata 1322A analog-to-digital interface (Axon Instruments, 
Sunnyvale, CA, USA). Whole cell recordings were primarily conducted in pairs to reduce 
possible differences due to passage number and cell treatment. These differences were 
minimized by conducting the cell transfections and whole cell recordings in parallel for 
each pair. The two pairs were wild type Kv3.1 and N220Q/N229Q channels, and the two 
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single mutant channels, N220Q and N229Q. In some cases, whole cell recordings of 
either wild type Kv3.1 or N220Q/N229Q were conducted along side the single mutants. 
The external bath solution utilized during recordings had the following composition (in 
mM): 5 potassium aspartate, 135 sodium aspartate, 1 MgCl2 hexahydrate, 10 Mes, 60 
mannitol (pH 6.3). The measured osmolarity of the external bath solution was 295-312 
mOsm. Borosilicate glass tubing (Sutter Instruments, Novato, CA, USA) was pulled with 
a P-97 Flaming-Brown micropipette puller (Sutter Instruments, Novato, CA, USA) and 
fire polished with a MF-830 microforge (Narishige, McHenry, IL, USA) to obtain patch 
pipettes with a resistance of 4-9 MΩ when filled with intracellular solution. The 
intracellular solution contained (in mM): 140 potassium aspartate, 10 EGTA, 5 MgCl2 
hexahydrate, 10 Hepes, 50 mannitol (pH 7.2). The measured osmolarity of the internal 
pipette solution was 320-340 mOsm. For comparative reasons, the solutions were similar 
to those previously used to examine the functional role of simple type glycans attached to 
the Kv3.1 channel in Sf9 cells (35). The only difference between the solutions was the 
slightly higher osmolarity for the mammalian cells. Both cell capacitance and series 
resistance was compensated for throughout the course of experiments. The patch pipette 
silver/silver chloride wire was connected to the input of an Axopatch 200B amplifier 
through a salt bridge (plastic pipette tip filled with 3% Agarose in 0.3M KCl). All Kv3.1 
currents were sampled at 10 kHz subsequent filtering at 1 kHz. Whole cell current 
recordings were accepted during these experiments only if membrane seal resistance was 
≥ 1GΩ, minimum current amplitudes were ≥ 400 pA and minimal cell capacitance was 
displayed after compensation. Of note, the endogenous current was minor in 
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nontransfected B35 cells (the mean maximum current amplitude was 37.9 ± 4.2 pA with 
a mean capacitance of 11.6 ± 1.6 pF, n =21) compared to the Kv3.1 transfected B35 cells 
(Table 1). Whole cell recordings were acquired from several voltage clamp protocols. For 
the activation protocols, K+ currents were elicited by depolarizing pulses (100 ms and 2 
s) from -40 mV to +80 mV in 10 mV increments at a holding potential of -50 mV. 
Currents were evoked from deactivation protocols by stepping to +40 mV (25 ms) and 
then stepping from -110 mV to 0mV (200 ms) in 10 mV increments from a holding 
potential of -50 mV.  
 
Current analysis 
 Digitized whole cell current recordings from stable transfected B35 cells were 
analyzed using the CLAMPFIT 9.0 analysis program (Axon Instruments, Sunnyvale, CA, 
USA). Graphs were generated using Origin 7.5 (OriginLab Corporation, Northampton, 
MA, USA). Normalized conductance-voltage relationships were constructed by 
normalizing conductance to maximal conductance and were fitted with a Boltzmann 
equation of the form: G = Gmax/[1 + exp(V0.5 - Vm)/q] where q represents the slope factor, 
Vm stands for the test potential, V0.5 is the potential at which the conductance was half 
maximal, G is the conductance and Gmax is the maximal conductance. For activation 
kinetics, whole cell current recordings were analyzed by both rise times and activation 
time constants. Rise times represent the time required for the current to rise from 10% to 
90% of its peak current at a given applied test potential. Activation time constants were 
fitted with a single exponential function at +40 mV. The mean deactivation time constant 
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(tau) was determined by fitting the current at -60 mV with a single exponential. For 
inactivation kinetics the percentage of current decay at +40 mV and +60 mV was 
determined by dividing the peak current amplitude by the current remaining near the last 
10 ms of the +40 mV and +60 mV sweep. The peak current amplitude was determined 
from 3 ms of data points for inactivating currents and noninactivating currents without 
transient peaks, as well as from 1 ms for noninactivating currents with transient peaks. 
Current density was calculated by dividing the maximum current amplitude for each 
stable transfected B35 cell by the cell capacitance. Data are presented as the mean ± S.E. 
and n represents the number of cells tested. Student’s t-test was utilized to evaluate the 
statistical comparisons. One-way ANOVA was used to evaluate statistical significance 
when more than two groups were compared. Statistical significance was considered at P 
< 0.05 or P < 0.01 as indicated in the figure legends. 
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Abstract 
Neuronal Kv3 voltage-gated K
+ channels have two absolutely conserved N-
glycosylation sites. Here, it is shown that Kv3.1, 3.3, and 3.4 channels are N-glycosylated 
in rat brain. Digestion of total brain membranes with peptide N glycosidase F (PNGase F) 
produced faster migrating immunobands than those of undigested membranes. 
Additionally, partial PNGase F digests showed that both sites are occupied by 
oligosaccharides. Neuraminidase treatment produced a smaller immunoband shift relative 
to PNGase F treatment. These results indicate that both sites are highly available and 
occupied by N-linked oligosaccharides for Kv3.1, 3.3, and 3.4 in rat brain, and 
furthermore that at least one oligosaccharide is of complex type. Additionally, these 
results point to an extracytoplasmic S1–S2 linker in Kv3 proteins expressed in native 
membranes. We suggest that N-glycosylation processing of Kv3 channels is critical for 
the expression of K
+
currents at the surface of neurons, and perhaps contributes to the 
pathophysiology of congenital disorders of glycosylation. 
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Introduction 
The Kv3 channel family is part of the large super gene family of voltage gated K
+ 
(Kv)
1
channels. These channels play an essential role in enabling neurons to fire 
repetitively at high frequencies (14). There are four different Kv3 genes: Kv3.1, 3.2, 3.3 
and 3.4, and by alternative splicing encode for multiple protein isoforms with divergent C 
termini(15,18,31-33). Hydropathy plots predict that Kv3 channels possess six 
transmembrane segments (S1–S6) with cytoplasmic amino-and carboxyl-termini (Figure 
3). The Kv3 multiple protein isoforms have two absolutely conserved sites for N-
glycosylation which lie within the S1–S2 extracytoplasmic loop. Amino acid sequence 
identity of the S1–S2 linker is 100% identical for the Kv3.1 protein of: rat, human, 
mouse, rabbit and cattle, and greater than 95% for the Kv3.4 protein (Figure 4). Sequence 
identity is also highly conserved for Kv3.2 and Kv3.3 proteins. 
Attachment of N-linked oligosaccharides to newly synthesized membrane 
proteins is the most ubiquitous protein co-translational modification in the lumen of the 
endoplasmic reticulum (ER) (105). The required protein consensus sequence is 
AsnXxxSer/Thr, where Xxx can be any amino acid except for proline. Maturation of the 
glycoprotein occurs in the lumen of the ER and Golgi apparatus. The importance of the 
N-glycosylation process has been indicated in congenital disorders of glycosylation 
(CDG) (64) and mice mutants (80,81,117,118). Of recent, endoplasmic reticulum (ER) 
stress has been suggested to be associated with neurodegenerative diseases (73).   
N-Glycosylation of K
+ 
channels has been shown to influence: folding, trafficking, 
and function (35,58,83,86,119). It has also been used as an extracellular marker to verify 
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Figure 3. Topological model of Kv3 channels 
 The Kv3 monomeric unit in a lipid bilayer. Transmembrane segments (S1–S6) are 
represented by cylinders in the lipid bilayer. The first transmembrane segment (S1) to the 
sixth transmembrane segment (S6) proceed counter clockwise. Black circles denote the 
Asn of the two native N-glycosylation consensus sequences for Kv3 channels. Branched 
structures represent N-linked oligosaccharides.  
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Figure 4. Amino acid sequence alignments of the S1–S2 linker of Kv3 channels 
 Alignments of available amino acid sequences of the S1–S2 linker for Kv3 
channels in: rat, human, mouse, rabbit, and cattle. Conserved, native N-glycosylation 
sites are shown as underlined, enlarged font. The italicized number indicates the first 
residue of the S1–S2 linker. The shaded regions represent amino acids which are non-
identical. Accession numbers are as follows: Kv3.1 Rat P25122, Human P48547, Mouse 
P15388, Rabbit AAX23602, Cattle AAX23601; Kv3.2 Rat P22462, Human AAO89503, 
Mouse NP_001020752; Kv3.3 Rat Q01956, Human Q14003, Mouse Q63959, Rabbit 
AAN15930; Kv3.4 Rat Q63734, Human Q03721, Mouse NP_666034, Rabbit 
AAM46839, Cattle XP_613047. 
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Figure 4
Cartwright et al., 2006
Kv3.1 Rat    210 ETHERFNPIVNKTEIENVRNGTQVRYYREAETEAFLTY
Kv3.1 Human  210 ETHERFNPIVNKTEIENVRNGTQVRYYREAETEAFLTY
Kv3.1 Mouse  210 ETHERFNPIVNKTEIENVRNGTQVRYYREAETEAFLTY
Kv3.1 Rabbit 210 ETHERFNPIVNKTEIENVRNGTQVRYYREAETEAFLTY
Kv3.1 Cattle 210 ETHERFNPIVNKTEIENVRNGTQVRYYREAETEAFLTY
Kv3.2 Rat    249 ETHEAFNIVKNKTEPVINGTSAVLQYEIETDPALTY
Kv3.2 Human  249 ETHEAFNIVKNKTEPVINGTSVVLQYEIETDPALTY
Kv3.2 Mouse  253 ETHEAFNIVKNKTEPVINGTSPVLQYEIETDPALTY
Kv3.3 Rat    311 ETHEGFIHISNKTVTQASPIPGAPPENITNVEVETEPFLTY
Kv3.3 Human  310 ETHEGFIHISNKTVTQASPIPGAPPENITNVEVETEPFLTY
Kv3.3  Mouse  310 ETHEGFIHISNKTVTQASPIPGAPPENITNVEVETEPFLTY
Kv3.3 Rabbit 312 ETHEGFIHISNKTVTQASPIPGAPPENVTNVEVETEPFLTY
Kv3.4 Rat    249 ETHEAFNIDRNVTEIHRVGNITSVRFRREVETEPILTY
Kv3.4 Human 248 ETHEAFNIDRNVTEILRVGNITSVHFRREVETEPILTY
Kv3.4 Mouse  252 ETHEAFNIDRNVTEIHRVGNITSVRFRREVETEPILTY
Kv3.4 Rabbit 72 ETHEAFNIDRNVTEIHRVGNITSVRFRREVETEPILTY
Kv3.4 Cattle 243 ETHEAFNIDRNVTEIHRVGNTTSVRFRREVETEPILTY
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topological K+ channel structure (35,120-123). Here we have evaluated utilization of the 
N-glycosylation consensus sequences of Kv3.1, 3.3, and 3.4 in rat brain. Western blots of 
total brain membranes demonstrated that Kv3.1, 3.3, and 3.4 proteins were expressed in 
rat brain. When total brain membranes were treated with peptide N glycosidase F 
(PNGase F) or neuraminidase, immunobands of Kv3.1, 3.3, and 3.4 migrated faster than 
those from untreated membranes. Endoglycosidase H (Endo H) treatment of total 
membranes did not alter the immunoband patterns of Kv3.1, 3.3, and 3.4 from those of 
untreated samples. Based on enzyme specificities and electrophoretic migration patterns, 
our results indicate that both N-glycosylation sites are highly available and occupied by 
N-linked oligosaccharides of either hybrid or complex types. In addition, these results 
indicate that the S1-S2 loop is extracytoplasmic in native membranes. Given the above 
observations, the high conservation of N-glycosylation sites, and CDG diseases, we 
suggest that N-glycosylation processing of the Kv3 channels is critical in regulating the 
expression of K+ currents at the surface of neurons. 
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Results  
N-Glycosylation of Kv3 channels 
 
Two absolutely conserved N-glycosylation consensus sequences of Kv3 proteins 
are located between the first two transmembrane segments (S1-S2; Figure 3). The first 
site is predicted to be 10 amino acid residues from the C-terminus of the S1 segment, the 
last site is at least 12 amino acid residues from the N-terminus of the S2 segment, and the 
number of amino acid residues between the sites is at least 4 (Figure 4). Membranes were 
isolated from total brain of an adult female rat. Total brain membranes were digested 
with EndoH (an endoglycosidase which removes high mannose oligosaccharides) [23], 
and PNGase F(an amidase which removes high mannose, hybrid, and complex 
oligosaccharides) (124) and then analyzed by Western blots (Figure 5). When brain 
membrane proteins separated on a 10% SDS gel were transferred to blotting membranes 
and probed with anti-Kv3.1b antibodies, a diffused immunoband which migrated to about 
110 kDa was observed (Figure 5A). The electrophoretic mobility of this band remained 
unchanged when membrane proteins were treated with Endo H. However, when 
membrane proteins were digested with PNGase F, the immunoband migrated much faster 
to about 84 kDa, as we have previously shown (35). The relative molecular weight of the 
Kv3.1 protein was much larger than the calculated molecular weight of 66 kDa. To 
demonstrate that the Kv3.1 immunoband did not shift as a result of inactive Endo H 
under the reaction conditions, partially purified Kv3.1 heterologously expressed in Sf9 
cells was added to total rat brain membranes prior to Endo H digestion (Figure 5B). 
Previously, we showed that Kv3.1 expressed in infected Sf9 cells has both sites occupied 
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Figure 5. Kv3 proteins are N-glycosylated in rat brain tissue 
 Total rat brain membranes were untreated (−) or treated (+) with Endo H or 
PNGase F as indicated, subjected to SDS-PAGE and immunoblotted using anti-Kv3.1b 
(A), anti-Kv3.3 (C), and anti-Kv3.4 (D) antibodies. As a control Endo H digestion was 
carried out in total rat brain membranes supplemented with partially purified Kv3.1 from 
infected Sf9 cells (B). The black arrows point to glycosylated (upper arrow) Kv3 protein 
derived from rat brain or unglycosylated (lower arrow) Kv3 proteins from rat brain or 
infected Sf9 cells for each panel. The gray arrow represents glycosylated Kv3.1 protein 
expressed in infected Sf9 cells(B).Ovals represent Kaleidoscope™ protein standards (top 
to bottom in kDa): 250, 150, 100, and 75. 
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by simple type N-glycans (35). This result is verified when Kv3.1 protein derived from 
Sf9 cells is digested in the presence of total rat brain membranes. Of note, the Kv3.1 
protein derived from rat brain shows a similar electrophoretic migration as undigested 
samples. Taken together, these results indicate that the N-glycans attached to Kv3.1 in the 
rat brain are hybrid or complex types, not simple type. 
Similar sets of experiments were performed using either anti-Kv3.3 (Figure 5C) 
or anti-Kv3.4 (Figure 5D) antibodies to probe blotting membranes. In both cases the 
immunobands migrated faster when total brain membranes were digested with PNGase F, 
but not Endo H. Relative molecular weights of Kv3.3 and Kv3.4 proteins in total rat brain 
membranes were about 131 kDa and 121 kDa, respectively. When samples were treated 
with PNGase F, relative molecular weights of Kv3.3 and Kv3.4 proteins were about 107 
kDa and 102 kDa, respectively. In all cases, the relative molecular weights were quite 
large compared to their calculated molecular weights of 94 kDa for Kv3.3 and 68 kDa for 
Kv3.4. Previous studies are in agreement that Kv3.1b (38-40,125), Kv3.3 (126) and 
Kv3.4 (127) proteins migrate much slower than their calculated molecular weights when 
expressed in native tissue. However, it was not demonstrated in these studies whether the 
slower migration patterns were due to N-glycosylation. Our results indicate that Kv3.1, 
3.3 and 3.4 channel proteins have N-linked oligosaccharides of hybrid or complex types, 
and furthermore that the channels are following the N-glycosylation processing route for 
delivery of functional channels to the plasma membrane. Additionally, these results show 
that the expression of Kv3.4 protein is easily detected, like Kv3.1 and 3.3, even though 
the transcript levels have been reported to be relatively low (22). 
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Occupancy of both conserved N-glycosylation sites 
 
To show that both native N-glycosylation consensus sequences were indeed 
occupied by oligosaccharides, partial PNGase F digestions were conducted (Figure 6). 
When membranes were digested with the two lower amounts of PNGase F, an 
immunoband corresponding to the Kv3.1 immunoband identified in untreated membranes 
was observed (Figure 6A). However, this immunoband was much broader and occurred 
in the downward direction. The Kv3.1 immunoband broadening appeared much like a 
diffused doublet, and suggested the removal of one of the N-linked oligosaccharides. 
Indeed this was the case, the lower band of the doublet became quite defined at the 
highest level of PNGase F, the upper band disappeared, and furthermore an even faster 
migrating band was observed (Figure 6A). The upper band corresponded to the fully 
glycosylated Kv3.1 protein and was similar to Kv3.1 identified in membranes which were 
not digested with PNGase F (Figure 5A). The fastest migrating band corresponded to the 
unglycosylated Kv3.1 protein which was identified by complete digestion with PNGaseF 
as shown in Figure 5A. The middle band was assigned to Kv3.1 with one site occupied 
by N-linked oligosaccharide. These results demonstrate the Kv3.1 protein has both sites 
utilized in native tissue, similar to that previously shown when Kv3.1 was expressed in 
Spodoptera frugiperda (Sf9) cells (35). When partial PNGase F digestions were carried 
out with Kv3.3 (Figure 6B) and Kv3.4 (Figure 6C) proteins, the findings were similar to 
that of the Kv3.1 channel. As the amount of PNGase F was increased, the upper 
immunoband or the fully glycosylated forms of both Kv3.3 and 3.4 channels disappeared, 
while two distinct lower bands could be observed. In both cases, the lowest band 
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Figure 6. Utilization of both N-glycosylation sites for Kv3 proteins  
 Total rat brain membranes were treated with various dilutions of PNGase F (25-
fold, +++; 80-fold, ++; and 100-fold, +). After digestions, samples were analyzed by 
Western blots using anti-Kv3.1b (A), anti-Kv3.3 (B), and anti-Kv3.4 (C) antibodies. The 
upper arrow represents fully glycosylated Kv3 proteins, the center arrow is one 
glycosylation site of the Kv3 protein occupied, and the lowest arrow is unglycosylated 
Kv3 protein. Ovals represent molecular weight standards (top to bottom in kDa): 250, 
150, 100, and 75. 
 53
Figure 6 
Cartwright et al., 2006
B.
C.
+++ ++ +
PNGase F
A.
+++ ++ +
PNGase F
+++ ++ +
PNGase F
Anti-Kv3.1
Anti-Kv3.3
Anti-Kv3.4
 
 54
corresponded to unglycosylated Kv3.3 or 3.4 proteins, while the middle band represented 
occupancy of one glycosylation site, and the upper band was occupancy of both 
glycosylation sites. 
 
N-Linked oligosaccharides are of complex type 
 
Neuraminidase, an enzyme which removes α2–3, α2–6, and α2–8 linked sialic 
acid residues from oligosaccharides (79), was utilized to determine whether the N-
glycans of Kv3.1, 3.3 and 3.4 were of complex type. Total brain membranes were treated 
with three different amounts of neuraminidase, and then Kv3.1b (Figure 7A), Kv3.3 
(Figure 7B), and Kv 3.4 (Figure 7C) proteins were identified by Western blotting. In all 
cases, a downward shift of the immunobands was observed in the samples treated with 
neuraminidase. The shift was much more dramatic for Kv3.1 and Kv3.3 proteins than that 
of the Kv3.4 protein. These results indicate that at least one N-linked oligosaccharide is 
of complex type for Kv3.1, 3.2, and 3.4.  
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Figure 7. N-Linked oligosaccharides of Kv3 proteins are of complex type 
Total rat brain membranes were untreated (−) or treated with increasing amounts 
(+, ++, +++) of neuraminidase, and immunoblotted using anti-Kv3.1b (A), anti-Kv3.3 
(B), and anti-Kv3.4 (C) antibodies. The upper arrows represent the native Kv3 glycoform 
and the lower arrow represents Kv3 protein with various amounts of sialic acid residues 
removed. Ovals are Kaleidoscope™ protein standards (top to bottom in kDa): 250, 150, 
100, and 75. 
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Discussion 
Here the results show that the two absolutely conserved N-glycosylation sites of 
Kv3.1 (NKT, amino acid residues at positions 220–222 and NGT, amino acid residues at 
positions 229–231), Kv3.3 (NKT, amino acid residues at positions 221– 223 and NIT, 
amino acid residues at positions 237–239), and Kv3.4 (NVT, amino acid residues at 
positions 259–261 and NIT, amino acid residues at positions 268–270) are occupied by 
large hydrophilic oligosaccharides in rat brain. Occupancy of these sites provides 
evidence that the S1–S2 linkers of Kv3.1, 3.3 and 3.4 channels are fairly flexible and in 
an aqueous environment (Figure 3). This finding is in agreement with glycosylation of 
the S1–S2 linker of other Kv channels (35,86,123,128-130). However, it is quite different 
from the X-ray structure of a Kv channel from Aeropyrum pernix (KvAP) which 
suggested the S1–S2 linker resides in the membrane for all Kv channels (131). 
Secondly, these results show that virtually all of the Kv3.1, 3.3, and 3.4 channel 
proteins are N-glycosylated in total rat brain membranes indicating the availability of 
sites to the oligosaccharyltransferase is high. Occupancy of N-glycosylation sites is also 
regulated by enzyme kinetics and substrate levels in the ER (132). Therefore, it is 
plausible that certain cell types of the brain, which have either lower enzyme activities or 
lower levels of substrate, may generate some Kv3 protein with vacant N-glycosylation 
sites. 
CDG group I patients have unoccupied N-glycosylation sites due to defective 
enzymes involved in the biosynthesis of the lipid-linked core oligosaccharide (64). Based 
on high occupancy of the Kv3.1, 3.3, and 3.4 channels in total brain, it would be very 
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likely that occupancy of Kv3.1, 3.3, and 3.4 channels would be lower in CDG group I 
patients than normal individuals. Previously, we have shown that unglycosylated Kv3.1 
channels expressed in Sf9 cells have slower activation kinetics than glycosylated Kv3.1 
channels (35). Taken together, it could be suggested that the Kv3 channels contribute to 
abnormal brain development, and aberrant function of the nervous system in CDG group 
I patients. 
CDG diseases emphasize the importance of occupied N-glycosylation sites and 
distinct N-linked oligosaccharide structures for mammalian physiology (64). The 
influence of N-glycosylation on the initiation and development of human neuronal 
diseases are unknown. However, it has recently been suggested that ER stress contributes 
to some human neurodegenerative diseases (73). Future studies are needed to determine 
whether environmental factors or infections which cause ER stress alter occupancy or N-
linked oligosaccharide structure of neuronal proteins such as the Kv3 channels. 
 
CHAPTER 5 - NOVEL KV3 GLYCOFORMS DIFFERENTIALLY EXPRESSED 
IN ADULT MAMMALIAN BRAIN CONTAIN SIALYLATED N-GLYCANS 
 
 
Ruth A. Schwalbe, Melissa J. Corey and Tara A. Cartwright 
Biochemistry and Cell Biology 86 (2008) 21-30 
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Abstract 
 
The N-glycan pool of mammalian brain contains remarkably high levels of 
sialylated N-glycans. This study provides the first evidence that voltage-gated K+ 
channels, Kv3.1, 3.3, and 3.4, possess distinct sialylated N-glycan structures throughout 
the central nervous system of the adult rat. Electrophoretic migration patterns of Kv3.1, 
3.3, and 3.4 glycoproteins from: spinal cord, hypothalamus, thalamus, cerebral cortex, 
hippocampus, and cerebellum membranes digested with glycosidases were used to 
identify the various glycoforms. Differences in the migration of Kv3 proteins were 
attributed to the desialylated N-glycans. Expression levels of the Kv3 proteins were 
highest in cerebellum, whereas those of Kv3.1 and Kv3.3 were much lower in the other 
five regions. The lowest level of Kv3.1 was expressed in the hypothalamus, whereas the 
lowest levels of Kv3.3 were expressed in both thalamus and hypothalamus. The other 
regions expressed intermediate levels of Kv3.3, with spinal cord expressing the highest.  
The expression level of Kv3.4 in the hippocampus was slightly lower than that in 
cerebellum, and was closely followed by the other four regions, with spinal cord 
expressing the lowest level. We suggest that novel Kv3 glycoforms may endow 
differences in channel function and expression among regions throughout the central 
nervous system.  
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Introduction 
Kv3 channels belong to the super gene family of voltage gated K+ (Kv)1 channels 
and are present in both axonal and somatodendritic compartments of neurons, where they 
regulate the intrinsic electrical excitability (16). Four mammalian genes have been 
identified which belong to the Kv3 family: Kv3.1, Kv3.2, Kv3.3 and Kv3.4. Expression 
levels of Kv3.1 and 3.3 transcripts are higher than those of Kv3.2 and Kv3.4 in adult rat 
brain (22,32,36). The amino acid sequence of the Kv3 proteins has revealed two N-
glycosylation consensus sequences that lie within the first extracellular loop. Previously, 
these two absolutely conserved N-glycosylation sites of Kv3.1, 3.3, and 3.4 proteins were 
shown to be utilized in adult rat brain (Figure 8) (116). 
N-Glycosylation of nascent membrane proteins is the most ubiquitous protein co-
translational modification (105). Inside the cell this modification has been shown to be 
involved in protein folding and assembly, as well as intracellular protein sorting (61,133). 
Outside the cell the oligosaccharides have been shown to be involved in: cell adhesion, as 
well as cell-ligand, cell-cell, and cell-microbe interactions (61,133). A more recent view 
of N-glycosylation is the role of N-linked oligosaccharides in the modulation of protein 
function (133). In the past decade, the biological importance of the N-glycosylation 
pathway in mammalian physiology has been emphasized by the identification of 
congenital disorders of glycosylation (CDG) in humans (134) and mutant glycosylation 
mice (80,81,117,118,135-137). Additionally, it has been suggested that ER stress, which 
would most likely alter N-glycosylation occupancy, may lead to several 
neurodegenerative diseases (73). 
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Figure 8. Topological model of a Kv3 monomeric unit with sialylated N-glycans  
The six transmembrane segments (S1-S6) are represented by cylinders in the lipid 
bilayer. Both N- and C- termini are localized in the cytoplasm. Black circles denote the 
Asn residues of the two native N-glycosylation consensus sequences for Kv3 channels. 
Branched structures signify N-sialylated glycans occupying the two native N-
glycosylation sites. The gray circles correspond to sialic acid residues which terminate 
the N-linked oligosaccharides. 
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To date there are few studies that have characterized the importance of N-
glycosylation of potassium channels. However, N-glycosylation of Kir1.1 stabilizes the 
opening state of the channel (119). Additionally, the activation kinetics of the Kv3.1 
channel with simple type N-glycans was faster compared to its unglycosylated 
counterpart heterologously expressed in Spodoptera frugiperdae, Sf9 cells (35). Here we 
show that Kv3.1, Kv3.3, and Kv3.4 glycoproteins are expressed in: hypothalamus, 
cerebral cortex, cerebellum, hippocampus, spinal cord, and thalamus of the adult rat. 
Moreover, we show that the protein expression patterns of these various regions are 
different for each of the Kv3 proteins. Immunoband shift assays of cerebellum, 
hypothalamus, cerebral cortex, thalamus, hippocampus and spinal cord membranes, both 
treated and untreated with various glycosidases, were used to identify different Kv3.1, 
3.3, and 3.4 glycoforms throughout the central nervous system. Additionally, the results 
indicated that the sialylated N-glycan structures of Kv3.1, 3.3 and 3.4 differed by their 
neutral N-glycan structures which give rise to the sialylated structures. 
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Results 
N-Glycans of neuronal Kv3 channels contain sialic acid residues 
 The two N-glycosylation sites in the first extracytoplasmic loop of Kv3.1, 3.3 and 
3.4 channels were shown to be utilized in rat brain (35,116). To directly demonstrate that 
the N-glycans of Kv3 channels were composed of sialyl residues, stripped brain 
membranes were treated with and without different combinations of PNGase F and 
neuraminidase under nondenaturing conditions (Figure 9). PNGase F is an amidase which 
removes high mannose, hybrid, and complex N-linked oligosaccharides (124). 
Neuraminidase (Clostridium perfringens) is an exoglycosidase which removes sialyl 
residues with α2,3- α2,6- and α2,8-linkages (79). Upon treatment of stripped brain 
membranes with PNGase F, there were large shifts in the electrophoretic mobilities of 
Kv3.1 (Figure 9A), Kv3.3 (Figure 9B), and Kv3.4 (Figure 9C) proteins. This result was 
similar to PNGase F digestions performed previously under denaturing conditions for 
these Kv3 channels (116). The immunoband shifts produced by neuraminidase were 
smaller than those generated by PNGase F treatment by approximately 75%. When 
membranes were treated with PNGase F and neuraminidase simultaneously the 
electrophoretic mobility shifts of Kv3.1 (Figure 9A), Kv3.3 (Figure 9B) and Kv3.4 
(Figure 9C) were virtually identical to those treated solely with PNGase F. These results 
directly demonstrated that the N-glycans of Kv3.1, 3.3, and 3.4 glycoproteins contain 
sialic acid residues. 
The values for the Mr for all three Kv3 proteins were greater (Kv3.1, 112,578 ± 
1,397 Da, n=30 blots; Kv3.3, 129,236 ± 1,166 Da, n=32 blots; and Kv3.4, 117,149 ± 
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Figure 9. N-Linked oligosaccharides of Kv3.1, Kv3.3, and Kv3.4 proteins are 
composed of sialic acid residues         
 Western blots of brain membrane proteins untreated (-) or treated (+) with various 
combinations of PNGase F and neuraminidase were probed with (A) anti-Kv3.1, (B) anti-
Kv3.3, and (C) anti-Kv3.4 antibodies. Ovals represent the KaleidoscopeTM protein 
molecular mass standards, as indicated. (D) The mean Mr values (in Da) for the Kv3 
immunobands (white bars) were as follows: Kv3.1, 112,578 ± 1,397 (n= 30 blots); Kv3.3, 
129,236 ± 1,166 (n=32 blots); Kv3.4, 117,149 ± 1,185 (n=31 blots). The asterisk 
indicates statistical significance between the neighboring white bars; p <0.05. The mean 
Mr values for the N-glycans (gray bars) were as follows: Kv3.1, 27,241 ± 1,408 (n= 11 
blots); Kv3.3, 27,724 ± 1,901 (n= 10 blots); Kv3.4, 25,395 ± 707 (n= 11 blots). These 
values represent the difference between the Mr for the Kv3 proteins with and without 
PNGase F treatment. The mean Mr values for the sialic acid residue content (black bars) 
were as follows: Kv3.1, 8,019 ± 929 (n=10 blots); Kv3.3, 6,376 ± 1,245 (n=7 blots); 
Kv3.4, 6,200 ± 777 (n=9 blots). These values denote the difference between Mr values for 
the Kv3 samples treated and untreated with neuraminidase. 
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1,185 Da, n=31 blots) than their calculated molecular masses deduced from amino acid 
sequences (Kv3.1, 66 kDa; Kv3.3, 94 kDa; and Kv3.4, 68 kDa) (Figure 9D, white bars). 
The mean Mr values for the Kv3 protein with the N-glycans removed were also higher 
(Kv3.1, 85,300 ± 1,373 Da, n=11 blots; Kv3.3, 105,562 ± 1,632 Da, n=10 blots; and 
Kv3.4, 95,350 ± 2,607 Da, n=11 blots). In all cases, the neighbors were statistically 
different from one another, supporting the specificity of the various Kv3 antibodies. In 
part the larger apparent molecular mass resulted from the N-glycans. However, other 
factors also appeared to influence the slower electrophoretic migration of these 
membrane proteins relative to the globular protein standards (116). 
The electrophoretic migration of the two N-linked oligosaccharides was 
determined by the difference between the means of the Mr for each Kv3 protein in the 
absence and presence of PNGase F. Interestingly, N-glycans were remarkably similar for 
all three Kv3 proteins (Kv3.1, 27,241 ± 1,408 Da, n=11 blots; Kv3.3, 27,724 ± 1,901 Da, 
n=10 blots; and Kv3.4, 25,395 ± 707 Da, n=11 blots) (Figure 9D, grey bars). The percent 
of the N-glycan shift resulting from sialic acid residues was also quite similar for all three 
Kv3 proteins (Kv3.1, 8,019 ± 929 Da, n=10 blots; Kv3.3, 6,376 ± 1,245 Da, n=7 blots; 
and Kv3.4, 6,200 ± 777 Da, n=9 blots) (Figure 9D, black bars). This calculation was 
determined by the difference between the electrophoretic migration of the respective Kv3 
protein treated and untreated with neuraminidase. The relatively large electrophoretic 
mobility shift produced by neuraminidase treatment of all three Kv3 proteins prior to N-
glycan removal suggested that the sialic acid content of the N-glycans was remarkably 
high. Hence, our results directly showed that the N-glycans are capped with at least 
  
69
 
several sialic acid residues for Kv3.1, 3.3, and 3.4 glycoproteins (Figure 8). They also 
confirmed that the Kv3 glycoproteins expressed in brain were of different sizes. 
 
Protein levels of Kv3.1,Kv3.3, and Kv3.4 throughout the central nervous system 
 When equal amounts of membrane protein were loaded per well, the amount of 
Kv3.1 (Figure 10A, left panel) protein in cerebellum was much higher than in: 
hypothalamus, cerebral cortex, hippocampus, spinal cord, or thalamus. It was also higher 
than that in stripped brain which correlates with the lower amounts in the other regions of 
brain. The Kv3.1 band in cerebellum was darker than those in the other regions on eleven 
out of eleven Western blots. The lightest band was detected in hypothalamus seven out of 
eleven times while differences were not observed between the other four regions. 
Statistical analysis supported the observation that Kv3.1 protein levels were highest in 
cerebellum but not that hypothalamus expressed the lowest level (Figure 10B, left panel). 
Kv3.3 protein levels in various regions of the central nervous system could be 
divided into four categories based on the Kv3.3 band intensities (Figure 10A, middle 
panel). Like Kv3.1, the Kv3.3 protein was found to be most highly expressed in 
cerebellum. The next darkest band was in the spinal cord which was followed by the 
bands in hippocampus and cerebral cortex. The lightest bands were observed in the 
thalamus and hypothalamus. In all cases, the ranking of the band intensities is supported 
by ten out of ten Western blots. Parametric tests agreed that cerebellum expressed the 
highest level of Kv3.3 protein whereas spinal cord had the second highest level (Figure 
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Figure 10. Differences in the Kv3.1, Kv3.3, and Kv3.4 protein expression levels in 
the various regions of the central nervous system     
 (A) For the Kv3.1, Kv3.3, and Kv3.4 Western blots, respectively, 50, 25, and 60 
µg of cerebellum (CM), hypothalamus (H), cerebral cortex (CX), hippocampus (HP), 
spinal cord (SC), thalamus (TH) and stripped brain (SB) membrane proteins were loaded 
into wells. Ovals represent the Kaleidoscope protein molecular mass standards, as 
indicated. (B) The protein levels were: CM, 3.3259 ± 0.1958; H, 0.6311 ± 0.0563; CX, 
0.8240 ± 0.0998; HP, 0.7333 ± 0.0892; SC 0.7973 ± 0.0608; TH, 0.6540 ± 0.0602 for 
Kv3.1 (n=11 blots, left panel); CM, 2.5636 ± 0.3369; H, 0.4494 ± 0.0481; CX, 0.7485 ± 
0.0510; HP, 0.7766 ± 0.0660; SC, 1.3531 ± 0.0925; TH, 0.4671 ± 0.0491 for Kv3.3, 
(n=10 blots, middle panel); CM, 1.3514 ± 0.1338; H, 0.9525 ± 0.1059; CX, 0.9141 ± 
0.1024; HP, 1.2301 ± 0.0971; SC, 0.7990 ± 0.0861; TH 0.8743 ± 0.0566 for Kv3.4 (n=9 
blots, right panel). I region/I stripped brain represents the intensity of each given region divided 
by the intensity of stripped brain. Each line indicates the two regions being compared and 
the statistical significance is indicated above the line(s). 
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10B, middle panel). Moreover, the tests suggested that the lowest Kv3.3 protein 
expression occurred in hypothalamus and thalamus  
Kv3.4 protein levels in the various regions could also be ranked into four groups 
according to the band intensities from ten different Western blots. However, the ranking 
of the groups was different (Figure 10A, right panel) from that observed for Kv3.3 
(Figure 10A, middle panel). On all ten Western blots, the darkest Kv3.4 band was 
observed in cerebellum while hippocampus was the next darkest on nine blots. The spinal 
cord expressed the lightest Kv3.4 band six out of ten blots. Bands observed in cerebral 
cortex, thalamus and hypothalamus were darker than spinal cord but lighter than those in 
either cerebellum or hippocampus. Statistical analysis favored the highest protein level in 
cerebellum, followed by hippocampus, and the lowest expression in the spinal cord. 
Taken together, our results showed that each of the Kv3.1, 3.3, and 3.4 proteins were 
expressed in the various regions of the central nervous system, and furthermore reported 
differences in the protein expression patterns for these Kv3 channels. 
 
Different Kv3.1, Kv3.3, and Kv3.4 glycoforms identified throughout the 
central nervous system 
When equal amounts of brain membrane protein samples were loaded per well, 
the electrophoretic migrations of all three Kv3 proteins in the various brain regions were 
slightly different from those in stripped brain (Figure 10A, left, middle and right panels). 
These small shifts in electrophoretic migration were also observed when reduced levels 
of brain membrane protein were loaded to give similar immunoband intensities (Figure 
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11A, left, middle and right panels). The relative speed of electrophoretic migration of the 
Kv3.1 protein from the various membranes was as follows: spinal cord and hypothalamus 
< thalamus < hippocampus and cerebral cortex < cerebellum membranes (Figure 11A, 
left panel). A similar migration pattern was observed on nine other Western blots. The 
mean Mr values for the Kv3.1 immunobands from the various membranes also suggested 
a similar size ranking (Figure 11B, left panel). However, statistical analysis failed to 
identify the Kv3.1 glycoform in the cerebellum as the smallest. 
Similar electrophoretic migration patterns were observed for both Kv3.3 and 3.4 
proteins on the representative Western blots (Figure 11A, middle and right panels), plus 
twelve and ten blots, respectively. Statistical analysis also supports the assigned sizes of 
the immunobands in the various regions (Figure 11B, middle and right panels). Overall, 
these results show that the Kv3.1, 3.3, and 3.4 proteins are modified in a different manner 
throughout the adult rat central nervous system. 
Treating samples with and without PNGase F demonstrated that small differences 
in the electrophoretic migration of Kv3.1, Kv3.3, and Kv3.4 glycoproteins were due to N-
glycosylation, and not another type of protein modification (Figure 12). Similar to the 
observations above (Figures 10 and 11), Kv3 proteins expressed in the various membrane 
samples showed dissimilarities in their electrophoretic migration when they were not 
treated with PNGase F (Figure 12A and B). On the contrary, when samples were treated 
with PNGase F the immunobands migrated to similar positions for Kv3.1, 3.3 and 3.4 in: 
cerebral cortex, hypothalamus, cerebellum, and stripped brain membranes (Figure 12A). 
The migration of deglycosylated Kv3.1, Kv3.3, and Kv3.4 proteins in thalamus, 
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Figure 11. The Mr values for Kv3 proteins are different in the various brain regions 
and spinal cord          
 (A) Western blots of the Kv3 proteins, as indicated, with relatively similar 
immunoband intensities in the various regions. Ovals represent the Kaleidoscope protein 
molecular mass standards, as indicated. (B) The mean Mr values (in Da) of Kv3 proteins 
were determined as follows. Kv3.1 (n=15 blots, left panel): CM, 110,386 ± 1,151; H, 
120,077 ± 934; CX, 113,324 ± 990; HP, 112,738 ± 1,345; SC, 121,540 ± 1,130; and TH, 
116,328 ± 1,049. Kv3.3 (n=13 blots, middle panel) CM, 125,034 ± 1,062; H, 131,322 ± 
1,194; CX, 125,300 ± 1,105; HP, 125,492 ± 1,022; SC, 132,761 ± 1,176; and TH, 
128,637 ± 1,089.  Kv3.4 (n=11 blots, right panel) CM, 112,527 ± 1,050; H, 123,002 ± 
1,559; CX, 116,025 ± 1,412; HP, 116,947 ± 1,437; SC, 128,086 ± 1,865; and TH, 
121,530 ± 1,300. CM, cerebellum; H, hypothalamus; CX, cerebral cortex; HP, 
hippocampus; SC, spinal cord; TH, thalamus; SB, stripped brain. 
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Figure 12. Differences in Mr values for the Kv3 proteins are due to N-glycosylation 
 Western blots of CM, H, CX, and SB membranes (A), and HP, SC and TH 
membranes (B) were untreated (-) or treated (+) with PNGase F. The oval represents the 
100 kDa protein standard. (C) The mean values (in Da) for the Kv3 proteins were 
determined as follows. Kv3.1 (n=5 blots): CM, 26,994 ± 1,598; H, 36,310 ± 2,095; CX, 
29,074 ± 1,577; HP, 27,033 ± 827; SC, 35,725 ± 1,498; and TH 31,396 ± 1,886. Kv3.3 
(n=5 blots) CM, 27,887 ± 2,289; H, 31,858 ± 3,016; CX, 29,240 ± 2,822; HP, 24,194 ± 
1,304; SC, 30,480 ± 2,035; and TH, 28,333 ± 1,646. Kv3.4 (n=4 blots) CM, 24,247 ± 
480; H, 36,775 ± 1,994; CX, 27,722 ± 1283 (n=5 blots); HP, 27,968 ± 1,708; SC, 33,446 
± 2,379; and thalamus (TH), 32,219 ± 2,137. CM, cerebellum; H, hypothalamus; CX, 
cerebral cortex; HP, hippocampus; SC, spinal cord; TH, thalamus; SB, stripped brain 
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hippocampus, and spinal cord were also relatively similar to those determined from 
stripped brain (Figure 12B). However, slight differences in the migration pattern of 
Kv3.1, 3.3 and 3.4 deglycosylated forms from spinal cord compared to thalamus and 
hippocampus could be observed but failed to be supported statistically. 
Different mobility shifts, which were attributed to the N-linked oligosaccharides 
of the Kv3 proteins in the various regions were represented as the mean Mr of the N-
glycans (Figure 12C, D and E). The Mr values of the N-glycans were determined by the 
differences in the migration of the Kv3 proteins treated and untreated with PNGase F. 
These values were found to be higher in: hypothalamus, spinal cord and thalamus, and 
lower in: hippocampus, cerebral cortex, and cerebellum. These two groups correlated 
with the high and low Mr groups identified for the Kv3 immunobands in these regions 
(Figure 11). The N-linked oligosaccharides produced the smallest effect on the 
electrophoretic migration of both Kv3.1 (Figure 12C) and 3.4 (Figure 12D) proteins in 
cerebellum while the effect on the Kv3.3 protein (Figure 12E) in cerebellum was similar 
to that in cerebral cortex and hippocampus. The N-glycan produced the largest effect on 
the migration of the Kv3.1 (Figure 12C) protein in spinal cord, whereas a difference in 
the migration of the Kv3.3 (Figure 12D) and 3.4 (Figure 12E) proteins in this region were 
not apparent. Taken together, these results showed that the shifts in electrophoretic 
mobility of the Kv3 proteins in the different membranes of the adult rat central nervous 
system were due to the attachment of unique N-glycan structures to Kv3.1, 3.3, and 3.4 
glycoproteins. 
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Differentially expressed Kv3 glycoforms contain sialylated N-glycans 
 To ascertain whether the Kv3 glycoforms were sialylated in all six regions, 
membrane samples were treated with neuraminidase and analyzed by Western blotting 
(Figure 13). Again, all three Kv3 proteins appeared to migrate differently than stripped 
brain in the untreated membranes. In all cases, Kv3 proteins of various membranes 
treated with neuraminidase migrated slightly faster than their corresponding untreated 
proteins. Additionally, the immunoband patterns for Kv3.1, 3.3, and 3.4 proteins in the 
various membranes were mostly retained for neuraminidase treated samples, indicating 
that the differences in electrophoretic mobility were not primarily due to the sialic acid 
content. These results demonstrated that the N-glycans of Kv3 proteins were sialylated 
in: hypothalamus, cerebellum, cerebral cortex, hippocampus, spinal cord and thalamus, 
and agree with the analysis of Kv3 proteins in stripped brain. The results also indicated 
that the differences in electrophoretic migration were primarily due to the neutral N-
glycan structures which give rise to the sialylated N-glycans. 
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Figure 13. Sialylated N-glycans of Kv3.1, Kv3.3 and 3.4 channels were detected in 
the spinal cord and different brain regions     
 Western blots of cerebellum (CM), hypothalamus (H), cerebral cortex (CX), 
hippocampus (HP), spinal cord (SC), thalamus (TH), and stripped brain (SB) membranes 
were untreated (-) or treated (+) with neuraminidase. Antibodies used for Western blots, 
as indicated. The oval represents the 100 kDa protein standard. 
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Figure 13
Schwalbe et al., 2007
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Discussion 
Previously, it was shown that both N-glycosylation sites of Kv3.1, 3.3, and 3.4 
proteins were occupied by N-linked oligosaccharides in adult rat brain (116). The data 
presented here directly demonstrated that the N-glycans were sialylated for these Kv3 
proteins in adult rat brain (Figure 9). Removal of sialic acid residues from the N-glycans 
caused glycosylated Kv3 proteins to migrate 25% of the distance of their deglycosylated 
counterparts. Moreover, sialylated N-glycans were present in all tested regions of the 
central nervous system (Figure 13). Therefore, these results showed that the N-glycans of 
Kv3.1, 3.3, and 3.4 proteins were capped with several sialyl residues in various regions of 
the central nervous systems (Figure 8). 
We have demonstrated that the expression patterns of Kv3.1, 3.3, and 3.4 proteins 
were different from one another throughout the central nervous system of the adult rat. 
Kv3.1 protein levels in cerebellum were much higher than those in other examined 
regions (Figure 10, left panels). In agreement with our study, Kv3.1 protein levels were 
much higher in cerebellum than thalamus, cerebral cortex, and hippocampus (38). 
Additionally, relatively high levels of Kv3.1 protein were detected in hippocampus 
(39,40) and cerebral cortex (39). However, contrary to our results, Kv3.1 protein levels 
(38), as well as Kv3.1 transcript levels (22,32,36), have been found to be higher in 
thalamus than those in: cerebral cortex and hippocampus. Moreover, very little if any 
Kv3.1 protein was observed in cerebral cortex and hippocampus (38). Additionally, 
Kv3.1 protein could not be detected in hypothalamus (39), and Kv3.1 mRNA molecules 
appeared absent in most of the neurons of the hypothalamus (22). An explanation of the 
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discrepancy between the protein expression pattern and the transcript expression pattern 
(22,32,36) of Kv3.1 in the various brain regions indicates that transcript levels do not 
adequately represent the protein levels, and although explanations of the discrepancies 
among protein levels were unclear, the discrepancies may have resulted from: the number 
of observations, purification procedure, detection method, or perhaps variability in the 
rats utilized for each of the independent studies. 
Kv3.3 protein levels were highest in cerebellum followed by that in spinal cord 
(Figure 10A and B, middle panels), similar to the Kv3.3 transcript levels (22). On the 
other hand, Kv3.3 protein was detected in hypothalamus, and it was more prominent in 
hippocampus and cerebral cortex than that in thalamus, which is unlike Kv3.3 transcript 
levels (38). Kv3.4 protein levels were highest in cerebellum, high in hippocampus, low in 
hypothalamus, cerebral cortex and thalamus, and lowest in spinal cord (Figure 10A and 
10B, right panels). In contrast, Kv3.4 transcript levels were much lower in: 
hypothalamus, cerebral cortex and hippocampus than in thalamus and spinal cord (22). 
The data presented here provides the first evidence for different Kv3 glycoforms 
in the adult central nervous system of rat (Figures 10, 11, 12, and 13). Overall, the size 
rankings of the Kv3.1, 3.3 and 3.4 glycoforms in the spinal cord and various regions of 
the brain were remarkably similar. The electrophoretic migrations of the Kv3.1 
glycoforms in cerebellum, cerebral cortex, and thalamus (Figure 11A and B, left panels) 
were in agreement with a previous study (38). However, the differences in migration 
were unsolved in the earlier study. In contrast, Kv3.1 proteins migrated much faster in 
cerebral cortex than cerebellum and hippocampus (39). 
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According to the electrophoretic migration shifts produced by the N-glycans of 
the Kv3 proteins (Figure 12), the N-glycan structures of the Kv3 proteins appear to be 
similar in identical regions of the central nervous system. This finding is in agreement 
with earlier reports, indicating that occupancy and structure of N-linked oligosaccharides 
are cell type specific (132). Moreover, we suggest that the Kv3.1, 3.3, and 3.4 
glycoproteins contain these distinct N-glycan structures in: spinal cord, hypothalamus, 
thalamus, cerebral cortex, hippocampus, and cerebellum of both human and mouse brains 
because the N-glycan structures from identical mammalian organs are conserved (138). 
Based on hydropathy plots of Kv3 channels, as well as other Kv channels, the S1-
S2 linker was predicted to be extracytoplasmic (Figure 8). Moreover, we directly 
demonstrated that both N-glycosylation sites of Kv3.1 which lie within the S1-S2 linker 
were utilized (35,116). The highly acidic N-glycans attached to neuronal Kv3 proteins, 
and their removal under non-denaturing conditions (Figure 9) indicates that the linker is 
in a hydrophilic environment and at the protein surface. These findings are incompatible 
with the linker residing in the membrane, along with the placement and orientation of the 
transmembrane segments, as proposed by the bacterial KvAP channel x-ray crystal 
structure (131). 
The Kv1 gene family, except for the Kv1.6 gene, is another gene family of 
voltage-gated K+ channels which contains an N-glycosylation consensus sequence within 
the S1-S2 linker. Kv1.1, 1.2, and 1.4 proteins were shown to contain sialylated N-glycans 
in rat brain membranes (16,58-60). Immunoband shifts produced by neuraminidase 
(Vibrio cholerae) treatment for Kv1.1, 1.2, and 1.4 glycoproteins (59) were not as 
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dramatic as the immunoband shifts for Kv3.1, 3.3, and 3.4 glycoproteins (Figure 9 and 
13), suggesting that sialyl residues were more abundant in Kv3 glycoproteins than the 
Kv1 glycoproteins. It would be of interest to further characterize the N-glycan structures 
of Kv1 and Kv3 glycoproteins and determine whether these structures can influence the 
transport of these proteins to either axonal or somatodendritic domains of neurons. 
Overall, this study has demonstrated that Kv3.1, 3.3, and 3.4 glycoproteins are 
expressed in: hypothalamus, cerebral cortex, cerebellum, hippocampus, spinal cord, and 
thalamus of adult rat. Additionally, it was observed that the protein expression pattern 
throughout the central nervous system was different for each Kv3 protein, and we directly 
demonstrated that the N-glycans of Kv3.1, 3.3, and 3.4 proteins were terminated with 
sialic acid residues (Figure 8). The results also revealed that different Kv3.1, 3.3, and 3.4 
glycoforms were expressed throughout the central nervous system, and that they differed 
in their desiaylated N-glycan. Future studies will entail examining the linkage of the 
sialic acid residues. Furthermore, it will be of great interest to examine the specific roles 
that the diverse N-linked sialoligosaccharides at the highly conserved N-glycosylation 
sites of the Kv3 glycoproteins in function, expression at the cell surface of either axonal 
or somatodendritic domains, and in cellular recognition events. 
CHAPTER 6 - ATYPICAL SIALYLATED N-GLYCAN STRUCTURES ARE 
ATTACHED TO NEURONAL VOLTAGE-GATED POTASSIUM CHANNELS 
 
 
Tara A. Cartwright and Ruth A. Schwalbe 
Bioscience Reports (2008) In press  
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Abstract 
 Mammalian brains contain relatively high amounts of common and uncommon 
sialylated N-glycan structures. Sialic acid linkages were identified for voltage-gated 
potassium channels, Kv3.1, 3.3, 3.4, 1.1, 1.2, and 1.4, by evaluating their electrophoretic 
migration patterns in adult rat brain membranes digested with various glycosidases. 
Additionally, their electrophoretic migration patterns were compared to those of N-CAM, 
transferrin, and the Kv3.1 protein heterologously expressed in B35 neuroblastoma cells. 
Metabolic labeling of the sugars combined with glycosidase digestion reactions were 
utilized to show that the N-glycan of recombinant Kv3.1 protein was capped with an 
oligo/polysialyl unit. All three brain Kv3 glycoproteins, like N-CAM, were terminated 
with α2,3-linked sialyl residues, as well as atypical α2,8-linked sialyl residues. 
Additionally, at least one of their antenna was terminated with an oligo/polysialyl unit, 
similar to recombinant Kv3.1 and N-CAM. In contrast, brain Kv1 glycoproteins consisted 
of sialyl residues with α2,8-linkage, as well as sialyl residues linked to internal 
carbohydrate residues of the carbohydrate chains of the N-glycans. This type of linkage 
was also supported for Kv3 glycoproteins. To date, such sialyl linkage has only been 
identified in gangliosides, not N-linked glycoproteins. We conclude that all six Kv 
channels contribute to the atypical sialylated N-glycan pool in mammalian brain. 
Identification of these novel sialylated N-glycan structures implicate a connection 
between potassium channel activity and atypical sialylated N-glycans in modulating and 
fine tuning the excitable properties of neurons in the nervous system.  
  
88
 
Introduction 
 
The N-glycan pool of mammalian brain contains remarkably high levels of sialyl 
residues and presents them in an atypical manner (69). Sialyl residues are commonly 
found at the outermost ends of carbohydrate chains (139). The common types of 
glycosidic bonds for sialyl residues include α2,3- and α2,6-linkages with the former being 
more prevalent in mammalian brain (69,95). An unusual glycosidic bond for sialyl 
residues is α2,8-linkage which gives rise to di/oligo/polysialic acid units (139). These 
structural units are attached to α2-3-linked sialyl residues on non-reducing terminal ends 
of N-glycans (97,139). In adult mammalian brain, there are only six proteins identified 
which have these homopolymers of 8 or more sialyl residues (88,90,98-102,140). 
Additionally, there are more α2,8-linked disialic acids (70,141) and oligosialic acid 
chains on glycoproteins than previously thought (88,97,98). Another unusual type of 
linkage is sialyl residues linked to internal residues of carbohydrates which has only been 
identified for gangliosides (103,104). Clearly, identification of these carriers is the first 
step in defining the roles of these unusual sialylated N-glycans.  
Kv1 and Kv3 channels belong to the super gene family of voltage-gated K
+
 (Kv)
1 
channels, and are responsible for the repolarization and shape of action potentials (5). 
The Kv1 channels, except Kv1.6 (59,86,123,129,130) , as well as the Kv3 channels 
(35,116) have one or two utilized N-glycosylation sites, respectively, between the first 
and second transmembrane segments (Figure 14). In the adult rat central nervous system, 
the Kv3 N-glycan structures have been shown to be quite diverse (37). Additionally, the 
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Figure 14. Biochemically-derived sialic acid linkages of the N-glycans attached to Kv 
channels         
 Topological models of the Kv3 (A) and Kv1 (B) α-subunits have two and one 
utilized N-glycosylation sites, respectively, within the S1-S2 linker. The Asn residues of 
these sites are signified by black circles. Cylinders represent the six transmembrane 
segments (S1-S6) within the lipid bilayer with amino and carboxyl-termini exposed to the 
cytoplasm. Branched tree structures correspond to the desialylated N-linked 
oligosaccharides. Sialyl residues of the carbohydrate chains with α2,3-linkage and α2,8-
linkage are depicted by dark grey circles and light grey circles, respectively. 
Additionally, one chain is terminated with an oligosialyl unit with internal α2,8-linkages 
(row of light grey circles). The N-glycans also contain sialyl residues linked to internal 
residues of the carbohydrate chains (white-filled circles).  
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Figure 14
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gating properties of Kv1.1 (58,83), 1.2 (84), and 3.1 (35) channels, as well as protein 
trafficking of the Kv1.2 (84) and 1.4 channels (84,86), were altered by the presence and 
type of N-glycan structures. Congenital disorders of glycosylation in humans (134), along 
with mutant glycosylation mice (80,81,117,118,135-137) also emphasize the importance 
of N-glycosylation in mammalian neuronal physiology. In this study, immunoband shift 
assays of glycosidase treated adult rat brain membranes were utilized to identify unique 
α2,8-linked sialylated N-glycans of Kv3 and Kv1 channels. The results also supported 
that the Kv3.1 glycoprotein heterologously expressed in B35 cells, as well as brain 
Kv3.1, 3.3, and 3.4 glycoproteins, have an oligo/polysialyl unit attached to their N-
glycans. Additionally, sialyl residues were shown to be linked to internal carbohydrate 
residues of the Kv1 N-glycans. Kv3 N-glycans also appeared to have branched sialyl 
residues. Previously, the occurrence of branched sialyl residues was unrecognized in N-
glycosylated proteins.  
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Results 
Neuronal Kv3 proteins are associated with α2,3-, α2,8-linked sialylated N-glycan 
structures 
  
 Previous studies have shown that N-CAM and sodium channels, along with other 
unidentified N-glycosylated proteins, in adult mammalian brain are bearers of 
di/oligo/polysialyl units (69,70,88,90,97-102,140,141). Generally, these units consist of 
an initial α2,3-linked sialyl residue followed by α2,8-linked sialyl residues (97,139). 
Kv3.1, 3.3, and 3.4 channels expressed in adult rat brain and spinal cord have sialylated 
N-glycans (37,116). Additionally, we showed that the type of N-glycan attached to each 
of the Kv3 proteins is different in the various regions of the adult rat brain (37). To 
further examine these sialylated N-glycans is quite challenging because expression levels 
of the Kv3 proteins are quite low. However, we have evaluated the sialic acid linkages of 
these neuronal Kv3 and Kv1 glycoproteins by utilizing a sialic acid linkage analysis kit 
combined with Western blots. Two sialylated N-glycosylated proteins, neuronal cell 
adhesion molecule (N-CAM) and transferrin were used as controls. Additionally, removal 
of sialic acid residues due to initial rates of hydrolysis was eliminated by prolonged 
incubation of the digestion reactions (111). Stripped brain membranes were treated with 
either sialidase A (specific for the cleavage of branched, α2,3-, α2,6-, and α2,8-linked 
sialic acid), sialidase C (specific for the cleavage of α2,3-, and α2,6-linked sialic acid), or 
sialidase S (specific for the cleavage of α2,3-linked sialic acid) under nondenaturing 
conditions. Samples were then denatured in reducing SDS-PAGE sample buffer and 
analyzed by Western blotting (Figure 15). A predominant immunoband (167 kDa) was 
detected in stripped brain membranes for N-CAM (Figure 15A). A fainter immunoband 
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Figure 15. Removal of sialic acid residues from Kv3 glycoproteins  
 Stripped brain membranes were digested (+) or undigested (-) with sialidase A, C, 
or S. Western blots were probed with: anti-N-CAM (A), anti-transferrin (B), anti-Kv3.1 
(C), anti-Kv3.3 (D), and anti-Kv3.4 (E) antibodies. Membrane proteins were separated on 
10% SDS gels for detection of Kv3 and N-CAM proteins while 15% SDS gels were 
utilized for transferrin. Upper lines correspond to fully sialylated glycoproteins while 
lower lines denote the desialylated glycoproteins. Middle lines represent partially 
desialylated glycoproteins. Molecular weight standards (kDa) are as indicated for each 
immunoblot. The relative electrophoretic mobility difference (∆Rf x 100 values) between 
undigested (-) and digested (+) transferrin, N-CAM and Kv3 proteins are listed below 
their respective Western blots. n corresponds to the number of Western Blots. Asterisks 
denote significant difference from the sialidase A immunoband shift.  
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Figure 15
Cartwright and Schwalbe, 2008
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(193 kDa) could also be detected but was not rigorously characterized due to its light 
intensity. These two immunobands corresponded to those previously identified (142-
144). Sialidase A treatment produced a larger immunoband shift than those produced by 
either sialidase C and S for the faster migrating species. Similar electrophoretic mobility 
shifts were observed on 6-7 Western blots (n). This is shown in the text box below the 
Western blot (Figure 15A) which reports the difference in the relative electrophoretic 
mobility (∆Rf x 100) for each treatment. Immunoband shifts produced by both sialidase 
C and S treatments were not significantly different while they were significantly different 
from those produced by sialidase A, as indicated by the asterisks. These results indicated 
that sialyl residues with α2,3-linkage could be detected for the N-CAM glycoprotein, 
while those with α2,6-linkage could not be identified. They also suggested that α2,8-
linked sialyl residues could be detected for the N-CAM glycoprotein. It is unlikely that 
the immunoband shift is greater for sialidase A treatment than either sialidase C or S 
treatments as a result of kinetic selectivity or N-glycan resistance because reactions were 
allowed to proceed overnight. Additionally, sialidase C removes α2,3-linked sialic acid at 
a faster rate than α2,6-linked sialic acid (145) while sialidase A removes α2,6-linked 
sialic acid at a faster rate than α2,3-linked sialic acid (111). The largest immunoband shift 
produced by sialidase A treatment could also suggest the presence of branched-sialylated 
structures. However, branched-sialylated structures have only been identified for 
gangliosides (103,104), not N-glycans. Taken together, the immunoband shift assays 
support that α2,3- and α2,8-linked sialic acids were attached to the N-glycans of N-CAM, 
as previously shown (98,146).  
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 The electrophoretic migration of transferrin (94 kDa) from untreated membranes 
(Figure 15B) was similar to previous reports (147,148). Moreover, we observed that the 
electrophoretic migration of transferrin synthesized in liver was virtually identical to that 
in brain (not shown). Identical immunoband shifts were detected for both sialidase A and 
C treatments while an immunoband shift was not detected for sialidase S treatment. The 
small immunoband shifts induced by the various treatments were replicated on 4-7 
Western blots (n) as indicated by the difference in the relative electrophoretic mobility 
(∆Rf x 100) (Figure 15B). These results revealed that the sialylated N-glycans of 
transferrin from brain consisted solely of α2,6-linked sialyl residues, similar to transferrin 
from blood (148,149) and semen (150).  
 In all cases, the immunobands for the Kv3.1 glycoprotein migrated faster for 
treated brain membranes than those of untreated membranes (Figure 15C). The 
electrophoretic migration of the Kv3.1 proteins treated with sialidase S was similar to that 
produced by sialidase C while that produced by sialidase A treatment was largest. The 
reproducibility of these immunoband shifts are summarized by the change in the 
electrophoretic mobility shifts from 7-10 Western blots (Figure 15C). These results were 
similar to those of the control, N-CAM, in that α2,3-sialylated structures could be 
detected for the Kv3.1 glycoprotein, as was α2,8- sialylated structures. Patterns of the 
immunoband shifts produced by the various sialidase treatments for the Kv3.3 (Figure 
15D) and Kv3.4 (Figure 15E) glycoproteins were similar to that of Kv3.1. Therefore, the 
results supported that all three Kv3 glycoproteins have α2,3- and α2,8-sialylated 
structures, similar to the N-CAM glycoprotein.  
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 To further examine the presence of α2,8-linked sialylated N-glycans for N-CAM, 
transferrin, Kv3.1, 3.3, and 3.4 proteins, stripped brain membranes were digested with 
either neuraminidase or sialidase C (Figure 16). Neuraminidase is identical to sialidase C. 
The reason we refer to the same enzyme with two distinct names is because they were 
purchased from two different companies. Of note, the concentration of neuraminidase is 
at least 1000-fold higher in the reaction mixtures than sialidase C. At this high 
concentration, the enzyme can remove α2,8-linked sialyl residues from 
sialoglycoconjugates but has a much greater preference for α2,3- and α2,6-linked sialyl 
residues, as indicated in the company literature accompanying the product. The 
immunoband shift generated by neuraminidase treatment of N-CAM was significantly 
larger than that produced by sialidase C (Figure 16A) while those of transferrin were 
virtually identical (Figure 16B). It is unlikely that the difference in the amount of sialic 
acids removed from N-CAM were due to initial rates of hydrolysis because reactions 
were incubated for prolonged periods. It is also unlikely that N-glycan resistance resulted 
in the difference in immunoband shifts because the immunoband shift of N-CAM 
produced by sialidase A treatment was also larger than that produced by sialidase C 
(Figure 15A). Additionally, immunoband shifts produced by transferrin were identical 
(Figure 16B). Taken together, the immunoband shift assay confirms the presence of α2,8-
sialylated N-glycans for N-CAM (98,146). Moreover, our results for N-CAM and 
transferrin support that the immunoband shifts are due to the removal of sialic acid 
residues, not initial rates of hydrolysis, N-glycan resistance, proteolysis or other 
glycosidase activities.  
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Figure 16. Sialyl residues with α2,8 linkages are present on neuronal Kv3 
glycoproteins         
 Stripped brain membranes were treated (+) or untreated (-) with either sialidase C 
or with neuraminidase. Anti-N-CAM (A), anti-transferrin (B), anti-Kv3.1 (C), anti-Kv3.3 
(D), and anti-Kv3.4 (E) antibodies were used for Western blots. Upper black lines 
represent immunobands of untreated brain membranes for the Kv3, N-CAM and 
transferrin proteins. Lower black lines signify removal of α2,6-linked sialyl residues for 
transferrin, and removal of α2,3- and α2,8-linked sialyl residues for N-CAM and the Kv3 
glycoproteins. Middle gray lines denote removal of α2,3-linked sialyl residues for N-
CAM and the Kv3 glycoproteins. Differences in the relative electrophoretic mobility 
(∆Rf x 100 values) for the Kv3, N-CAM and transferrin glycoproteins are beneath their 
respective Western blots. n refers to the number of Western Blots. Asterisks indicate 
immunoband shifts significantly different from those produced by neuraminidase 
treatment.  
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Figure 16
Cartwright and Schwalbe, 2008
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∆Rf x 100 (+/-C): 1.4 ± 0.1, n=4, *
A.
N-CAM
+- - -
- - -+
150 kDa-
Sialidase C:
Neuraminidase:
∆Rf x 100 (+/-Neur): 1.4 ± 0.1, n=5
∆Rf x 100 (+/-C): 0.9 ± 0.1, n=6, *
B.
Transferrin
+- - -
- - -+
100 kDa-
Sialidase C:
Neuraminidase:
∆Rf x 100 (+/-Neur): 1.9 ± 0.1, n=7
∆Rf x 100 (+/-C): 1.4 ± 0.2, n=3
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 Immunoband shifts produced by neuraminidase treatment of the Kv3.1 (Figure 
16C), 3.3 (Figure 16D), and 3.4 (Figure 16E) glycoproteins were markedly greater than 
those produced by sialidase C treatment. These larger electrophoretic migrations 
produced by neuraminidase treatment were observed on 4-10 Western blots (Figure 16C, 
16D, 16E). Additionally, the difference between the electrophoretic mobility shifts 
produced by neuraminidase and sialidase C were significantly different. These results 
revealed that the N-glycans of the Kv3.1, 3.3, and 3.4 proteins are similar to N-CAM in 
that they contain α2,8- sialylated N-glycans.  
 
N-Glycan of Kv3.1 protein is heavily sialylated in neuroblastoma cells 
 Recombinant Kv3.1 was partially purified from transfected rat B35 
neuroblastoma cells, and subsequently treated with various amounts of PNGase F (Figure 
17A). Kv3.1 protein heterologously expressed in B35 cells migrated as two dark 
immunobands. The upper immunoband corresponded to the Kv3.1 protein with processed 
N-glycans and migrated slightly faster than Kv3.1 glycoprotein in adult rat brain (not 
shown). The lower immunoband represented simple type N-glycans attached to Kv3.1 
(not shown), similar to heterologously expressed N-glycosylated Kv3.1 protein in Sf9 
cells (35). At the highest level of PNGase F, a predominant immunoband was detected, 
representing the unglycosylated Kv3.1 protein. However, at lower amounts of PNGase F 
additional immunobands were detected. The two immunobands directly above the 
aglycoform immunoband signified either one or two simple N-glycans. The two upper 
immunobands represented Kv3.1 protein with either one or two complex N-glycans. 
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Figure 17. The N-glycans of Kv3.1 protein expressed in neuroblastoma cells are 
composed of oligo/polysialyl units      
 Western blots of Kv3.1 digested with PNGase F (A) and neuraminidase (Neur) 
(B). Partially purified Kv3.1 protein from transfected B35 cells was digested (+) and 
undigested (-) with various dilutions (0-, 10-, 20-, 40- and 80-fold) of PNGase F. The 
number of pluses (+) represents increasing amounts of PNGase F, while the minus (-) 
signifies the absence of PNGase F. Partially purified Kv3.1 protein from transfected B35 
cells metabolically labeled with a sialic acid precursor ([
3
H]-N-acetyl mannosamine) 
were untreated (Control) or treated with either neuraminidase or Endo N, and 
subsequently separated on 10 % SDS gels with DATD as the crosslinker (C). Gel slices 
of heterologously expressed Kv3.1 with complex N-glycans were collected, and 
radioactivity was measured by scintillation counting. Counts per minute (CPM). A one-
way ANOVA using Bonferroni comparison exhibited statistical differences (P = 0.01) 
between control (n =3), Neur (n =2) and Endo N (n =3) as represented by asterisks. n 
represents the number of SDS gels.  
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Figure 17 
Cartwright and Schwalbe, 2008
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When partially purified Kv3.1 protein was treated with neuraminidase, the upper 
immunoband migrated much slower while the lower immunoband did not shift (Figure 
17B). These results demonstrated that both N-glycosylation sites of Kv3.1 are fully 
occupied however not fully processed when heterologously expressed in B35 cells. 
Additionally, the fully processed N-glycans of Kv3.1 were heavily sialylated, like those 
in adult mammalian brain. 
 
Oligo/polysialyl moieties are attached to neuronal Kv3 proteins 
 To demonstrate that an oligo/polysialyl moiety was attached to the N-glycan of 
the Kv3.1 protein, partially purified recombinant Kv3.1 protein was digested with Endo 
N (Figure 17C). This glycosidase cleaves internal α2,8-linkages with a minimal length of 
5 sialyl residues (99,151). In brief, B35 cells were transfected with Kv3.1 and then 
metabolically labeled with [
3
H]-N-acetyl mannosamine. Radioloabeled Kv3.1 protein 
partially immunoaffinity purified from transfected B35 cells was separated on 10% SDS 
gels in which bis-acrylamide was replaced with DATD. Gel slices were excised between 
the 75 and 150 kDa markers. This region of the gel contained the Kv3.1 protein with 
complex N-glycans as revealed by Western blot analysis. The amount of radioactivity in 
the gel slice was determined by scintillation counting. Gel slices from samples treated, 
with either neuraminidase or Endo N, had much less radioactivity than those from 
untreated samples. As expected, the radioactivity signal from samples treated with 
neuraminidase was smaller than that of Endo N treated samples. These results indicated 
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that an oligo/polysialyl unit is associated with the Kv3.1 glycoprotein heterologously 
expressed in B35 cells.  
 To determine whether the N-glycans of Kv3 proteins consisted of oligo/polysialyl 
moieties, membrane proteins were treated with and without Endo N (Figure 18). When 
partially purified Kv3.1 protein from B35 cells was treated with Endo N, the upper 
immunoband of Kv3.1 migrated slightly slower while the lower immunoband did not 
shift (Figure 18A). A similar result was also observed for N-CAM (Figure 18B) which 
has an oligo/polysialyl unit (98,146). The upward shift was surprising because sialidase 
A, sialidase C and neuraminidase produced downward shifts. However, this can be 
explained in that some of the N-glycan chains are terminated by α2,3-linked sialyl 
residues and disialyl units, and removal of these residues generate a downward shift 
(Figure 14A). On the other hand, the chain terminated by an oligo/polysialyl unit 
produces an upward shift when it is removed. In other words, the oligo/polysialyl unit 
makes the glycoprotein more compact while the mono- and di-sialyl moieties make the 
glycoprotein less compact. This indeed appears to be the case as shown by the 
immunoband pattern of N-CAM treated with various combinations of Endo N and 
sialidase C (Figure 18F). The N-CAM immunoband from membranes treated with both 
Endo N and sialidase C migrated slightly further than the control but less than that from 
sialidase C treatment alone.  
 The immunoband patterns of the Kv3 glycoproteins were much like that of N-
CAM. Immunobands shifted upward for Kv3.1 (Figure 18C), 3.3 (Figure 18D), and 3.4 
(Figure 18E) proteins when brain membranes were treated with Endo N. In all cases, the  
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Figure 18. Brain Kv3 glycoproteins are composed of oligo/polysialyl units 
 B35 cells heterologously expressing Kv3.1 were partially purified, digested (+) 
and undigested (-) with Endo N, and analyzed by Western blotting utilizing the anti-
Kv3.1 antibody (A). Stripped brain membranes digested (+) and undigested (-) with 
either Endo N, sialidase C or both were analyzed by Western blotting using: anti-N-CAM 
(B and F), anti-Kv3.1 (C and G), anti-Kv3.3 (D and H), and anti-Kv3.4 (E and I) 
antibodies. Beneath each respective Western blot are the differences in the relative 
electrophoretic mobility (∆Rf x 100 values) for the Kv3 and N-CAM glycoproteins. n 
corresponds to the number of Western Blots.  
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Figure 18
Cartwright and Schwalbe, 2008
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small upward immunoband shifts generated by Endo N were reproduced on at least three 
separate Western blots for each of the glycoproteins. Immunoband shifts produced by 
Endo N were neither detected for transferrin nor Kv1.1 glycoproteins (not shown) 
Additionally, treatment of the membranes with both Endo N and sialidase C produced 
immunobands for Kv3.1 (Figure 18F), 3.3 (Figure 18G), and 3.4 (Figure 18H) proteins 
which migrated in between those of the control and sialidase C treatment. These results 
support that brain Kv3.1, 3.3, and 3.4 proteins, like recombinant Kv3.1 protein and N-
CAM (98), have an oligo/polysialyl unit attached to their N-glycans.  
 
Detection of branched sialyl residues attached to Kv3 glycoproteins 
 To date, sialyl residues linked to internal carbohydrate residues have only been 
observed for gangliosides (103,104). To determine whether the N-glycans of the neuronal 
Kv3 proteins have this unusual type of linkage the immunoband shifts produced by 
neuraminidase and sialidase A treatments were examined. The specificities of 
neuraminidase and sialidase A are identical, except the latter can also remove branched 
sialyl residues. Immunoband shifts of stripped brain membranes treated with sialidase A 
were larger than those produced by neuraminidase for Kv3.1 (Figure 19A), Kv3.3 (Figure 
19B), and Kv3.4 (Figure 19C) glycoproteins, as well as N-CAM (Figure 19D), on 5-8 
Western blots, while the immunoband shifts were quite similar for transferrin on 4-7 
Western blots (Figure 19E). Additionally, the larger electrophoretic mobility shift 
produced by sialidase A treatment compared to that produced by neuraminidase treatment 
was significantly different for all three Kv3 glycoproteins, as well as N-CAM, while they  
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Figure 19. Detection of branched sialyl residues attached to the N-glycans of Kv3 
proteins         
 Stripped brain membranes were treated (+) or untreated (-) with either sialidase A 
or neuraminidase. Samples were immunoblotted with: anti-Kv3.1 (A), anti-Kv3.3 (B), 
anti-Kv3.4 (C), anti-N-CAM (D) and anti-transferrin (E) antibodies. Upper black lines 
represent fully sialylated glycoproteins. Lowest black lines denote completely 
desialylated glycoproteins. Middle gray lines signify partially desialylated glycoproteins. 
The relative electrophoretic mobility difference (∆Rf x 100 values) for the transferrin, N-
CAM and Kv3 glycoproteins are reported below each of their respective Western blots. n 
represents the number of Western Blots. Asterisks signify significant difference from the 
sialidase A immunoband shift.  
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Figure 19 
Cartwright and Schwalbe, 2008
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were not significantly different for transferrin.  These results indicate that either neuronal 
Kv3.1, Kv3.3, Kv3.4 glycoproteins, as well as N-CAM, have sialyl residues linked to 
internal residues of the carbohydrate chains or that their sialylated N-glycans are more 
resistant to the action of neuraminidase than sialidase A.  
 
N-Glycans of Kv1.1, 1.2, and 1.4 proteins contain α2,8-linked and branched sialyl 
residues 
 Earlier studies have shown that the sole N-glycosylation site of Kv1.1, 1.2, and 
1.4 proteins are occupied by sialylated N-glycans in rat brain (59). However, the types of 
sialic acid linkage of their N-glycans have not been identified. Adult rat brain membranes 
were treated with neuraminidase, sialidase A, sialidase C, or sialidase S under 
nondenaturing conditions (Figure 20). The electrophoretic migrations of the Kv1.1 (87 
kDa), Kv1.2 (92 kDa), and Kv1.4 (106 kDa) glycoproteins were much slower than 
anticipated from their amino acid sequences (Kv1.1, 65 kDa; Kv1.2, 65 kDa; and Kv1.4, 
75 kDa). When stripped brain membranes were treated with either sialidase C or S, the 
immunobands for the Kv1.1 (Figure 20A), 1.2 (Figure 20B), and 1.4 (Figure 20C) 
glycoproteins migrated to virtually identical positions as those of untreated brain 
membranes. In contrast, the Kv1.1, 1.2, and 1.4 immunobands migrated slightly faster 
when membranes were treated with neuraminidase and much faster when treated with 
sialidase A. The immunoband shifts produced by neuraminidase and sialidase A were 
observed on 3-6 Western blots for all three of the Kv1 glycoproteins (Figure 20A, 20B, 
20C). These results demonstrated the removal of α2,8-linked sialyl residues from 
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Figure 20. Kv1.1, Kv1.2 and Kv1.4 glycoproteins in brain contain branched and 
α2,8-linked sialyl residues        
 Western blots of stripped brain (A, B and C) and heart (D) membrane proteins 
untreated (-) or treated (+) with neuraminidase (N), sialidase A, C, or S were probed with: 
anti-Kv1.1, anti-Kv1.2, and anti-Kv1.4 antibodies. Upper black lines signify fully 
sialylated Kv1 glycoproteins. Lowest black lines represent the completely desialylated 
Kv1 glycoproteins. Middle gray lines denote partially desialylated Kv1 glycoproteins. 
Below each Western blot are the differences in the relative electrophoretic mobility (∆Rf 
x 100 values) of the Kv1 glycoproteins. The number of Western blots is symbolized by n. 
Asterisks represent significant difference from the sialidase A immunoband shift.  
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Figure 20 
Cartwright and Schwalbe, 2008
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neuronal Kv1.1, 1.2, and 1.4 glycoproteins. They also suggested either the presence of 
sialic acids linked to internal residues of the carbohydrate chain or that the action of 
neuraminidase was hindered by the Kv1 glycoproteins.  
 To determine whether the Kv1 proteins were preventing access of neuraminidase 
to the sialylated N-glycans, we examined the sialylated N-glycan of the Kv1.2 protein 
expressed in heart. The electrophoretic migration of the Kv1.2 protein (79 kDa) in heart 
was faster than that in brain (Figure 20D). When heart membranes were digested with 
neuraminidase and sialidase A, the immunoband shifts were identical. This result 
indicated that the Kv1.2 protein was not preventing the removal of sialic acid by 
neuraminidase. Additionally, our results indicated that both neuraminidase and sialidase 
A were efficient in removing sialic acid from the N-glycan of the Kv1.2 protein. The 
results also demonstrated that the N-glycan of the Kv1.2 protein from heart was different 
from that expressed in brain. For instance, identical immunoband shifts were generated 
by treatment of heart membranes with neuraminidase, sialidase A or sialidase C, while an 
immunoband shift was not observed when membranes were treated with sialidase S. This 
result indicated that Kv1.2 glycoprotein in heart was rich in α2,6-linked sialic acid. Taken 
together, our results support that brain Kv1.1, 1.2, and 1.4 glycoproteins have α2,8-linked 
sialic acids, as well as sialic acid residues linked to internal residues of the carbohydrate 
chains.  
 To directly demonstrate that the sialyl residues were removed from the N-glycans 
of the Kv1.1 (Figure 21A), 1.2 (Figure 21B), and 1.4 (Figure 21C) proteins, stripped 
brain membranes were digested with different combinations of neuraminidase, sialidase 
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Figure 21. Branched and α2,8-linked sialic acid residues are attached to the N-
linked oligosaccharides of Kv1.1, Kv1.2 and Kv1.4 proteins   
 Stripped brain membrane proteins were untreated (-) or treated (+) with various 
combinations of: neuraminidase, sialidase A and PNGase F, and then immunoblotted 
using anti-Kv1.1 (A), anti-Kv1.2 (B) and anti-Kv1.4 (C) antibodies. Uppermost lines 
correspond to fully sialylated Kv1 glycoproteins, upper middle line represents partially 
desialylated glycoproteins, lower middle lines signify fully desialylated glycoproteins, 
and the lowest lines denote unglycosylated Kv1 proteins.  
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Figure 21
Cartwright and Schwalbe, 2008
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A and PNGase F. In all cases, Kv1 immunobands were shown to migrate slightly faster 
for samples treated with neuraminidase compared to those untreated. Additionally, they 
migrated even faster for those treated with sialidase A, and fastest for those treated with 
PNGase F. However, when samples were treated simultaneously with PNGase F and 
either neuraminidase or sialidase A, the Kv1 immunobands migrated to similar positions 
as those treated solely with PNGase F. Taken together, these results have directly shown 
that the N-glycans of the Kv1.1, 1.2, and 1.4 proteins, like Kv3 glycoproteins, were 
capped with α2,8-linked sialyl residues, and have sialyl residues attached to internal 
residues of the carbohydrate chains.  
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Discussion 
Here we have established an immunoband shift assay for detecting common and 
uncommon sialic acid linkages of native glycoproteins which are present in low amounts 
and difficult to purify. Changes in relative electrophoretic mobility due to the various 
sialidase treatments were interpreted as sialic acid removal, not proteolysis, or other 
glycosidase activities. Kinetic selectivity was eliminated by extending the incubation 
periods of the reactions (111). When sialylated N-glycans of the Kv3 (37) and Kv1 
proteins (Figure 21) were absent, immunoband shifts produced by the various 
exosialidases were absent. These results demonstrated that proteolysis did not contribute 
to immunoband shifts. Contamination of different glycosidase activities in the various 
enzymes was also unlikely since the immunoband shift assays verified α2,3- and α2,8-
linkages for N-CAM (98). To address N-glycan resistance, both sialidase A and 
neuraminidase were used to identify α2,8-linked sialyl residues. Additionally, when heart 
Kv1.2 glycoprotein was treated with neuraminidase and sialidase A, the immunoband 
shifts were identical. This result indicated that the Kv1.2 protein was not hindering the 
action of neuraminidase, and therefore supported that sialyl residues were linked to 
internal residues of the carbohydrate chain of the neuronal Kv1 glycoproteins.  
Utilization of this immunoband shift assay has demonstrated that the N-glycan 
chains were capped with α2,3-linked sialyl residues for the Kv3.1, 3.3, and 3.4 proteins 
(Figure 14A) from adult rat brains. Sialyl residues with α2,3- and α2,6-linkage are 
common linkages with the former being more prevalent in adult rat brain (69). Secondly, 
sialylated N-glycans of the neuronal Kv3.1, 3.3, and 3.4 (37,116) and Kv1.1, 1.2, and 1.4 
  
118
 
(59) glycoproteins were shown to have α2,8-linked sialyl residues capping their 
carbohydrate chains (Figure 14). It was also found that Kv3.1, 3.3, and 3.4 glycoproteins, 
like N-CAM (98) and recombinant Kv3.1, have at least one of their carbohydrate chains 
capped with an oligo/polysialyl unit (Figure 14A). Moreover, our results supported a 
more compact glycoprotein when an oligo/polysialyl unit was attached and a less 
compact glycoprotein when mono/disialyl moieties were attached. Therefore, indicating 
the N-glycans were capped with monosialyl residues and disialyl units as showed in our 
proposed model of Kv3 glycoproteins. The results also supported that brain Kv1.1, 1.2, 
and 1.4 glycoproteins were capped with disialyl units (Figure 14B). As mentioned, sialyl 
residues with α2,8-linkage give rise to di/oligo/polysialyl units which are primed by an 
α2,3-linked sialyl residue (97). Less than 10% of sialylated glycoproteins in adult rat 
brain contain disialyl units (70). Moreover, it has been indicated that at least six 
glycoproteins contain oligosialyl units and about thirteen glycoproteins contain disialyl 
units in adult mammalian brains (88). The biological importance of the di/oligosialyl 
units of glycoproteins is unsolved. However, it may be that these di/oligosialyl units are 
involved in: cell adhesion, differentiation, and signal transduction, like gangliosides (88). 
Identification of six brain glycoproteins with di/oligosialyl units is the initial step in 
elucidating the roles of these atypical types of N-glycans.  
An earlier study has shown that sialyl residues were linked to internal residues of 
the oligosaccharide moiety of gangliosides (103,104), and that sialidase A could cleave 
this type of linkage (109). To date, sialyl residues linked to internal residues of the 
carbohydrate chains of N-glycans has not been described. Here we have demonstrated 
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that the N-glycans of brain Kv1.1, 1.2, and 1.4 proteins (Figure 14B) have such branched 
sialyl residues. This finding is supported by the very large immunoband shift produced by 
sialidase A treatment relative to neuraminidase treatment for brain Kv1.1, 1.2, and 1.4 
glycoproteins (Figure 20), along with the demonstration that the Kv1.2 protein did not 
interfere with neuraminidase activity in heart membranes. The Kv3.1, 3.3, and 3.4 
glycoproteins (Figure 14A), as well as N-CAM, also appeared to have this novel type of 
sialic acid linkage.  
Identification of these different Kv1 and Kv3 glycoforms and their unique sialic 
acid linkages suggest critical biological roles of their attached glycoconjugates. 
Additionally, the absolute conservation of the two N-glycosylation sites in the S1-S2 
linker of the Kv3 proteins (35,37,116), along with the highly conserved site in the S1-S2 
linker of the Kv1 subfamily members with the exception of Kv1.6 (16,59) argue the 
importance of the sialyloligosaccharides in regulating neuronal excitability. Previously, 
we showed that the activation kinetics was slowed in unglycosylated Kv3.1 channels 
compared to those with simple type N-glycans (35). The activation rates of the Kv10.1 
channel was much slower for the aglycoform than the glycoform (85). Additionally, 
currents were greatly reduced when N-glycosylation of HERG was abolished as a result 
of diminished cell surface expression (87). Also, it was shown that glycosylation of the 
Kir1.1 channel can stabilize the open state (119). Secondly, sialyl residues of 
glycosylated Kv channels have been demonstrated to regulate ion channel activity. 
Removal of sialyl residues from Kv1.1 and 1.2 channels decreased their activation rates, 
and furthermore a greater positive potential was required for their activation (58,83,84). 
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Therefore, it may be that the attachment of atypical sialylated N-glycans to the Kv3 and 
Kv1 channels assists in regulating action potential waveforms by influencing the rates of 
repolarization. Future studies will entail determining the roles of these uncommon 
sialylated N-glycans on channel activities of the Kv3 and Kv1 glycoproteins.  
Overall, this study has identified novel sialylated N-glycans for two classes of 
voltage-gated potassium channels. Six members from these classes were shown to 
contain glycoconjugates with α2,8-linked sialyl residues which consist of 
di/oligo/polysialyl units. Additionally, sialyl residues linked to internal carbohydrate 
residues were shown to be components of the N-glycans of Kv1 glycoproteins, as well as 
Kv3 glycoproteins, which until now has only been identified in gangliosides (103,104). 
This unique N-glycan modification of branched sialyl residues was also identified for N-
CAM. We speculate that these novel sialylated N-glycans of the Kv3 and Kv1 channels 
are important modifications in regulating channel function or channel expression at the 
cell surface of either axonal or somatodendritic domains. Additionally, the sialylated N-
glycans of the Kv3 and Kv1 proteins may play a role in cellular recognition events which 
perhaps involve plasticity and synapse formation.  
CHAPTER 7 - NEURONAL N-GLYCOSYLATION PROCESSING REGULATES 
VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY 
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Abstract 
 Atypical sialylated N-glycans are attached to the Kv3.1 protein in adult rat brain, 
along with the heterologously expressed Kv3.1 protein in rat B35 neuroblastoma cells. 
Glycosylated (wild type), partially glycosylated (N220Q and N229Q), and 
unglycosylated (N220Q/N229Q) Kv3.1 proteins were characterized utilizing transfected 
B35 cells. Electrophoretic migration of partially glycosylated Kv3.1 proteins treated with 
neuraminidase showed that both N-glycans were sialylated. Whole cell current recordings 
showed that the glycosylated Kv3.1 protein favored a subpopulation of channels with fast 
activation and inactivation rates. In contrast, the predominant subpopulation of the 
aglycoform had slow activation and inactivation rates. Only the glycosylated Kv3.1 
protein could produce the subpopulation of channels with fast activating and inactivating 
rates for the inactivating current type. Both glycosylated and partially glycosylated Kv3.1 
channels could generate this subpopulation when expressing the noninactivating current 
type while this subpopulation for the aglycoform was seldom. The predominant effect 
resulting from the absence of an N-glycan at position 220 was a reduction in current 
density while at 229 was a shift in the threshold potential for channel activation. Thus, 
mammalian neuronal N-glycosylation processing of the Kv3.1 channel has a greater 
effect on activation and inactivation properties than when the Kv3.1 glycoprotein was 
processed in insect cells (35). Additionally, sialoglycoconjugates at the cell surface 
contribute to the uniform transmembrane electrical field detected by the voltage sensor of 
the channel. We propose that cell-specific N-glycosylation processing of glycosylated ion 
channels provides a universal cellular mechanism for regulating ion channel function.  
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Introduction 
Voltage-gated potassium channels (Kv)1 are essential components responsible for 
determining the intrinsic electrical excitability of neurons by repolarizing action 
potentials (5). The Kv3 channel subfamily members, Kv3.1-Kv3.4, localized in the 
axonal and somatodendritic compartments of neurons (16) have two absolutely conserved 
N-glycosylation sites within the S1-S2 extracytoplasmic linker (35). The Kv3.1 channel, 
a delayed rectifier, has unique functional characteristics when heterologously expressed 
in Xenopus oocytes (20-23) and CHO cells (28) which include slow inactivation rates, 
fast activation and deactivation rates, and channel activation at more depolarized 
potentials than other Kv channels. Expression of the Kv3.1 channel in mammalian cells 
also produced noninactivating currents with transient peaks which lacked saturation at 
more positive potentials (24,26,29), along with noninactivating currents without transient 
peaks (14,26,29).  
The N-glycan structures of the Kv3 proteins are quite diverse in the various 
regions throughout the adult rat central nervous system (37). Of recent, it has been 
demonstrated that the Kv3.1 (Figure 22A), 3.3, and 3.4, and Kv1.1, 1.2, and 1.4 proteins 
of adult rat brain, as well as Kv3.1 heterologously expressed in B35 cells, contain 
atypical sialylated N-glycans (152). These unique N-glycans were shown to consist of 
sialyl residues with α2,8-linkage. This type of linkage gives rise to di/oligo/polysialic 
acid units (69,70,97,139). It was also discovered that the atypical N-glycans had sialyl 
residues linked to internal residues of the carbohydrate chain (152) which previously was 
solely identified for gangliosides (103,104). The information on the cellular roles of these 
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unique sialyl linkages is very limiting, if not absent, as is the effect of neuronal N-
glycosylation processing on voltage-gated K+ channels. However, some studies of N-
glycosylation processing on Kv channels have been conducted utilizing non-excitable cell 
systems. Previously, we have presented evidence that the absence of simple type N-
glycans on Kv3.1 channels when expressed in Spodoptera frugiperdae (Sf9) insect cells 
causes slower activation rates, and furthermore, a slight positive shift in voltage 
dependence relative to its glycosylated counterpart (35). Additional studies have also 
shown that N-glycans alter the gating function of Kv1.1 (58,83), Kv1.2 (84) and Kv10.1 
channels (85), as well as influences proper trafficking of the Kv1.2 (84) and Kv1.4 
channel (86). 
The primary aim of this paper was to determine whether cell-specific N-
glycosylation processing modulates Kv3.1 channel activity. Activation rates of the 
heterologously expressed wild type Kv3.1 glycoprotein in B35 cells were greater than 
those for the Kv3.1 glycoprotein heterologously expressed in Sf9 cells (35). Moreover, 
the ratio of the rise times at +40 mV of the unglycosylated Kv3.1 channel to that of the 
glycosylated Kv3.1 channel expressed in B35 cells compared to that in Sf9 cells was 
much greater in B35 cells. It was also shown that the wild type Kv3.1 channel expressed 
in B35 cells could have fast inactivation rates while this property was unobserved for the 
wild type Kv3.1 channel expressed in Sf9 cells (35). Of note, utilization of the two 
independent heterologous expression systems supports that both highly conserved 
mutations are not responsible for the observed differences in the Kv3.1 channel 
properties. Instead, our results support that the wild type Kv3.1 channel associated with 
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atypical sialylated N-glycans can favor subpopulations with fast activating rates and 
either fast or slow inactivating rates while the absence of N-glycans largely favored the 
slow activating and inactivating rates. Furthermore, the results indicated that cell-specific 
glycoconjugates at the cell surface could influence the voltage sensor of the Kv3.1 
channel. Taken together, our results strongly highlight the concept that atypical sialic acid 
linkages present in mammalian brain (69,70,97) are critical in modulating K+ currents of 
neurons. 
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Results 
Both N-Glycans of the Kv3.1 protein are sialylated in B35 neuroblastoma cells 
 Mammalian brain N-glycans of Kv3 and Kv1 channels have high contents of 
sialic acid residues and display them in an uncharacteristic manner (69). To our 
knowledge, atypical N-glycosylation of endogenous and heterologous Kv glycoproteins 
has not been established when evaluating channel function. Recently, it was shown that 
the Kv3.1 channel heterologously expressed in B35 cells generates Kv3.1 glycoprotein 
with uncommon sialylated N-glycans (152). Here we have utilized this same expression 
system to study the affect of neuronal N-glycosylation processing on Kv3.1 channel 
activity. Wild type Kv3.1 protein has two N-glycosylation sites (Figure 22A) which are 
occupied in native tissue (116) and a heterologous expression system (35). Kv3.1 N-
glycosylation mutants were constructed by removing both sites (N220Q/N229Q) and one 
site at a time (N220Q and N229Q) (35). In all cases, the FLAG epitope was attached to 
the C-terminus of each Kv3.1 protein for purposes of isolation and identification. Kv3.1 
proteins were M2 immunoaffinity purified from stable transfected B35 cells. Partially 
purified Kv3.1 samples were then analyzed by Western blots (Figure 22B and 22C). Wild 
type Kv3.1 migrated predominantly as the fully processed form (132 kDa) and a faster 
migrating immunoband (88 kDa) (Figure 22B). As previously shown, wild type Kv3.1 is 
associated with atypical sialylated N-glycans in B35 cells, and the electrophoretic 
migration of the fully processed form was slightly slower than that observed in rat brain 
(152). The faster immunoband had a similar electrophoretic migration as the Kv3.1 
glycoprotein produced in Sf9 cells (35,116). Additionally, the faster migrating form was 
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Figure 22. Topological model of the Kv3.1 glycoprotein and immunoblot analysis of 
wild type and N-glycosylation mutants of Kv3.1 protein heterologously expressed in 
B35 cells   
(A) Schematic of the predicted topology of the Kv3.1 α-subunit. The amino acid 
sequence of the S1-S2 linker from rat (P25122) with the two native N-glycosylation 
consensus sites, NKT (220 to 222) and NGT (229 to 231) underlined. Trees denote the 
attachment of oligosaccharides at native consensus sites. Sialyl residues of the 
carbohydrate chains with α2,3-linkage and α2,8-linkage are depicted by black-filled 
circles and grey-filled circles, respectively. One of the carbohydrate chains is terminated 
with an oligosialyl unit (row of light grey circles). The N-glycans also contain sialyl 
residues linked to internal residues of the carbohydrate chains (white-filled circles). (B) 
Immunoblot analysis of M2 immunoaffinity purified Kv3.1 proteins from B35 cells 
transfected with recombinant vectors containing wild type Kv3.1, N220Q/N229Q, 
N220Q, and N229Q cDNA molecules. Upper arrow and upper line represent both N-
glycosylation sites occupied by complex and simple type N-glycans, respectively, while 
the lower arrow and middle line signify occupancy of one site. The lowest line denotes 
the unglycosylated Kv3.1 protein. (C) Immunoblot analysis of immunoaffinity purified 
N220Q and N229Q Kv3.1 mutant proteins from transfected B35 cells were digested (+) 
and undigested (-) with neuraminidase. Kaleidoscope® protein molecular mass standards 
are as indicated. 
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sensitive to Endo H digestion while the upper band was resistant (not shown). Of note the 
faster migrating form has both N-glycosylation sites occupied by simple type N-glycans, 
and therefore will be referred to as unprocessed N-glycans. When both sites were 
abolished (N220Q/N229Q), a single migrating species (81 kDa) was detected which 
corresponded to the unglycosylated Kv3.1 protein. Two immunobands for each of the 
single N-glycosylation Kv3.1 mutants with quite similar electrophoretic mobility were 
detected. The upper bands (N220Q, 106 kDa and N229Q, 107 kDa) will be referred to as 
processed N-glycans and the lower bands (N220Q, 83 kDa and N229Q, 85 kDa) as 
unprocessed N-glycans (Figure 22B). In both cases, the upper immunobands were 
sensitive to neuraminidase treatment while the lower immunobands were insensitive 
(Figure 22C). Additionally, the electrophoretic migration of the faster immunobands was 
similar to those detected for the single mutant proteins associated with simple type N-
glycans expressed in Sf9 cells (35).  
 To evaluate whether endogenous Kv3.1, 3.3 and 3.4 proteins could be detected in 
B35 cells, nontransfected B35 membrane proteins, as well as partially purified Kv3.1 
protein samples, were subjected to SDS-PAGE and immunoblotted using anti-Kv3 
antibodies (not shown). In all cases, endogenous Kv3.1, 3.3, and 3.4 glycoproteins were 
not observed in nontransfected B35 cells, nor were endogenous Kv3.3 and 3.4 proteins 
found to form heteromultimers with the heterologously expressed Kv3.1 glycoprotein. 
Overall, these results have shown that both sites were occupied by sialylated N-glycans, 
and that the occupancy of these sites was independent of one another. Moreover, the 
removal of one or even both of these sites does not greatly influence Kv3.1 protein 
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expression in neuronal cells, similar to that described in Sf9 cells (35). Based on the 
Western blotting studies, wild type Kv3.1, N220Q/N229Q, and both N220Q and N229Q 
will be referred to as the glycosylated, unglycosylated, and partially glycosylated forms 
of the Kv3.1 channel, respectively, throughout the text. 
 
Glycosylated Kv3.1 channels have faster inactivation kinetics than their 
unglycosylated counterparts 
To examine whether neuronal N-glycosylation processing affects Kv3.1 channel 
activity, current measurements were performed in the whole cell mode of the patch clamp 
technique. Whole cell currents of B35 cells heterologously expressing wild type Kv3.1 
(Figure 23A) and N220Q/N229Q (Figure 23B) were detected when the applied test 
potential was greater than -30 mV, and furthermore began to saturate at about +40 mV. 
These whole cell current recordings were similar to those previously described for 
infected Sf9 cells (35), oocytes (20-22) and mammalian cells (40,153) heterologously 
expressing the Kv3.1 channel. This current pattern which saturates at more depolarized 
potentials will be defined as the inactivating current type. It was also noted that the 
inactivation of wild type Kv3.1 currents with respect to time appeared to be more 
dramatic than those from earlier reports. The whole cell currents of the wild type Kv3.1 
channel could be observed to decrease with time at less depolarized potentials and to a 
greater extent than the N220Q/N229Q channel. The percent of current remaining at the 
end of the 100 ms sweep for wild type Kv3.1 was 13% and 18% smaller at +40 mV (gray 
and black bars on the left-side) and +60 mV (gray and black bars of the right-side),  
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Figure 23. Whole cell current recordings of wild type Kv3.1 and N220Q/N229Q 
channels display variations in the rate of inactivation 
Exemplar currents mediated by wild type Kv3.1 (A) and N220Q/229Q (B) channels 
expressed in B35 cells. Currents were measured in the whole-cell configuration during 
100 ms depolarizing test pulses from −40 to +80 mV from a holding potential of -50 mV. 
(C) Percentage of current remaining at +40 mV (left) and +60 mV (right) for wild type 
Kv3.1 (light gray, 83.9 ± 3.1 at +40 mV, 77.8 ± 3.4 at +60 mV) and N220Q/N229Q (dark 
gray, ± 96.3 ± 1.1 at +40 mV, 94.5 ± 1.4 at +60 mV) inactivating currents. (D) Frequency 
distribution histogram for percent current remaining at +60 mV for wild type Kv3.1 (light 
gray, n=37) and N220Q/N229Q (dark gray, n=26) inactivating currents. (E) Bar graph 
summarizing percent current remaining at +60 mV for fast (54.1 ± 4.6) and slow (90.7 ± 
0.8) forms of the wild type Kv3.1 inactivating current type. (F) Representative tracings 
showing the broad distribution of fast inactivating currents for the wild type Kv3.1 
channel. The percent of current remaining at +60 mV from left to right were: 19.7%, 
43.9%, and 69.3%. Asterisks denote the level of significance against either wild type 
Kv3.1 (P < 0.05) or fast inactivating currents (P < 0.01). Data are expressed as mean ± 
S.E. n corresponds to the number of cells tested. 
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respectively, than those of the N220Q/N229Q channel (Figure 23C). These current 
remaining values are given in Table 1 which summarizes the whole current parameters 
for all four forms of the Kv3.1 channel. Taken together, these results showed that the 
glycosylated Kv3.1 channel has faster inactivation kinetics than its unglycosylated 
counterpart. 
To further characterize the decrease of the currents with respect to time for the 
inactivating current type, frequency distribution histograms were constructed for the 
percent of current remaining at +60 mV for both wild type Kv3.1 (Figure 2D, lower 
panel) and N220Q/N229Q (Figure 23D, upper panel) channels. More than 80% of the 
N220Q/N229Q cells showed greater than 90% of current remaining while only about 
40% of the wild type Kv3.1 cells displayed this slow inactivating behavior. It was also 
apparent that the number of wild type Kv3.1 cells showed a very broad range of 
inactivating kinetics while that of N220Q/N229Q cells was quite narrow. Therefore, the 
inactivating current type of the wild type Kv3.1 channel was further categorized by the 
time-dependence of current inactivation. We refer to these two time-dependent 
inactivating kinetic categories as the fast form and the slow form. The fast form included 
all wild type Kv3.1 transfected B35 cells which had percent current remaining values of 
less than 76% at +60 mV while the slow form encompasses the remainder of the wild 
type Kv3.1 transfected B35 cells. As shown, the percent of current remaining for the fast 
form was about 40% less than the slow form (Figure 23E). The wide range of current 
remaining values for the fast form is illustrated in the selected whole cell recordings 
(Figure 23F, percent of current residual at +60 mV: 19.7%, left panel; 43.9%, middle 
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panel; and 69.3 %, right panel). The inactivating rates for N220Q/N229Q transfected B35 
cells were more like the slow form since all had greater than 76% current remaining 
(Figure 23D). However, the inactivating rates of the slow form of wild type Kv3.1 was 
significantly faster than those of N220Q/N229Q (Table 1 and 2). These results indicated 
that the wild type Kv3.1 protein associated with atypical sialylated N-glycans can express 
the inactivating current type with a broad spectrum of inactivation rates. They also 
support that both the fast and slow forms of the wild type Kv3.1 channel have faster 
inactivation rates than those of the N220Q/N229Q channel. 
Inactivation kinetics of the wild type Kv3.1 (Figure 24A) and N220Q/N229Q 
(Figure 24B) channels were also examined using a similar voltage protocol, as above, 
except the duration (2 s) of the pulse was increased by about 20-fold. The whole cell 
recordings showed that initially the currents quickly increased with time, and then 
decreased as the duration of the pulse continued. Additionally, the decrease in current 
amplitudes at the end of pulses relative to the maximum current amplitudes was greater 
for the wild type Kv3.1 channel than the N220Q/N229Q channel. For example, the 
percent of current remaining for the wild type Kv3.1 channel was about 72% of the 
unglycosylated Kv3.1 channel when the test potential was +40 mV (Figure 24C). The 
frequency distribution histograms of both wild type Kv3.1 and N220Q/N229Q channels 
covered broad ranges (Figure 24D). However, the overall range of values for the wild 
Kv3.1 channel was lower than those of the N220Q/N229Q channel. The same cells 
expressing the fast and slow forms of the wild type Kv3.1 inactivating current type were 
used to characterize the inactivation kinetics of the longer pulse at +40 mV. The percent 
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Table I: Electrophysiological parameters of glycosylated, unglycosylated and  
partially glycosylated forms of the Kv3.1 channel in B35 cells 
 
 The biophysical parameters are shown for the inactivating current (inact i) and 
noninactivating current (noninact i) types. As defined, the former showed current 
saturation at more positive potentials while the latter lacked current saturation. The 
noninactivating current type was further grouped by the presence (w transient peak) or 
absence (w/o transient peak) of a transient peak. % I remaining, corresponds to the 
percent of current remaining near the last 10 ms of the indicated sweep relative to the 
peak current amplitude; RT stands for rise times; τact, activation time constant; V1/2(peak) 
and V1/2(ss'), voltage at which 50% of activation is reached based on conductance-voltage 
curve determined from the current amplitude of the peak current (peak) or the last 10 ms 
of the sweep (ss'); dV(peak) and dV(ss'), slope factor based on conductance-voltage curve; 
τdeact, deactivation time constant of deactivation. Unpaired Student’s t-test was used to 
compare wild type Kv3.1 and N220Q/N229Q transfected B35 cells, as well as N220Q 
and N220Q transfected B35 cells. A value of P < 0.05 was considered significant (*). 
N.S. indicates that N220Q and N229Q were not significantly different. To compare all 
four forms of the Kv3.1 protein one-way ANOVA followed by Bonferroni’s post hoc-
tests was utilized. A value of P < 0.05 indicated that the wild type transfected cells were 
considered significantly different from the Kv3.1 mutant transfected B35 cells (*). 
Values are given as mean ± S.E. In all cases n corresponds to the number of cells tested. 
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Table I: Electrophysiological parameters of glycosylated, unglycosylated and 
partially glycosylated forms of the Kv3.1 channel in B35 cells 
 
 Wild type N220Q/N229Q N220Q N229Q 
Kv (100 ms) protocol     
  Inactivation kinetics     
% i remaining at +40 mV     
Inact i 83.9 ± 3.1 (n=37) 96.3 ± 1.1 (n=26)** 95.8 ± 1.0 (n=17)NS* 98.0 ± 0.8 (n=12)* 
Noninact i 92.8 ± 0.8 (n=68) 98.6 ± 0.5 (n=13)** 94.0 ± 1.4 (n=10)NS 92.7 ± 1.0 (n=29) 
   w transient peak 90.0 ± 0.8 (n=44) 96.6 ± 0.7 (n=4)* 92.6 ± 1.3 (n=8)NS 90.6 ± 0.9 (n=22) 
   w/o transient peak 97.7 ± 1.1 (n=24) 99.6 ± 0.2 (n=9)NS 99.3 ± 0.1 (n=2)NS 99.4 ± 0.3 (n=7) 
% i remaining at +60 mV     
Inact i 77.8 ± 3.4 (n=37) 94.5 ± 1.4 (n=26)** 94.7 ± 1.1 (n=17)NS* 96.7 ± 0.8 (n=12)* 
Noninact i 87.8 ± 0.9 (n=68) 96.9 ± 1.2 (n=13)** 89.0 ± 1.5 (n=10)NS 87.8 ± 0.8 (n=29) 
   w transient peak 84.9 ± 0.6 (n=44) 90.8 ± 0.8 (n=4)** 87.4 ± 1.1 (n=8)NS 86.2 ± 0.7 (n=22) 
   w/o transient peak 93.1 ± 1.9 (n=24) 99.6 ± 0.2 (n=9)* 95.4 ± 4.3 (n=2)NS 93.1 ± 0.9 (n=7) 
  Activation kinetics     
RT at +40 mV (ms)     
Inact i 7.7 ± 0.6 (n=37) 16.2 ± 1.5 (n=26)** 10.7 ± 1.0 (n=17)NS 12.9 ± 1.5 (n=12)* 
Noninact i 3.9 ± 0.3 (n=68) 9.6 ± 1.4 (n=13)** 3.3 ± 0.4 (n=10)NS 3.0 ± 0.1 (n=29) 
   w transient peak 3.0 ± 0.1 (n=44) 3.9 ± 0.2 (n=4)** 2.7 ± 0.04 (n=8)NS 2.8 ± 0.1 (n=22) 
   w/o transient peak 5.8 ± 0.7 (n=24) 12.2 ± 1.3 (n=9)** 5.8 ± 0.5 (n=2)* 3.7 ± 0.4 (n=7) 
τact at +40 mV (ms)     
Inact i 3.1 ± 0.3 (n=37) 7.1 ± 0.7 (n=26)** 4.3 ± 0.3 (n=17)** 6.1 ± 0.8 (n=12)* 
V1/2 (peak) (mV) 10.1 ± 0.8 (n=37) 8.1 ± 0.6 (n=26)** 9.2 ± 0.8 (n=17)** 12.7 ± 0.9 (n=12)* 
V1/2 (ss′) (mV) 5.7 ± 0.7 (n=37) 7.1 ± 0.6 (n=26)** 8.6 ± 0.8 (n=17)** 12.4 ± 0.9 (n=12)* 
dV (peak) 11.2 ± 0.5 (n=37) 9.6 ± 0.3 (n=26)** 9.9 ± 0.4 (n=17)** 9.5 ± 0.4 (n=12)* 
dV (ss′) 9.8 ± 0.5 (n=37) 9.2 ± 0.4 (n=26)** 9.6 ± 0.5 (n=17)** 9.3 ± 0.5 (n=12)* 
  Current density (pA/pF)     
All I types 295 +/- 20 
(n=105) 
138 +/- 19 (n=39)** 199 +/- 34 (n=27)* 322 +/- 31 (n=41) 
Inact i 163 +/- 24 (n=37) 88 +/- 13 (n=26)* 97 +/- 21 (n=17)NS 132 +/- 26 (n=12) 
Noninact i  366 +/- 24 (n=68) 239 +/- 39 (n=13)* 373 +/- 50 (n=10)NS 401 +/- 33 (n=29) 
  % Current type     
Inact i 35% (n=105) 67% (n=39) 63% (n=27) 29% (n=41) 
Noninact i 65% (n=105) 33% (n=39) 37% (n=27) 71% (n=41) 
   w transient peak 65% (n=68) 31% (n=13) 80% (n=10) 76% (n=29) 
   w/o transient peak 35% (n=68) 69% (n=13) 20% (n=10) 24% (n=29) 
Kv(2sec) protocol     
% i decay at +40 mV     
Inact i 39.5 ± 2.8 (n=27) 55.2 ± 3.2 (n=18)** 60.2 ± 2.7 (n=14)NS* 65.0 ± 4.6 (n=9)* 
Deactivation protocol     
τdeact at -60 mV (ms) 1.29 ± 0.04 (n=31) 1.45 ± 0.04(n=19)** 1.29 ± 0.07 (n=11)NS 1.11 ± 0.05 (n=8)* 
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Table II: Comparison of the biophysical parameters for the fast and slow forms of 
 
the wild type Kv3.1 channel 
 
 Wild type (fast) and wild type (slow) denote B35 cells transfected with wild type 
Kv3.1 which expressed the inactivating current type with fast and slow inactivating 
currents with respect to time. If the percent of current remaining at +60 mV was less than 
76% at the end of the pulse relative to the peak current amplitude then those were 
referred to as the fast form of wild type Kv3.1, and all others were referred to as the slow 
form. Asterisks denote statistical significance compared with the fast form of wild type 
Kv3.1 (P <0.05) by unpaired Student's t test. Values are given as mean ± S.E. In all cases 
n corresponds to the number of cells tested. 
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Table II: Comparison of the biophysical parameters for the fast and slow forms of  
the wild type Kv3.1 channel 
 
 Wild type (fast) Wild type (slow) 
Kv (100 ms) protocol   
  Inactivation kinetics   
% I remaining at +60 mV 54.1 ± 4.6 (n=13) 90.7 ± 0.8 (n=24)* 
  Activation kinetics   
RT at +40 mV (ms) 4.3 +/- 0.4 (n=13) 9.6 +/- 0.7 (n=24)* 
τact at +40 mV (ms) 1.5 ± 0.2 (n=13) 3.9 ± 0.4 (n=24)* 
V1/2 (peak) (mV) 13.8 +/- 1.5 (n=13) 9.0 +/- 0.8 (n=24)* 
V1/2 (ss′) (mV) 1.8 +/- 1.0 (n=13) 7.6 +/- 0.8 (n=24)* 
dV (peak) 14.0 +/- 1.0 (n=13) 9.9 +/- 0.5 (n=24)* 
dV (ss′) 10.1 +/-0.8 (n=13) 9.4 +/-0.5 (n=24) 
  Current Density (pA/pF) 274 ± 53 (n=13) 103 ± 14 (n=24)* 
Kv(2sec) protocol   
% i remaining at +40 mV 20.3 ± 3.1 (n=7) 45.5 ± 1.9 (n=20)* 
Deactivation protocol   
τdeact at -60 mV (ms)  1.28 ± 0.09  (n=10) 1.29 ± 0.04  (n=21) 
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Figure 24. Prolong depolarization steps enhance the differences in the inactivation 
rates of wild type Kv3.1 and N220Q/N229Q channels 
A comparison of whole cell currents induced in B35 cells transfected with wild type Kv3.1 
(A) and N220Q/N229Q (B) by 2 sec depolarizing steps from a -50 mV holding potential to 
potentials between -40 and 80 mV in 10 mV steps. (C) Percentage of current remaining at +40 
mV for wild type Kv3.1 (light gray, 39.5 ± 2.8 at +40 mV) and N220Q/N229Q (dark gray, 55.2 ± 
3.2 at +40 mV). (D) Histograms showing the frequency for occurrence of percent current 
remaining at +40 mV for wild type Kv3.1 (light gray, n=27) and N220Q/N229Q (dark gray, 
n=18) inactivating currents. (E) A summary bar graph illustrating the percent current remaining at 
+40 mV for the fast (20.3 ± 3.1) and slow (45.5 ± 1.9) forms of wild type Kv3.1 inactivating 
currents. (F) Whole cell recordings showing the broad range of the fast inactivation kinetics for 
the wild type Kv3.1 channel from left to right: 8.8%, 15.6%, and 28.6%. The thick black lines 
show the current response elicited at +40 mV. Statistically significant differences between wild 
type and N220Q/N229Q (P < 0.05) or fast and slow forms (P < 0.01) of the wild type Kv3.1 
inactivating current type are indicated by asterisks. Data are expressed as mean ± S.E. n 
corresponds to the number of cells tested. 
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of current remaining for the fast form of wild type Kv3.1 was about 45% of the slow 
form (Figure 23E). Moreover, the percent of current remaining for the slow form of wild 
type Kv3.1 (Table 2) was about 20% less than that of N220Q/N229Q (Table 1). 
Representative whole cell recordings were selected to exemplify the broad range of the 
inactivation rates of the wild type Kv3.1 channel (Figure 24F, percent of current 
remaining at +40 mV: 8.8%, left panel; 15.6%, middle panel; and 28.6%, right panel). 
These results corroborated that the glycosylated Kv3.1 channel has a faster inactivation 
rate than the unglycosylated Kv3.1 channel. They also showed that wild type Kv3.1 
expressed in B35 cells can generate Kv3.1 channels with a broad spectrum of inactivation 
rates. Taken together, these results indicate that neuronal N-glycosylation processing 
regulates Kv3.1 channel inactivation properties. 
 
Neuronal N-glycosylation processing regulates the voltage dependence of channel 
activation and inactivation 
Voltage dependence of channel activation was analyzed using peak current 
amplitudes and current amplitudes at the end of the 200 ms pulse (Figure 25A). The 
membrane conductance determined from the peak current amplitude vs. applied test 
potential indicated that more depolarization was required for 50% of wild type Kv3.1 
channels to reach activation (V0.5 [test potential at which g/gmax = 0.5] is 10.1 ± 0.8 mV, 
n=37) than when the membrane conductance was determined from the current amplitude 
at the end of the 100 ms pulse (V0.5 is 5.7 ± 0.7 mV, n=37). It was also observed that 
fewer channels were activated as the applied voltage was increased when using peak 
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Figure 25. Activation (G-V) curves of wild type Kv3.1 and N220Q/N229Q channels  
Channel activation versus voltage curves analyzed by using the current amplitude at 
the peak (○) and the last 10 ms of the 100 ms sweep at the applied voltage (□) for the 
inactivating current type of wild type Kv3.1 (A, n =37), and N220Q/N229Q (B, n =26), 
along with the fast (C, n=13), and slow (D, n=24) forms of the inactivating current type 
for wild type Kv3.1. Each set of data points were fitted with a Boltzmann function of the 
form: G = Gmax/[1 + exp(V1/2 - Vm)/q] where q represents the slope factor, Vm stands for 
the test potential, V1/2 is the potential at which the conductance was half maximal, G is 
the conductance and Gmax is the maximal conductance. The Boltzmann parameter values 
are reported in both Tables I and II. 
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current amplitudes to determine the slope of normalized membrane conductance voltage 
relationship (dV [slope of normalized membrane conductance voltage relationship] is 
11.2 ± 0.5 mV, n=37) than when the membrane conductance was determined from the 
current amplitude at the end of the sweep (dV is 9.8 ± 0.5 mV, n=37). Similar voltage-
conductance plots were constructed for the N220Q/N229Q channel. The voltage 
dependence of activation parameters from either peak current amplitudes or current 
amplitudes at the end of the pulses for the N220Q/N229Q channel were significantly 
different (V0.5 (peak) is 8.1 ± 0.6 mV; V0.5 (ss’) is 7.1 ± 0.6 mV, dV(peak) is 9.6 ± 0.3 mV, and 
dV(ss’) is 9.2 ± 0.4 mV, n=26). However, the differences between the parameters were not 
as large as those for the wild type Kv3.1 channel. These results showed that wild type 
Kv3.1 currents inactivate more readily with time than those of N220Q/N229Q, 
suggesting a subpopulation of the wild type Kv3.1 channels have faster inactivation rates. 
When comparing the voltage dependence of activation parameters determined 
from current amplitudes at the end of the sweep for wild type Kv3.1 and N220Q/N229Q 
channels, more depolarization was required to activate 50% of the N220Q/N229Q 
channels than wild type Kv3.1 channels. In contrast, when peak current amplitudes were 
utilized to construct the Boltzmann plots, less depolarization was required for 50% of the 
N220Q/N229Q channels to reach activation than the wild type Kv3.1 channels. 
Additionally, the percent of wild type Kv3.1 channels activated as a function of applied 
voltage was less than those for the N220Q/N229Q channel whether determined from 
peak current amplitudes or current amplitudes at the end of the applied pulses. These 
results indicated that neuronal N-glycosylation processing of the wild type Kv3.1 protein 
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generates a subpopulation of glycosylated Kv3.1 channels which requires more 
depolarization to be activated, and are more readily inactivated than the unglycosylated 
Kv3.1 channel. 
The voltage dependence of channel activation analysis was also conducted for 
wild type Kv3.1 transfected B35 cells which expressed the fast (Figure 25C) and slow 
(Figure 25D) forms. Conductance-voltage curves constructed from peak current 
amplitudes showed more depolarization was required for 50% of the fast form to reach 
activation than that of the slow form (V0.5 (peak): fast form, 13.8 ± 1.5 mV, n=13; slow 
form, 9.0 ± 0.8 mV, n=24). On the contrary, when determining this same parameter from 
the current amplitudes at the end of the pulses, then less depolarization was required for 
50% of the fast form to reach activation than that of the slow form (V0.5 (ss’): fast form, 1.8 
± 1.0 mV, n=13; slow form, 7.6 ± 0.8 mV, n=24). Additionally, it was observed that 
fewer channels were activated as the applied voltage was increased for the fast form (dV 
is 14.0 ± 1.0, n=13) than for the slow form (dV is 9.9 ± 0.5, n=24) when using peak 
current amplitudes to determine parameters. However, when using current amplitude at 
the end of the pulse for the two groups, their parameters were not significantly different. 
These results indicate that neuronal N-glycosylation processing of the wild type Kv3.1 
protein can generate at least two distinct subpopulations of glycosylated Kv3.1 channels 
which activate and inactivate over a different voltage range. In comparing the slow form 
of the wild type Kv3.1 channel to the N220Q/N229Q channel, slightly more 
depolarization was required to activate 50% of the slow form channels and fewer of these 
channels were activated as the applied voltage increased (Table 1 and 2). Therefore, these 
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results support that the voltage dependence of Kv3.1 channel activation and inactivation 
are modulated by neuronal N-glycosylation processing. 
 
Noninactivating current behavior was more common for the glycosylated Kv3.1 
channel 
Previously, whole cell recordings of wild type Kv3.1 expressed in mammalian 
cells (24,26,29) and infected Sf9 cells (35) were shown to have little saturation in current 
amplitude in response to large depolarization steps. For clarity, this type of whole cell 
current pattern will be defined as the noninactivating current type. The wild type Kv3.1 
(Figure 26A) and N220Q/N229Q (Figure 26B) channels expressed in B35 cells also 
displayed noninactivating current behavior. The noninactivating currents were the 
predominant current type expressed by the wild type Kv3.1 channel while inactivating 
currents were the predominant type for the N220Q/N229Q channel (Table 1). It was also 
observed that the noninactivating currents of wild type Kv3.1 channels usually had a 
transient current peak at the initial phase of the sweep (Figure 26A) while the 
N220Q/N229Q channel usually lacked the transient peak (Figure 26B) (Table 1). Based 
on the presence and absence of the transient peak at +40 mV, the noninactivating current 
type was further divided into two groups. One group was referred to as the 
noninactivating currents with transient peaks, while the other group was referred to as the 
noninactivating currents without transient peaks. The percent of current remaining at the 
end of the sweep at +40 mV and +60 mV were determined for both types of 
noninactivating currents of wild type Kv3.1 and N220Q/N229Q (Figure 26C). The wild 
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Figure 26. Comparison of the noninactivating current patterns from wild type 
Kv3.1 and N220Q/N229Q channels 
Representative whole cell currents are displayed from B35 cells transfected with 
wild type Kv3.1 (A) and N220Q/N229Q (B). (C) Percentage of current remaining at +40 
mV (left) and +60 mV (right) of the noninactivating current type for wild type Kv3.1 
(light gray, 92.8 ± 0.8 at +40 mV; 87.8 ± 0.9 at +60 mV) and N220Q/N229Q (dark gray, 
98.6 ± 0.5 at +40 mV, 96.9 ± 1.2 at +60 mV). Asterisks show significant differences (P < 
0.05) versus wild type Kv3.1. Data are expressed as mean ± S.E. n corresponds to the 
number of cells tested. 
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type Kv3.1 channel had a faster inactivation rate at the more depolarized potential while 
those for the N220Q/N229Q channel were quite similar. Additionally, the inactivation 
rates were faster for wild type Kv3.1 than N220Q/N229Q at the various potentials (Table 
1). The two different types of noninactivating currents for the glycosylated Kv3.1 channel 
were also reported to inactivate at a faster rate than those of the unglycosylated Kv3.1 
channel (Table 1). Moreover, when comparing the two different noninactivating current 
types displayed by either form of the Kv3.1 channel expressed in B35 cells, the 
noninactivating current with transient peaks showed a greater inactivation rate than those 
without transient peaks (Table 1). These results corroborated the inactivation kinetics of 
the inactivating current type in that the glycosylated Kv3.1 channel inactivates at a faster 
rate than its unglycosylated counterpart. The results also suggested that the 
noninactivating current types with transient peaks express a subpopulation of Kv3.1 
channels which have faster inactivation kinetic properties, similar to the inactivating 
current type. 
 
N-Glycosylation of the Kv3.1 channel increased current density 
Channel density at the cell surface was determined for all types of current of the 
wild type Kv3.1 (Imax/cap is 295 ± 20 pA/pF, n=105) and N220Q/N229Q (Imax/cap is 138 
± 19 pA/pF, n=39) channels (Figure 27A). This larger current density of the wild type 
Kv3.1 channel correlated with its more prevalent noninactivating current behavior. 
However, both inactivating and noninactivating currents expressed larger channel 
densities at the cell surface for wild type Kv3.1 (Imax/cap: 163 ± 24 pA/pF, n=37,  
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Figure 27. Differences in the current density are expressed by the various whole cell 
current types of the wild type Kv3.1 and N220Q/N229Q channels 
(A) Bar graph representing the current densities of all current types, inactivating 
current type, and noninactivating current type from B35 cells transfected with wild type 
Kv3.1 (light gray, inactivating current type is 163 ± 24; noninactivating current type is 
366 ± 24; and all types of current is 295 ± 20 pA/pF) and N220Q/N229Q (dark gray, 
inactivating current type is 88 ± 13; noninacivating current type is 239  ± 39; and all 
types of current is 138 ± 19, pA/pF). (B) Bar graph representing the current densities of 
the fast (274 ± 53 pA/pF) and slow (103 ± 14 pA/pF) forms of the inactivating current 
type of the wild type Kv3.1 channel. (C) The plot displays the frequency distribution of 
current density for the fast (lower panel, n=13) and slow (upper panel, n=24) forms. 
Asterisks indicate the level of significance against either wild type Kv3.1 (P < 0.05) or 
fast inactivating currents (P < 0.01). 
  
151
 
Figure 27
Cartwright and Schwalbe, 2008
C.
0 200 400 600
0
1
2
3
4
0
2
4
6
8
N
um
be
r o
f E
ve
nt
s
% Current Density
current density (pA/pF)
0
100
200
300
400
wt  220/229wt  220/229wt  220/229
Inactivating
currents
All current 
types
Noninactivating
currents
C
ur
re
nt
 d
en
si
ty
 (p
A
/p
F)
wt wt t220/
229
220/
229
220/
229
A.
n=
10
5
n=
39
n=
26
n=
13
n=
37
n=
68
*
*
*
current density (pA/pF)0
100
200
300
wt (fast) wt (slow)fast
wt
slow
wt
B.
C
ur
re
nt
 d
en
si
ty
 (p
A
/p
F)
n=
13
n=
24
*
 
  
152
 
inactivating currents; and 366 ± 24 pA/pF, n=68, noninactivating currents) than for 
N220Q/N229Q (Imax/cap: 88 ± 13 pA/pF, n=26, inactivating currents; and 239 ± 39 
pA/pF, n=13, noninactivating currents) (Table 1). These results demonstrated that N-
glycosylation of the Kv3.1 channel regulates the current density at the cell surface. 
 It was determined that the current density for the fast form (Imax/cap is 274 ± 53 
pA/pF, n=13) of the wild type Kv3.1 channel was at least 2.5 times larger than the slow 
form (Imax/cap is 103 ± 14 pA/pF, n=24). The frequency distribution of the current 
densities for the slow form was quite narrow while the fast form covered a broad range. 
In fact, close to 80% of the slow form expressed current densities of less than 150 pA/pF 
while only approximately 15% of the fast form expressed these small current densities. 
The large current densities for the fast form support that the fast inactivation of the wild 
type Kv3.1 channel was due to N-glycosylation processing and not to endogenous 
protein. 
 
Glycosylated Kv3.1 channels have faster activation rates than their unglycosylated 
counterpart 
To compare activation kinetics of the inactivating currents, the whole cell current 
recordings of wild type Kv3.1 and N220Q/N229Q were normalized at +20 mV and +30 
mV (Figure 28A), +40 mV and +50 mV (Figure 28B) and +60 and +70 mV (Figure 28C) 
and overlaid in pairs for clarity. The activation rates were slowest at the lowest applied 
test potential and fastest at the highest potential for both forms of Kv3.1 which indicates 
voltage dependence of channel activation. Additionally, the rise times were faster for the  
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Figure 28. Variations in the activation rates of the various whole cell current types 
for wild type Kv3.1 and N220Q/N229Q channels 
Time course of normalized currents from wild type Kv3.1 (light grey curves) and 
N220Q/N229Q (dark gray curves) at +20 mV (thick lines) and +30 mV (thin lines) (A), 
+40 mV (thick lines) and +50 mV (thin lines) (B), and +60 mV (thick lines) and +70 mV 
(thin lines) (C). (D) Plot of activation rise time as a function of applied voltage for wild 
type Kv3.1 (■, n=37 unless indicated) and N220Q/N229Q (●, n=26 unless indicated) 
transfected B35 cells. (E) Bar graph representation of activation time constants (τact) at 
+40 mV for wild type Kv3.1 (3.1 ± 0.3 ms), including the fast (1.5 ± 0.2 ms) and slow 
(3.9 ± 0.4 ms) forms, and N220Q/N229Q (7.1 ± 0.7 ms). (F) Rise time at +40 mV for the 
fast (light gray, 4.3 ± 0.4 ms) and slow (light gray, 9.6 ± 0.7 ms) forms of wild type 
Kv3.1. (G) Bar graph characterizing the rise times at +40 mV for wild type Kv3.1 (light 
gray) and N220Q/N229Q (dark gray) transfected B35 cells for inactivating current type 
(wild type Kv3.1, 7.7 ± 0.6; N220Q/N229Q, 16.2 ± 1.5 ms) and noninactivating current 
types with (wild type Kv3.1, 3.0 ± 0.1; N220Q/N229Q, 3.9 ± 0.2 ms) and without (wild 
type Kv3.1, 5.8 ± 0.7; N220Q/N229Q, 12.2 ± 1.3 ms) transient peaks. Asterisks represent 
statistical significance compared with either the fast inactivating (P < 0.01) or wild type 
Kv3.1 currents (P < 0.05). Data are expressed as mean ± S.E. n corresponds to the 
number of cells tested. 
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wild type Kv3.1 channel than the N220Q/N229Q channel at and beyond -20 mV (Figure 
28D). The activation time constant at +40 mV for the wild type Kv3.1 channel was more 
than twice as fast as the N220Q/N229Q channel (Figure 28E). Interestingly, activation 
time constants (Figure 28E) and rise times (Figure 28F) at +40 mV were at least twice as 
fast for the fast form of the wild type Kv3.1 channel compared to the slow form. 
Moreover, the activation rates of the slow form were at least 1.7 times faster than those of 
the N220Q/N229Q channel. When comparing the rise times of all three types of current 
for the wild type Kv3.1 channel, the noninactivating current with transient peaks was 
faster than those without transient peaks while the inactivating current was the slowest 
(Figure 28G). All three current types for the N220Q/N229Q channel had a similar 
ranking. In all cases, the rise times of each current type were faster for the wild type 
Kv3.1 channel compared to those of the N220Q/N229Q channel (Figure 28G). These 
results demonstrated that N-glycosylation enhances the activation rates of the Kv3.1 
channel. 
 
N-Glycosylation of the Kv3.1 channel increases the deactivation rate 
The deactivation rates of Kv3 channel are rapid (14). To examine the deactivation 
kinetics, transfected B35 cells were briefly clamped at +40 mV to activate the wild type 
Kv3.1 (Figure 29A) and N220Q/N229Q (Figure 29B) channels, and subsequently the 
channels were deactivated by clamping the cells to less depolarized potentials. Both 
glycosylated and unglycosylated forms of the Kv3.1 channel displayed rapid deactivation 
rates (Figure 29C). However, the deactivation rate of the wild type Kv3.1 (τdeact at -60 
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Figure 29. Deactivation rates of wild type Kv3.1 and N220Q/N229Q channels  
Representative deactivation current traces from B35 cells expressing wild type 
Kv3.1 (A) and N220Q/N229Q (B). Cells were held at -50 mV and depolarized to +40 
mV for 25 ms followed by repolarization from -110 mV to 0 mV for 200 ms. (C) 
Summary of deactivation time constants (τdeact) obtained at –60 mV from B35 cells 
expressing wild type Kv3.1 (light gray bars, 1.29 ± 0.04 ms) and N220Q/N229Q (dark 
gray bars, 1.45  ± 0.04 ms). Asterisks denote statistical significance (P < 0.05) when 
compared to wt Kv3.1. Data are expressed as mean ± S.E. n corresponds to the number of 
cells tested. 
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mV was 1.29 ± 0.04 ms, n=31) channel was significantly faster than that of the 
N220Q/N229Q (τdeact at -60 mV was 1.45 ± 0.04 ms, n=19) channel. These results 
showed that N-glycosylation of the Kv3.1 channel slightly enhances the deactivation 
rates of the channel.   
 
Analysis of the partially glycosylated Kv3.1 channels 
 After detecting differences in the channel activities of the Kv3.1 protein with both 
N-glycosylation sites occupied (glycosylated form) and unoccupied (unglycosylated 
form), we evaluated the channel properties of the Kv3.1 proteins with either 1 of the 2 
sites occupied (partially glycosylated forms). Similar whole cell voltage protocols were 
utilized for the partially glycosylated Kv3.1 forms (N220Q and N229Q) as those for the 
glycosylated and unglycosylated Kv3.1 channels. Both N220Q (Figure 30A, left panel) 
and N229Q (Figure 30A, right panel) channels were shown to produce currents when 
transfected B35 cells were clamped to test potentials >-30 mV and >-20 mV, 
respectively, for a duration of 200 ms. Similar to the glycosylated and unglycosylated 
Kv3.1 channels, the partially unglycosylated Kv3.1 channels expressed all three types of 
current. Inactivating currents were more prevalent than noninactivating currents for the 
N220Q channel, like the unglycosylated channel. On the other hand, the major current 
type expressed by the N229Q channel was the noninactivating current, similar to the 
glycosylated Kv3.1 channel. For both partially glycosylated Kv3.1 forms most of the 
noninactivating currents had transient peaks, like the glycosylated Kv3.1 channel. The 
current density, including all current types, of the N220Q channel was significantly 
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Figure 30. Functional characterization of B35 cells expressing the single N-
glycosylation mutants, N220Q and N229Q 
Representative whole cell traces of N220Q (left panels) and N229Q (right panels) 
inactivating current type (A and C) and noninactivating current type (B). The duration of 
the voltage steps were 100 ms (top and upper middle traces) and 2 sec (lower middle 
traces). (D) Deactivation current traces from B35 cells expressing the single mutant 
Kv3.1 channels. 
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Figure 30
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smaller than that of the N229Q channel (Table 1). The difference in the overall current 
density was due to the inactivating currents being the predominant current type of the 
N220Q channel. 
Inactivation kinetics of the N220Q andN229Q were examined using the voltage 
protocols with both 100 ms (Figure 22A and B) and 2 s (Figure 22C) voltage step 
durations. Both of the partially glycosylated Kv3.1 channels displayed significantly 
slower decreases in current with time compared to the glycosylated Kv3.1 channel for the 
inactivating current type, similar to the unglycosylated Kv3.1 channel (Table 1). In 
contrast, the current inactivation rates of the noninactivating currents for the N220Q and 
N229Q channels were significantly faster than the N220Q/N229Q channel, like the wild 
type Kv3.1 channel (Table 1). The membrane conductance vs. applied voltage curves 
were quite similar whether determined from peak current amplitudes or current 
amplitudes at the end of the pulses for the partially glycosylated Kv3.1 channels, similar 
to that of the unglycosylated Kv3.1 channel (Figure 30D). This result indicates that the 
partially unglycosylated channels expressed in transfected B35 cells express slow 
inactivating kinetics. Somewhat similar amounts of partially glycosylated Kv3.1 channels 
were activated as the applied voltage was increased, like the unglycosylated Kv3.1 
channel. The amount of applied voltage required to activate 50% of the N220Q channel 
was less depolarized than the N229Q channel and more depolarized than the 
unglycosylated Kv3.1 channel. The inactivating currents of the partially glycosylated 
Kv3.1 channels had differences in their activation rates while their noninactivating 
currents were similar. For instance, the activation rate of the inactivating currents of 
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N229Q channels was at least 1.7 times slower than the wild type Kv3.1 channel while 
that of the N220Q channel was at least 0.6 times faster than the N220Q/N229Q channel 
(Table 1). The deactivation rates of the partially glycosylated Kv3.1 channels were not 
significantly different (Figure 30E). These results demonstrated that the partially 
glycosylated Kv3.1 channels share some biophysical properties with the glycosylated 
Kv3.1 channel and others with the unglycosylated Kv3.1 channel. 
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DISCUSSION 
 
 Heterologous expression of wild type and mutant forms of the Kv3.1 channel in 
B35 cells were utilized to generate various glycoforms, as well as the aglycoform. Earlier 
studies have shown that the N-glycan associated with the Kv3.1 protein has α2,8-linked 
sialyl residues and that both sites were fully occupied by N-glycans in transfected B35 
cells (152) and adult rat brain (35,116,152) (Figure 22A). This atypical linkage leads to 
the formation of di-, oligo-, or poly-sialyl units (69,70,96,97) and to date a limited 
number of proteins have been identified to carry these modifications 
(70,88,90,97,98,100-102,140). Here both sites were shown to be occupied by sialylated 
N-glycans, and furthermore each was fully occupied when one site was abolished. These 
results were surprising based on the N-glycosylation survey of membrane glycoproteins 
which predicts that usually the site after the one closest to the amino-terminus is 
inefficiently utilized (154). Secondly, the attachment of N-glycans to either both sites or 
to each site, independently, was inefficient when the Kv3.1 protein was heterologously 
expressed in infected Sf9 cells (35). Based on previous studies, occupancy of an N-
glycosylation site can be regulated by the primary sequence, protein folding and 
assembly, orientation of the protein to the membrane, and the distance of site to the 
endoplasmic reticulum membrane (66,79,154). Our present and past (35) studies which 
utilized two independent heterologous expression systems revealed that occupancy of the 
N-glycosylation sites of the Kv3.1 protein can also be regulated by cell type. 
Additionally, the results showed that the efficiency of N-glycan attachment to these sites 
was independently regulated.  
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 To date, atypical N-glycosylation of endogenously and heterologously expressed 
Kv glycoproteins has not been established when characterizing channel function. Here we 
have shown that the processing of the N-glycans to atypical sialoglycoconjugates of the 
wild type Kv3.1 protein can generate a subpopulation of wild type Kv3.1 channels with 
enhanced inactivation and activation kinetics. As mentioned, the wild type Kv3.1 protein 
expressed in B35 cells produced an inactivating current type and a noninactivating 
current type. These current types were based on current saturation at more depolarized 
potentials and those that lacked current saturation, respectively. Moreover, the 
inactivating current type of wild type Kv3.1 channel was further divided into the fast 
form and the slow form which was based on current decay as a function of time. 
Detection of the fast form was unexpected since the inactivation rate of the wild type 
Kv3.1 channel has been described to be quite slow in oocytes (20-22) CHO cells (28) 
native tissue (13,28,29,40) and Sf9 cells (35). However, it appears that when the wild 
type Kv3.1 channel was expressed in L929 cells the inactivation rates were faster than in 
the former mentioned expression systems (153), and perhaps more comparable to those 
expressed in B35 cells. The fast rate of inactivation for the wild type Kv3.1 channel was 
also supported by the conductance-voltage relationships. The conductance-voltage curve 
determined from peak current amplitudes showed a rightward shift compared to that 
determined from current amplitudes near the end of pulses (Figure 25A and 25C). This 
rightward shift was due to a shallower slope for the conductance-voltage curve 
determined from peak current amplitudes. These results support increased instability of 
the open state near the resting potential for the fast form of the wild type Kv3.1 channel 
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compared to the slow form. The activation rate at +40 mV of the slow form of the wild 
type Kv3.1 channel was at least 2.2-fold slower than that of the fast form (Table 2). 
Taken together, these results revealed that a subpopulation of the wild type Kv3.1 
channels with faster inactivation and activation kinetics, along with a less stable opening 
state near the resting potential, exists in the B35 neuroblastoma cellular model. 
 A subpopulation of wild type Kv3.1 channels with faster inactivation and 
activation kinetics could also be shown for the noninactivating current type. This type of 
current was first described when Kv3.1 was expressed in HEK cells, and the transient 
peak was suggested to be due to the accumulation of external potassium ions (24). In 
comparing the inactivating and noninactivating current types, we refer to the transient 
peaks of the noninactivating currents as the subpopulation of wild type Kv3.1 channels 
with fast inactivation rates while the currents thereafter represent the subpopulation of the 
wild type Kv3.1 channels with slow inactivation rates. It was determined that the rise 
times at +40 mV of the noninactivating currents without transient peaks was about 2-fold 
slower than those of the noninactivating current with transient peaks (Table 1). 
Additionally, the rise times of the noninactivating currents without transient peaks had 
slower rise times than the fast form of wild type Kv3.1 but faster than the slow form. This 
result suggests a third subpopulation of wild type Kv3.1 channels may exist which has 
the fast activation rates but slow inactivation rates. This third subpopulation of the wild 
type Kv3.1 channel is also supported when comparing the ratio of the rise times at +40 
mV for the slow form to fast form (2.2), and the noninactivating current type without 
transient peaks to those with transient peaks (1.9). Therefore, two subpopulations of the 
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wild type Kv3.1 channel with fast activation rates and either fast or slow inactivation 
rates can be identified for the noninactivating current type. 
 An explanation of the fast inactivation kinetics displayed by the wild type Kv3.1 
channel expressed in B35 cells could be the result of the Kv3.1 protein interacting with 
the Kv3.4 protein to form a heteromultimer Kv3 channel. For instance, it has been shown 
that the Kv3.1 channel could contain a fast inactivating component if it forms a 
heteromultimeric channel with the Kv3.4 protein (14,22). Based on several results, the 
present study does not support that the Kv3.1 protein interacted with endogenous Kv3.4 
protein to form heteromultimeric Kv3 channels. The Kv3.4 protein was not detected as an 
endogenous protein in B35 cells. Additionally, the current density of the fast form was 
about 2.7 times greater than the slow form (Figure 27B), and it was also approximately 
72 times greater than that of nontransfected B35 cells. Therefore, these results argue 
against the Kv3.1 protein forming a heteromultimeric Kv3 channel with the Kv3.4 
protein in the B35 neuroblastoma cellular model.  
 Here the results favor that the fast inactivation and activation kinetics of the wild 
type Kv3.1 channel are due to the occupancy of both sites by sialylated N-glycans. The 
fast inactivating kinetics of the inactivating current type displayed by transfected B35 
cells expressing the wild type Kv3.1 channel were undetected in 55 out of 55 of the 
transfected B35 cells expressing either the unglycosylated or partially glycosylated forms 
of the Kv3.1 channel. Moreover, the rise times at +40 mV of the unglycosylated Kv3.1 
channel was 2.1-fold slower than the glycosylated wild type Kv3.1 channel. Those of the 
partially glycosylated Kv3.1 channels were also slower compared to the glycosylated 
  
167
 
wild type Kv3.1 channel. The peak current amplitude conductance-voltage curve of the 
aglycoform was also shifted to the left relative to that of the glycosylated Kv3.1 channel. 
Additionally, the aglycoform expressed the noninactivating current with transient peaks 
only 10% of the time, unlike the wild type Kv3.1 channel. The rise times at +40 mV of 
the noninactivating current type of the aglycoform Kv3.1 channel was 2.5-fold slower 
than those of the glycosylated Kv3.1 channel. Thus, these results argue that occupancy of 
the two N-glycosylation sites of the Kv3.1 protein by sialoglycoconjugates are required 
to generate the subpopulation of Kv3.1 channels with enhanced inactivation and 
activation rates, and instability of the open state near the resting potential. 
 The partially glycosylated Kv3.1 channels could produce the subpopulation of 
Kv3.1 channels with fast inactivation and activation kinetics. However, it depended on 
the current type and a much higher current density than that of the glycosylated Kv3.1 
channel. This result was contradictory to an earlier study which proposed that the fast 
inactivating component was the result of lower current amplitudes expressed by the wild 
type Kv3.1 channel in Xenopus oocytes (23). Here when the current density of the 
partially glycosylated channels were high they commonly expressed the noninactivating 
current type. Moreover, these currents had transient peaks the majority (>75%) of the 
time, similar to the wild type Kv3.1 channel. The activation rates of the noninactivating 
current types of the partially glycosylated Kv3.1 channels were also found to be relatively 
fast, like the glycosylated Kv3.1 channel. Interestingly, it was also discovered that sole 
occupancy of the Asn at position 220 by a sialoglycoconjugate could generate the 
subpopulation more than 53% of the time while the sole attachment of the 
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sialoglycoconjugate at position 229 was only 30% of the time. Therefore, N-
glycosylation of the first site could more readily generate the Kv3.1 channels with fast 
inactivation and activation kinetics than that of the second site due to a greater ability to 
express noninactivating currents with large current density in B35 cells. 
 Based on the analysis of the inactivating currents of the various forms of the 
Kv3.1 channel, vacancy of the N-glycosylation sites, independently or together, had 
major changes on the voltage dependence of channel activation. The conductance-voltage 
curve generated by the N220Q channel was almost identical to the slow form of the wild 
type Kv3.1 channel. Additionally, the activation rate of the N220Q channel was quite 
comparable to the slow form of the wild type Kv3.1 channel. These results indicated that 
the sole vacancy of position 220 by an N-glycan could disrupt the production of the fast 
form of the wild type K3.1 channel. When only the second N-glycosylation site was 
vacant, the threshold potential of Kv3.1 channel activation was more positive (5-10 mV) 
than the other three forms of the Kv3.1 channel. This slightly greater depolarization 
potential produced a conductance-voltage curve with a similar shape to the 
unglycosylated Kv3.1 channel, except that it was shifted to the right. Taken together, 
these results supported that the vacancy of either one of the N-glycosylation sites will 
disrupt the production of the fast form, and that the vacancy of position 229 will increase 
the threshold potential for channel activation. Moreover, it is critical that both sites be 
occupied simultaneously to confer the unique properties of the Kv3 channel, such as the 
destabilization of the open state near the resting potential and the fast activation kinetics. 
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 Cell-specific glycoconjugates presented at the cell surface influence the voltage 
sensor of the wild type Kv3.1 channel. More depolarization (about 6 mV) was required to 
activate 50% of the Kv3.1 channels expressed in Sf9 cells (35) compared to those 
expressed in B35 cells. A possible reason for this difference could be explained by the 
surface potential theory (5) due to sialylated N-glycans of B35 cells (69,138,152) and the 
lack of these N-glycans for Sf9 cells (35,155). Previously, this theory was applied to 
explain the removal of sialic acid from N-glycans for the Kv1.1 (58,83) and Kv1.2 (84) 
channels. However, this does not appear to be a plausible explanation for the Kv 3.1 
channel since the slopes of the G-V curves were different in both the Sf9 (35) and B35 
cells. Secondly, the voltage sensor of the Kv3.1 channel appeared unaware of the 
attachment of the atypical sialylated N-glycans since the amount of depolarization to 
activate similar amounts of the unglycosylated Kv3.1 channel expressed in B35 cells was 
less. Of interest, the half-maximal conductance of the unglycosylated Kv3.1 channel 
expressed in Sf9 cells (35) was greater (about 12 mV) than that expressed in B35 cells 
and the slopes of the G-V curves were quite similar. Taken together, the attachment of 
sialoglycoconjugates to the cell surface appears to contribute to the uniform 
transmembrane electrical field detected by the voltage sensor of the Kv3.1 channel. 
However, attachment of both sialylated N-glycans lacks detection by the voltage sensor 
when the Kv3.1 channel resides in the matrix of B35 cells. 
 Mechanisms involved in gating of the Kv3.1 channel are regulated by N-
glycosylation. More depolarization was required to activate 50% of the N229Q channel 
than the wild type Kv3.1 channel. This result suggests that the sialylated N-glycan 
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attached to position 229 was detected by the voltage sensor. However, the slopes of the 
G-V curves were different between the N229Q and wild type Kv3.1 channels, and 
furthermore less depolarization was required to activate the aglycoform than the N229Q 
channel. These results argue against the voltage sensor detecting the sialylated N-glycan 
at position 229 of the wild type Kv3.1 channel. Perhaps the voltage dependence of the 
N229Q channel activation can be more easily explained by the gating stabilizing theory 
(5), similar to the N220Q and N220Q/N229Q channels. When the attachment of the N-
glycan at position 229 was prevented, the open state of the Kv3.1 channel was more 
destabilized near the resting membrane potential, like the unglycosylated Kv1.1 (58,83) 
and Kv1.2 (84) channels. An earlier study of the Kir1.1 channel also showed that the 
open state was destabilized by the absence of N-glycosylation (119). On the other hand, 
the absence of an N-glycan at position 220 caused more stabilization of the open state 
near the resting potential, and furthermore when both N-glycans were absent the open 
state was even more stabilized. Therefore, the results indicated that attachment of both N-
glycans cooperate together to destabilize the open state of the Kv3.1 channel near the 
resting membrane potential. For instance, it may be that attachment of sialylated N-
glycans to both positions 220 and 229 are required for the correct placement and 
orientation of the first extracellular loop in the plasma membrane to favor the various 
conformational states of the glycosylated Kv3.1 channel. 
 To date, studies relating the activation kinetics of the Kv3.1 channel to cell-
specific N-glycosylation processing are absent. The wild type Kv3.1 protein is associated 
with simple type N- glycans when heterologously expressed in Sf9 cells (35) while it is 
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associated with atypical sialylated N-glycans when heterologously expressed in B35 cells 
(152). The activation rates for both inactivating current and noninactivating current types 
of the wild type Kv3.1 channel in infected Sf9 cells (35) were much slower than those of 
the wild type Kv3.1 channel in B35 cells. Additionally, when comparing the ratio of the 
rise times at +40 mV of the unglycosylated Kv3.1 channel to that of the glycosylated 
Kv3.1 channel expressed in B35 cells (2.1 for inactivating current type and 2.5 for 
noninactivating current type) and those in Sf9 cells (1.5 for inactivating current type and 
1.4 for noninactivating current type) the ratios were higher for those of B35 cells. These 
results, along with the slightly faster rise time of the Kv3.1 aglycoform expressed in B35 
cells compared to the glycosylated Kv3.1 expressed in Sf9 cells, indicate that the 
sialylated N-glycans attached to the Kv3.1 channel are enhancing the activation rates to a 
greater degree than the simple N-glycans attached to the Kv3.1 channel. Utilization of the 
ratios also eliminates changes of the activation kinetics due to the conserved mutations. 
Next, when comparing the ratio of the rise times at +40 mV for the glycosylated Kv3.1 
channel in Sf9 cells to those in B35 cells (2.5 for inactivating current type and 2.6 for 
noninactivating current type) and the ratio of the unglycosylated Kv3.1 channel in Sf9 
cells to that in B35 cells (1.8 for inactivating current type and 1.5 for noninactivating 
current type) the ratios were higher for the glycosylated Kv3.1 channel than the 
aglycoform. Taken together, these results indicate that the sialoglycoconjugates attached 
to the cell surface have remarkably similar affects on both the wild type Kv3.1 and 
N220Q/N229Q channels, and furthermore support that the type of N-glycan attached to 
the Kv3.1 channel regulates the activation rates. 
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 Both the type of N-glycan and current density are critical factors in the production 
of the subpopulation of Kv3.1 channels with fast activation and inactivation kinetics. 
When the N-glycans of Kv3.1 were of simple type as found in Sf9 cells the current 
density was smaller (35) than when atypical sialylated N-glycans were attached to the 
Kv3.1 channel. Additionally, the number of wild type Kv3.1 transfected B35 cells that 
expressed the noninactivating current type was about 1.4-fold greater than that from wild 
type Kv3.1 infected Sf9 cells (35). Another notable difference was the noninactivating 
currents with transient peaks at +40 mV of the wild type Kv3.1 transfected B35 cells 
were absent in infected Sf9 cells expressing the wild type Kv3.1 channel (35). These 
results indicate that current density and current type of the Kv3.1 channel depends on the 
type of N-glycan carried by the Kv3.1 channel. The production of the subpopulation of 
Kv3.1 channels with fast activation and inactivation kinetics was undetected in infected 
Sf9 cells and was only observed in transfected B35 cells when the current density was 
quite large. For instance, the current density of the fast form of the wild type Kv3.1 
channel was about 2.7-fold greater than that of the slow form. Additionally, the 
noninactivating current type which has the larger current density was needed to generate 
the fast activation and inactivation kinetics of the Kv3.1 channel for partially 
glycosylated Kv3.1 channels. Taken together, these results indicated that neuronal N-
glycosylation processing is essential in generating the Kv3.1 channel with fast activation 
and inactivation rates. 
Here several subpopulations of the wild Kv3.1 channels expressed in transfected 
B35 cells have been identified. The glycosylated Kv3.1 channel could produce a 
  
173
 
predominant subpopulation with fast activation and inactivation rates for 35% of the cells 
expressing the inactivating current type. This subpopulation was undetected for the 
inactivating currents of the aglycoform and partially glycosylated Kv3.1 channels in B35 
cells, as well as wild type and glycosylation mutant Kv3.1 channels in Sf9 cells (35). The 
noninactivating current type of the glycosylated and partially glycosylated Kv3.1 
channels revealed a subpopulation with fast activation and slow inactivation. Of note, the 
subpopulation with fast activation and inactivation kinetics were unobserved for the 
inactivating current type produced by Kv3.1 channels with simple type N- glycans (35). 
However, a subpopulation with faster activation rates was suggested by the 
noninactivating current type. Taken together, the results indicate that the attachment of 
atypical sialylated N-glycans to the Kv3.1 protein changes the equilibrium of the various 
subpopulations of Kv3.1 channels in B35 cells, and consequently increases the 
subpopulations of Kv3.1 channels with fast activation rates. 
In conclusion, this study indicates that the attachment of atypical sialylated N-
glycans to positions: 220 and 229 of the Kv3.1 channel is essential for stabilizing the 
open state distal from the resting membrane potential. The atypical sialylated N-glycans 
were shown to be critical structural determinants in modulating the activation and 
inactivation rates of the Kv3.1 channel, and therefore the N-glycans were assigned a 
novel functional role in regulating the transitions of the channel. As mentioned, our 
results support that the production of the subpopulations of Kv3.1 channels were 
dependent on both N-glycan type and high current density. Additionally, earlier studies 
have indicated that sequestration of Kv channels in high density clusters at synapses is 
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responsible for effective synaptic signaling (30). We propose that neuronal N-
glycosylation processing of the Kv3.1 channel, as well as other glycosylated ion 
channels, provides a novel and vital cellular mechanism for sequestering ion channels in 
high density clusters, and thus in regulating the independent structural and functional 
plasticity of individual synapses. 
CHAPTER 8 - SUMMARY 
 The primary research goal of this dissertation was to characterize the N-glycan 
structures of Kv3 and Kv1 glycoproteins in rat brain, as well as to determine how 
neuronal N-glycosylation processing regulates Kv3.1 voltage-gated K+ channel function. 
In the pursuit of this research goal, the following four specific aims were devised for this 
investigation: 1) to demonstrate that both absolutely conserved N-glycosylation sites of 
Kv3.1, Kv3.3, and Kv3.4 channels are occupied by complex oligosaccharides in rat brain, 
2) to demonstrate that sialylated N-glycan structures attached to Kv3.1, Kv3.3, and Kv3.4 
channels are different throughout the central nervous system of the adult rat, 3) to 
determine the different linkages of sialyl residues associated with N-glycans attached to 
Kv3.1, 3.3, 3.4, 1.1, 1.2, and 1.4 channels in rat brain, as well as a rat neuroblastoma cell 
line and 4) to determine whether atypical sialylated N-glycans associated with the Kv3.1 
protein modulate channel activity. Collectively these specific aims are critical to 
understanding how N-glycan processing of K+ channels influences the firing patterns and 
the duration of action potentials in neurons, as well as regulates cell volume, lymphocyte 
differentiation and cell proliferation.   
 The impetus for the present investigation was an observation which was made 
during a previous study in our laboratory upon treatment of rat brain membranes with 
PNGase F (35). In this study, it was shown that the Kv3.1 channel protein was N-
glycosylated in rat brain, and the N-linked oligosaccharides were of either hybrid or 
complex type in composition, unlike the simple type detected for Kv3.1 in Sf9 cells (35). 
Additionally, it was demonstrated that the Kv3.1 protein heterologously expressed in Sf9 
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cells had both absolutely conserved sites of N-glycosylation utilized. Based on these 
earlier observations, Specific Aim 1 of this present investigation was designed to 
ascertain whether the Kv3.3 and Kv3.4 channel proteins derived from rat brain were N-
glycosylated, like the Kv3.1 channel protein. Furthermore, occupancy of both absolutely 
conserved N-glycosylation sites of the Kv3.1, Kv3.3, and Kv3.4 channel proteins, as well 
as the type of attached N-glycans, were also examined in the adult rat brain. 
  The results in Specific Aim 1 (chapter 4) demonstrated that the Kv3.1, Kv3.3, and 
Kv3.4 channel proteins were N-glycosylated in the adult rat brain, and that both 
absolutely conserved glycosylation sites were completely utilized. The results also 
demonstrated that at least one N-linked oligosaccharide was of complex type for Kv3.1, 
Kv3.3, and Kv3.4. In these studies, the demonstration that both absolutely conserved N-
glycosylation sites were fully occupied and processed for Kv3.1, Kv3.3, and Kv3.4 
proteins provided strong evidence that the S1-S2 linker of these Kv3 channel proteins 
was topologically extracellular. Furthermore, this finding was also in agreement with 
utilization of the native N-glycosylation site in the S1-S2 linker of other Kv channels 
such as Kv1.1 (129), Kv1.2 (123), Kv1.4 (86) and Kv1.5 (130). However, it was in 
disagreement with the x-ray crystal structure of the bacterial potassium channel KvAP 
which placed the S1-S2 linker for all Kv channels in the plasma membrane (131). As 
previously mentioned (Chapter 4, Discussion), this structural difference could be due to 
differences between bacterial Kv channels and eukaryotic Kv channels. Occupancy of 
both absolutely conserved N-glycosylation sites of the Kv 3.1, Kv3.3 and Kv3.4 channels 
  
177
 
in the rat brain also allows us to speculate that occupancy of these channels would be 
lower in CDG I patients than normal individuals.  
 Given the above observation that both absolutely conserved N-glycosylation sites 
within the S1-S2 extracytoplasmic loop of Kv3.1, Kv3.3, and Kv3.4 channels were 
occupied in rat brain and that at least one oligosaccharide was of complex type, 
additional studies were needed to determine whether the N-glycans of these channels 
were composed of sialyl residues. Further studies were also needed to establish whether 
the structural composition of the N-glycans attached to the Kv3.1, Kv3.3, and Kv3.4 
glycoproteins were distinct in the various regions of the adult rat brain. As demonstrated 
in Specific Aim 2 (chapter 5) the Kv3.1, Kv3.3, and Kv3.4 glycoproteins expressed in 
brain were of different sizes and their N-glycans were terminated with at least several 
sialyl residues. It was also demonstrated that the Kv3.1, Kv3.3, and Kv3.4 glycoproteins 
were expressed in the hypothalamus, thalamus, cerebellum, cerebral cortex, hippocampus 
and spinal cord of the adult rat. Our studies also provided the first evidence that each of 
the Kv3.1, Kv3.3, and Kv3.4 glycoproteins were expressed as different glycoforms in the 
central nervous system of the adult rat. Additionally, we observed that the N-glycans of 
the differentially expressed Kv3 glycoforms were sialylated in all six regions of the 
central nervous system. Taken together, these studies demonstrated that cell specific N-
glycosylation of Kv3 channels occurs throughout the central nervous system, and 
therefore is essential for carrying out physiological responses. 
 Additionally, it was observed that protein expression levels for Kv3.1 and Kv3.3 
were similar with the highest levels observed in the cerebellum, while the lowest levels 
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were observed in the thalamus and hypothalamus. However, Kv3.3 protein levels were 
higher in the spinal cord than both the cerebral cortex and hippocampus, while those for 
Kv3.1 were quite similar to each other. The Kv3.4 protein levels in both the cerebellum 
and hippocampus were the highest, while the cerebral cortex, thalamus, hypothalamus 
and spinal cord expressed lower levels. These results differed from those previously 
reported for the Kv3.1 protein expression levels (38,39), as well as the Kv3.1 (22,32,36), 
Kv3.3 (38) and Kv3.4 (22) transcript levels.  
   In Specific Aim 2, we demonstrated that the N-glycan structures attached to 
brain Kv3 glycoproteins were heavily sialylated. Our laboratory expanded upon these 
findings in Specific Aim 3 (chapter 5) by further evaluating the sialic acid linkages of the 
Kv3 glycoproteins in rat brain, as well as in transfected B35 neuroblastoma cells. 
Previous studies have demonstrated that brain Kv1.1, Kv1.2, and Kv1.4 glycoproteins 
(16,58-60) contain sialylated N-glycan structures. Therefore, it was of further interest to 
our laboratory to characterize the sialyl linkages of these carbohydrate chains in Specific 
Aim 3 as well.  
 Examination of these sialylated N-glycan structures revealed that the N-glycan 
chains of brain Kv3.1, Kv3.3, Kv3.4, Kv1.1, Kv1.2 and Kv1.4 glycoproteins were 
terminated with atypical disialyl units. As stated previously less than 10% of sialylated 
glycoproteins in the adult rat brain contain disialyl units (70). These same studies also 
demonstrated that brain Kv3.1, Kv3.3, and Kv3.4 glycoproteins, like Kv3.1 
heterologously expressed in B35 cells, have at least one of their carbohydrate chains 
terminated with an oligo/polysialyl unit. Notably, this is the first time that di/oligosialyl 
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units have been shown to be associated with voltage-gated K+ channels. The biological 
importance of atypical di/oligosialyl units of glycoproteins is unknown. However, the 
identification of two classes of voltage gated potassium channels with di/oligosialyl units 
is the initial step in determining the biological roles of these atypical types of N-glycans. 
We speculate that perhaps di/oligosialyl units are involved in cell adhesion, 
differentiation and signal transduction, similar to gangliosides (88).  
 Additionally, sialyl residues were shown to be linked to internal residues of the 
carbohydrate chains of the Kv1.1, Kv1.2, and Kv1.4 N-glycans. This unique N-glycan 
modification of branched sialyl residues was also identified for the Kv3.1, Kv3.3, Kv3.4, 
and N-CAM glycoproteins. Prior to this investigation, this unusual glycosidic bond for 
sialyl residues had only been identified in gangliosides (103,104) and not carbohydrate 
chains of N-glycans. Overall, we conclude that all six Kv channels contribute to the 
sialylated N-glycan pool in mammalian brain. We speculate that these novel sialylated N-
glycans of the Kv3 and Kv1 channels are important modifications in regulating channel 
function and are responsible for fine tuning the excitable properties of neurons in the 
nervous system. Additionally, the sialylated N-glycans of the Kv3 and Kv1 proteins may 
also play an important role in channel expression at the cell surface of either axonal or 
somatodendritic compartments of neurons. 
 As described in the text above Specific Aim 3 demonstrated that the Kv3.1 
channel heterologously expressed in B35 cells generated a Kv3.1 glycoprotein with 
atypical sialylated N-glycan structures. To our knowledge the effect of neuronal N-
glycosylation processing on Kv3.1 channel activity had not been evaluated in this same 
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expression system and therefore, laid the scientific ground work for Specific Aim 4 
(chapter 7). In this Specific Aim immunoblots of B35 cells heterologously expressing 
glycosylated (wild type), unglycosylated (N220Q/N229Q) and partially glycosylated 
(N220Q and N229Q) Kv3.1 channels were utilized to examine site occupancy. These 
western blotting studies of the various Kv3.1 proteins in B35 cells demonstrated that 
occupancy of each of the N-glycosylation sites was independent of one another. 
Moreover, these studies demonstrated that the removal of one or both N-glycosylation 
sites did not greatly influence Kv3.1 protein expression in B35 cells indicating that Kv3.1 
protein can properly fold without the attachment of N-glycans. Immunoband shift assays 
of partially glycosylated Kv3.1 proteins digested with neuraminidase also indicated that 
both N-glycosylation sites were occupied by sialylated N-glycans. Finally, immunoblots 
confirmed that endogenous Kv3.1, Kv3.3, and Kv3.4 glycoprotein expression was below 
detection limits in nontransfected B35 cells, nor were endogenous Kv3.3 and Kv3.4 
glycoproteins found to form heteromultimers with the heterologously expressed Kv3.1 
glycoprotein. 
 In order to examine whether the attachment of uncommon sialylated N-glycan 
structures affected Kv3.1 channel activity, whole cell current measurements were 
performed in the whole cell mode of the patch clamp technique. An analysis of whole cell 
currents identified at least three subpopulations of Kv3.1 channels expressed in B35 
which were dependent on N-glycosylation processing. The wild type Kv3.1 channels 
associated with atypical sialylated N-glycans favored the subpopulation which exhibited 
fast activation and inactivation rates with much greater frequency than those Kv3.1 
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channels which lacked N-glycans. The partially glycosylated Kv3.1 channels, like the 
aglycoform, also lacked the subpopulation with fast activation and inactivation rates for 
the inactivating current type. However, this subpopulation could be favored by the 
partially glycosylated Kv3.1 channels, like the glycosylated Kv3.1 channel, when the 
current density was large, and the current type was noninactivating. It was also observed 
that the predominant current type for the wild type Kv3.1 and N229Q channels were 
noninactivating currents while inactivating currents were the predominant type for the 
unglycosylated and N220Q channels. Additionally, the noninactivating currents of the 
wild type and the partially glycosylated Kv3.1 channels customarily displayed transient 
peaks at the initial phase of the sweep while the unglycosylated Kv3.1 channels were 
generally deficient. These results suggest that the noninactivating current types with 
transient peaks express a subpopulation of glycosylated or partially glycosylated Kv3.1 
channels which have faster or fast inactivation kinetic properties respectively. 
 In order to analyze the voltage dependence of wild type Kv3.1 and 
N220Q/N229Q channel activation membrane conductance vs. voltage curves were 
constructed. These curves showed that more depolarization was required for 50% of the 
wild type channels to reach activation than that of the aglycoform channels. Therefore, 
these results argue against the voltage sensor detecting the sialylated N-glycans of the 
wild type Kv3.1 channels. Moreover, less depolarization was required for 50% of the 
N220Q channels to reach activation than that of the N229Q channels. These studies also 
demonstrated that channel density at the B35 cell surface for the unglycosylated channel 
was greatly reduced compared to the wild type Kv3.1 channel for both inactivating and 
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noninactivating currents. The current densities, for all current types of the N220Q 
channel were also significantly smaller than that of the N229Q channel. Furthermore, the 
activation rates for the wild type Kv3.1 channels were faster compared to the 
unglycosylated channels. An analysis of the deactivation kinetics showed that the 
magnitude of the deactivation constant was greater for the wild type Kv3.1 channel than 
the N220Q/N229Q channel, while the deactivation time constants for the N220Q channel 
and the N229Q channel were not significantly different. Taken together, these studies 
support that neuronal N-glycosylation processing of the Kv3.1 protein is critical in 
regulating the equilibrium of the various subpopulations of Kv3.1 channels. And in 
particular can favor the subpopulation of Kv3.1 channels with fast activation and 
inactivation kinetics. We propose that cell-specific N-glycosylation processing of 
glycosylated channels provides a universal cellular mechanism for regulating ion channel 
function. 
 
Conclusion 
 The novel findings of the above studies have provided substantial insight 
regarding the structures of the N-glycans attached to rat brain Kv3 and Kv1 
glycoproteins. Based on these findings we have proposed the following topological 
model for the Kv3 and Kv1 monomeric α-subunits within the lipid bilayer. As illustrated 
in Figure 14, Kv3 (A) and Kv1 (B) α-subunits consist of six transmembrane segments 
(S1-S6) with both N and C termini localized in the cytoplasm. One or two utilized N-
glycosylation sites lie within the S1-S2 extracytoplasmic loop of the Kv1 and Kv3 
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glycoproteins, respectively. The occupied N-glycans (branched structures) of the Kv3 
brain glycoproteins were capped with monosialyl residues (single dark gray circles) and 
disialyl units (rows with one dark gray and one light gray circle). Moreover, at least one 
antenna was terminated with an oligo/polysialyl unit (row of light gray circles). In 
contrast, brain Kv1 glycoproteins were capped with disialyl units (rows with one dark 
gray and one light gray circle). Both brain Kv1 and Kv3 glycoproteins also contained 
sialyl residues linked to internal residues of the carbohydrate chains (white filled circles). 
 This investigation has provided the first evidence in the scientific literature that 
two distinct voltage-gated potassium channel families, Kv3 and Kv1, which are highly 
expressed in mammalian brain, contain atypical sialylated N-glycan structures. 
Additionally, these same studies have also demonstrated that the attachment of unique 
sialylated N-glycans structures to the Kv3.1 glycoprotein are crucial components in 
regulating channel activation and inactivation rates. To date, only a small number of 
glycoproteins are known to be carriers of oligo/polysialic acid chains in the adult 
mammalian brain (70,88,98). Furthermore, information on the cellular roles of these 
uncommon sialoglycoconjugates is sparse. The identification of six Kv brain 
glycoproteins with di/oligosialyl units in this dissertation is the initial step in elucidating 
the roles of these uncommon sialoglycoconjugates. Based on the data presented in this 
dissertation, we propose that occupancy of Kv3 channel N-glycosylation sites by these 
uncommon sialoglycoconjugates assists in regulating action potential waveforms by 
influencing the rates of repolarization. An understanding of the physiological roles of 
these atypical sialylated N-glycans on channel activities of the Kv3 glycoproteins is 
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essential for unraveling the complex electrical properties of neurons in maintaining the 
central nervous system. Furthermore, these studies may be essential in laying the 
foundation for utilizing occupancy of N-glycosylation sites by atypical 
sialoglycoconjugates for designing effective therapeutic agents, as well as providing a 
diagnostic marker for neurodegenerative diseases. 
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